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1GENErAL INTrODUCTIONTattoos: definition, usage and incidence
Body art involves decorating the skin of the human body. Forms of body art include 
tattoos, piercings, scarification, subdermal implants (also called beadings or boegroes), 
shaping, body painting, tongue splitting or elf ears. Tattoos are one of the most popular 
forms of body art. It is defined as creating a permanent design by placing exogenous 
pigment particles and additives into the dermis.1 The demand, and sometimes need for 
tattoos should not be underestimated. In the last decades, tattoos have become more 
popular. In Europe and the USA the overall prevalence of tattoos in the population is 
around 10-20% and rising.2-10 The percentage of tattooed Europeans increased from 5-10% 
in 2003 to 12% in 2016.11 Also, in the USA, an increase of tattooing is reported. Data 
from the Harris Poll survey from 2003 showed that 16% of the Americans was tattooed; 
in 2015 this percentage rose to 29%.12 In the Netherlands, 8-12% of the population 
older than 12 years has a tattoo.13 In the past, tattoos were associated with sailors, 
criminals, soldiers and prostitutes. Also, tattooing was more prevalent among men. 
However, this all has changed over the last decades. Nowadays, in the Netherlands and 
several other countries, women (60%) are more frequently tattooed than men (40%).13 
Furthermore, the uses of tattoos are broadened, for example permanent makeup: tattooing 
of the eyeliner, lips, lipliner or eyebrows. Tattoos are not only used for decorative reasons, 
but also for several medical purposes: nipple areola tattooing after breast cancer surgery, 
radiology markings, camouflage of scars or even medical marking of colon- or oral mucosa.
In general, tattooing is considered to be safe. However, different complications can 
occur. The exact incidence of tattoo complications is unknown. Furthermore, despite 
its popularity, little is known about the clinical spectrum, pathogenesis and treatment 
of dermatological and systemic tattoo complications. Nonetheless, it is important for 
clinicians to timely identify and treat these complications. The literature consists of only 
few original studies regarding tattoo complications of which most are case-reports and 
case-series. Moreover, in the last decades there has been changes in the composition 
of the inks as well as a great shift in the international tattoo industry. Inorganic tattoo 
pigments, such as heavy metals, have been widely replaced by organic pigments such 
as azo pigments. The results of the shift in tattoo inks regarding tattoo complications is 
unknown.14,15 Currently, safety of tattoos and permanent make-up is discussed in the EU, 
mainly focused on content analysis of tattoo inks.16-19 However little research has been 
performed about the impact, nature and number of complications that occur associated 
with tattooing. Also, permanent makeup is an upcoming form of tattooing of the last 
decade and its popularity is increasing. As the type of use of tattooing has broadened 
and new tattoo inks have been introduced, new complications may occur. Therefore, it is 
important that research on tattoo complications is performed to assess the risk of these 




Because of its enormous popularity, worldwide use and potential serious 
complications, this thesis is relevant for many healthcare workers and all people involved 
in the tattoo industry: dermatologists, general practitioners, internists, pulmonologists, 
ophthalmologists, cosmetic doctors, tattoo artists, beauticians, tattoo ink producers, 
regulatory authorities and policymakers. Furthermore, tattoo clients should be well 
informed about the possible adverse events that can occur during and after tattooing. 
In the past, medical research on tattoos was underexposed. Hopefully, this thesis will 
trigger more research.
Tattoo adverse events
An adverse reaction may occur due to the tattooing procedure itself and/or subsequent 
application of aftercare products. Numerous articles report the wide spectrum of adverse 
reactions related to tattooing, ranging from superficial infections, allergic reactions, 
vasculitis and sarcoidosis. These reactions have a different time of onset of symptoms, 
appearing immediately after placement of the tattoo until several years later. This 
introduction will focus on cutaneous adverse reactions of tattoos. Systemic, temporary 
(henna), psychosocial and complications due to removal of tattoos will not be discussed 
in this chapter.
SYMPTOMS 
Cutaneous adverse reactions to tattoos can be roughly divided into four categories: 
infections, inflammatory reactions, miscellaneous complications and seldomly reported 
neoplasms. An overview of the dermatoses is listed in table 1. The most frequently 
reported dermatoses will be discussed.
Reported complaints related to previously mentioned categories of adverse reactions 
vary from local itch and pain to skin elevation and burning sensations at distinct sites. 
Reliable incidence rates of adverse reactions are missing. Kazandjieva et al. 
reported several long-term adverse reactions such as infections in 5 out of 234 patients 
(2.1%). 20 However in self-reported questionnaires physical complaints are reported more 
often. This may implicate that many persons who have gotten a tattoo do not seek for 
medical advice regarding adverse reactions to tattoos.  An internet survey, performed in 
German-speaking countries, reported skin problems in 67% of the 3411 collected reports 
that had occurred within a few weeks after tattooing. Furthermore, 6 percent reported 
persistent skin problems in the tattooed area.21 Another study performed in 154 Danish 
individuals who attended a clinic of venereology, reported reactions secondary to tattooing 
in 27% of the individuals. Complaints were mainly minor, varying from skin elevation to 
itching.22 The ‘beach study’, performed in 144 sunbathers (individuals sunbathing from 
June to September 2011 at the beaches of Denmark) with in total 301 tattoos, reported 
adverse reactions such as swelling, itching, pain and redness in 42% of the individuals.23 

















































































































































































































































































































































































































































































































































































































































































































































































































were sun related. A cross-sectional survey in 38 American states found that among the 501 
participants, 3.2% stated to have a history of a tattoo infection. In tattoos of at least one 
month old, pruritus and pain occurred in 22.6% and 3.8% respectively.24 The Dutch Food 
and Drug Administration (‘Nederlandse Voedsel en Warenautoriteit’, NVWA) performed 
an analysis on tattooed individuals above the age of 12 years old in the Netherlands. 
Three percent reported inflammation, bleeding or allergic reactions related to tattooing.13 
In a survey of 300 randomly selected tattooed people in New York City, 10.3% reported 
experiencing an adverse tattoo reaction.25
Taken together, many articles report on various adverse reactions due to tattooing and 
show that symptoms such as itching and morphological changes such as skin thickening are 
remarkably common. However, incidence rates of these adverse reactions vary. It should 
be noted that all above-mentioned data are self-reported and do not include a confirmed 
clinical diagnosis. 
INFECTIONS
Tattooing is a technique to penetrate the skin barrier for the intended deposition of 
coloured materials. This procedure bears the intrinsic risk of causing an infection. Hygiene 
regulations have been tightened in the past and since then incidences have dropped. 
However even with appropriate precautions microbial contamination after tattooing may 
still occur. The risk of infection depends on several determinants: the skin condition under 
which the tattoo has been placed, proper sterilization of equipment, contamination of ink, 
disinfection of the skin and proper aftercare. For instance, a Danish study showed that 
already 10% of the unopened tattoo ink stock bottles in Denmark were contaminated with 
a variety of bacteria. Among them were pathogenic as well as non-pathogenic bacteria. 
Furthermore, 28% of the analysed stock bottles were inadequately sealed.26 The Dutch 
NVWA has performed microbiological research on unopened ink stock bottles between 
2008 and 2013. Remarkably in 2009 and 2010 they have noticed a substantial number 
of contaminated samples. Respectively 15% and 8% of the samples were polluted with 
microorganisms. All contaminated samples were produced by one manufacturer. In 
the subsequent years, the number of contaminated samples decreased to 1 to 3%.27 
Despite hygiene legislation infections are still thought to be the most frequent 
complication. Also, as the incidence of tattooing and worldwide travelling is increasing, 
a new assessment of the number and type of tattoo infections is needed.
Bacterial infections
Although no exact incidence rates are available, the most frequent clinical infections are 
impetigo and folliculitis (fig. 1). For these superficial infections Staphylococcus aureus, 
Streptococcus pyogenes, Clostridium difficile and Pseudomonas aeruginosa are the most 
important culprits. Furthermore, infections involving the inner layers of the skin, like cellulitis 




local pain, erythema and swelling, but also fever and purulence. Cellulitis or erysipelas 
should not be confused with temporary tattoo-induced oedema. This transient oedema is 
induced by the tattooing procedure, especially when applied to the lower extremities. This 
reaction is frequent and may occur in any individual.29 Most bacterial infections are easily 
treatable and treatment is regularly not different from that of any other bacterial infection. 
However, various pathogens can be more difficult to treat. For instance, an outbreak of 
tattoo infections with methicillin-resistant Staphylococcus aureus (MRSA) was observed in 
three American states.30
In the last decades one case of secondary syphilis occurring within a tattoo has been 
described. In the 19th century syphilis was more commonly described. Back in those days, 
tattoo artists would moisten the needle with saliva or use non-sterile or used needles.  This 
could result in tattooist contaminating the patient with Treponema pallidum.31 






During the last years, several tattoo related outbreaks of Mycobacterium chelonae have 
been reported in the literature. This occurs, in particular when grey ink is prepared by 
dilution of black ink with water. If the water is contaminated by Mycobacterium chelonae, 
a typical bacterium in non-sterile water, this microbe can cause infection. Less commonly, 
Mycobacterium haemophilum, Mycobacterium abscessus, Mycobacterium immunogenum, 
Mycobacterium massiliense and Mycobacterium fortuitum cause tattoo related skin 
infections.32,33 Interestingly, mycobacterial infections appear more frequently in the grey or 
black areas of a tattoo. Clinical symptoms include papules, pustules or ulcerating nodules, 
which are typically confined to the tattooed area.34    
Primary cutaneous tuberculosis can occur following tattooing.20 This occurs after 
inoculation with Mycobacterium tuberculosis or Mycobacterium bovis in individuals who 
have not previously acquired immunity. Within 2-4 weeks an erythematous papule or 
nodule arises, progressing to a superficial ulcer (tuberculous chancre). Often, painless 
regional lymphadenopathy occurs within 3 to 8 weeks. If the patient’s immune system 
is compromised, progression to lupus vulgaris and tuberculosis cutis verrucosis or even 
hematogenous spread may occur.35 Histologically, epithelioid histiocytes, Langerhans 
giant cells and tuberculoid granulomas with or without central caseous necrosis can be 
found. A positive tuberculin test is of great diagnostic value for primary tuberculosis. 
Reports of tattoo inoculation with Mycobacterium leprae are mainly described in 
areas where leprosy is endemic and unhygienic tattooing is common.36 Leprosy skin 
lesions may manifest decades after inoculation. Clinical presentation mainly depends on 
the immunologic status of the host. 
If a mycobacterial infection is clinically suspected, a biopsy, tissue culture and PCR 
for mycobacterium species should be performed. Histologically, these reactions are 
characterized by suppurative granuloma formation with polymorphonuclear leukocytes.





Serious viral infections, like HIV, hepatitis B (HBV) and hepatitis C (HCV), have been 
reported to be transmitted through tattooing. However, in almost all reports the tattoo was 
performed in a non-professional setting. Under present hygiene legislation and performed 
by professional tattoo artists, transmission of the above-mentioned viral infections is 
unlikely. Moreover, a substantial number of patients carrying HIV, HBV or HCV, are exposed 
to other possible modes of transmission like drug use by injections. Nonetheless, for this 
reason, in the Netherlands, those who have set a tattoo are prohibited to donate their 
blood for 6 months after placement of the tattoo. This can last up to 12 months depending 
on local regulations. 19,37
Isolated reports on the presence of human papilloma virus (HPV), herpes simplex virus 
(HSV) and mollusca contagiosa (MCV) have been described in tattoos.19 This infection 
can either be transmitted by tattooing or re-activated from an already present indolent 
virus. The incubation period is usually weeks to months. In one case, a 32-year old 
patient developed HPV lesions exclusively within the tattoo lines after a latency period 
of 2.5 years.38 The triggering factor was a recent sunburn, suggesting that ultraviolet(UV)-
radiation could induce immunosuppression and trigger re-activation of HPV.  When 
multiple viral lesions spontaneously occur within a tattoo, it may be the reason to test for 
underlying immunodeficiencies. 
Fungal infections
Fungal infections after tattooing are rare. However anecdotal cases of infection with 
dermatophytes, aspergillus fumigatus, sporotrichosis, zygomycosis or Acremonium fungi 
have been described. Fungal infections should be considered whenever cutaneous 
complications exacerbate while using topical corticosteroids. 31,39. 
Parasitic infections
Cutaneous leishmaniasis arising in tattoos is rarely described with all cases occurring in 
individuals known with visceral leishmaniasis or HIV (which leads to immunosuppression).31 
Re-using needles may be a possible form of transmission. No other parasitic infections in 
tattoos have been reported so far.
INFLAMMATOrY COMPLICATIONS
Allergic reactions to tattoo pigments
Most chronic tattoo reactions are caused by an allergic reaction to tattoo pigments. Allergic 
reactions to tattoo pigments cause chronic itch, pain or swelling, generally confined to one 
tattoo pigment colour.40 The symptoms can cause a reduced quality of life.41 In allergic 
reactions to tattoo pigments, colours red or nuances of red pigments are most frequently 
involved.42 Already in 1927, the first red tattoo reaction was described.43,44 Not only the red 




multiple colours in one tattoo can be affected, most likely caused by one pigment present 
in all tattoo colours.47
The clinical presentation is mainly an elevation confined to the red tattooed skin of 
which the most common one is called the ‘plaque-type’ reaction (fig. 3). 48-50 Other clinical 
varieties include excessive hyperkeratotic, ulcero-necrotic or even generalized reactions.51 
Few clinical studies have been done and the literature mainly consists of case reports and 
case series. In these, a great variety in the time of onset of symptoms is reported: varying 
between several days up to several years after tattooing. Little is known about the natural 
course and eliciting factors.
Histological examination is crucial in the diagnosis of chronic tattoo complications. 
The differential diagnosis includes bacterial or mycobacterial infections and autoimmune 
skin diseases such as sarcoidosis, lichen planus or psoriasis. Also, atopic dermatitis or 
contact dermatitis to aftercare products can occur. However, the exact histopathology of red 
tattoo reactions is not known, and many variations have been described. As in the clinical 
presentation, the literature mainly consists of case-reports and case studies and only few 
studies have been performed.52-54 Obtaining more knowledge about the histopathology 
of red tattoo reactions would therefore be beneficial for diagnostics, but also for revealing 
its aetiology. These reactions are thought to be a delayed allergic reaction, but the exact 
pathomechanism is unknown. Clinical and in vitro research on red tattoos reactions could 
Figure 3. Red and yellow tattoo on the left foot with ‘plaque’ elevation in the red tattooed skin: 




also provide more knowledge in its aetiology. Furthermore, although thought to be an 
allergic reaction, the causative allergen is still unknown. In the past, mercury was thought 
to be the causative allergen. However, in the last decades there has been changes in 
the composition of the inks as well as a great shift in the international tattoo industry: 
inorganic tattoo pigments (such as heavy metals) have been widely replaced by organic 
pigments (such as azo pigments).14,15 Still, red tattoo reactions seem to be the most 
frequent chronic tattoo reactions. Though tattoo ink may still contain heavy metals, be it 
as chromophores, shading additives or contaminants. Nevertheless, mercury is no longer 
thought to be the causative allergen. 
Because of the continuous presence of tattoo pigments in the dermis, these reactions 
are chronic and patients experience persistent and sometimes severe symptoms. Therefore, 
treatment can be challenging. The therapeutic options mainly include anti-inflammatory 
therapy such as topical and intralesional corticosteroid administration, surgical excision, 
dermatome shaving and ablative laser treatment. Only few studies have been performed 
and most scientific literature consists of cases and case-series.53,55,56 Consequently, there 
is a need for further research to acquire more knowledge about appropriate treatment 
modalities. Also, objective outcomes should be used for follow-up of treatment effect, 
for example by measuring the volume of a ‘plaque-like’ red tattoo reaction before and 
after treatment. 
Allergic reactions to tattoo (after) care
Not only tattoo pigments can cause allergic reactions, the tattooing procedure itself or 
the tattoo aftercare bare several health risks. For example, during tattooing a severe 
type I allergic reaction to latex has been reported, caused by the latex gloves worn by 
the tattoo artist.57 Also, topical products used in the aftercare of tattooing may cause 
contact dermatitis.58 In these products frequently potential allergens are used such as 
fragrance, panthenol and wool alcohols.
Autoimmune skin diseases
Individuals with chronic autoimmune skin disease, such as psoriasis, vitiligo, granuloma 
annulare, lichen planus, lichen sclerosus, pyoderma gangrenosum, lupus erythematodes, 
morphea, M. Darier, and sarcoidosis have a risk of localization of the skin disease in 
a tattoo (fig. 4).1,31 These skin diseases have in common that a local skin injury can lead 
to the appearance of the disease. This is called the Koebner phenomenon. The Koebner 
phenomenon was first described in 1876 by Heinrich Koebner who discovered the formation 
of psoriasiform lesions in, notably, a recently placed tattoo in a psoriatic patient.59 
Individuals with the above-mentioned skin diseases should be warned of the potential 
risk of localization of the disease in a tattoo, especially if the dermatosis is active. Of 





Clinical characteristics are identical to those in non-tattooed skin, however physical 
examination may be hampered due to the ink. Usually symptoms of auto-immune skin 
diseases develop within a few weeks after tattooing. However, the literature shows 
a high variation in time interval between tattooing and onset of symptoms. Horner et 
al. described a patient with new-onset psoriasis guttata in a tattoo 7 months after its 
placement, suggesting an older skin trauma may also elicit an isomorphic inflammatory 
response (Koebner phenomenon).60
As the popularity and demand for tattoos is rising, more patients with auto-immune (skin)
diseases want a tattoo. However, little is known about the specific risks these patients have 
when getting tattooed. There may be a local flare-up in the tattoo due to Koebnerization 
or a higher chance of getting a secondary infection due to immunosuppressive medication. 
New studies in autoimmune patients are needed to determine these risks. Also, for 
clinicians, it is important to recognize auto-immune skin diseases in tattoos as there may 
be systemic involvement, for example in lupus erythematosus and sarcoidosis. 
Inflammatory chronic black tattoo reaction (papulo-nodular reactions)
Because black ink is most frequently used in tattooing, chronic inflammatory non-
allergic black tattoo reactions account for a significant part of all tattoo complications. 
Its clinical presentation mainly includes papules and nodules in the black tattooed skin 
(fig. 5). Sepehri et al. observed this association between black pigment and the papulo-
nodular type of tattoo reactions.61 Sarcoidosis is clinically expected to be nodular and it is 
known that reactions in black tattoos can be a manifestation of (systemic) sarcoidosis and 
can even be its first. In the study of Sepehri et al. 29% of the papulo-nodular reactions 
Figure 4. Sharply defined squamous plaques within and around tattoos: psoriasis Koebner 




were diagnosed as cutaneous or systemic sarcoidosis. The authors therefore state that 
a papulo-nodular tattoo reaction should be seen as a clue to the diagnosis of sarcoidosis. 
The majority of these black tattoo reactions were however non-sarcoidosis and their exact 
pathomechanism remains unknown. In a similar study, pigment overload was noted in 42% 
of papulo-nodular reactions, suggesting that repeatedly introducing foreign material in 
the skin may trigger local auto-immunity. Furthermore, they observed a new phenomenon, 
called the rush phenomenon. It is the abrupt and widespread reaction of other black tattoos, 
triggered by a recent placed tattoo with a papulo-nodular reaction. This phenomenon was 
observed in 70% of the sarcoidosis group and 28% of the non-sarcoidosis group, which 
may indicate an even stronger association with sarcoidosis. 
As this is one of the few studies in chronic black tattoo reactions, the results need to be 
confirmed by other studies. This should be done not only for regular decorative tattoos, 
but also for permanent makeup, as this a is a growing trend of tattooing in the last decade. 
However, little is known about its complications, clinical presentation, relation to systemic 
autoimmune diseases, aetiology and treatment methods. 
Vasculitis
Isolated cases of localized cutaneous vasculitis have been reported. They occurred shortly 
after tattooing, however their true relationship remains unknown. In clinical care, additional 
investigations are required to exclude other causes of vasculitis, such as infection, drug 
reactions, malignancy or systemic diseases.62
Figure 5. A papulo-nodular non-sarcoïd reaction: nodules in a black tattoo on trunk and extremities.
CHAPTER 1
22
1 HISTOLOGICAL CLASSIFICATION OF INFLAMMATOrY COMPLICATIONS: 
LICHENOID, PSEUDOLYMPHOMATOUS AND 
GrANULOMATOUS rEACTIONS
A clear classification of inflammatory adverse reactions according to the clinical 
appearance and histopathological patterns remains challenging. The current literature 
describes various patterns of adverse reactions to tattoos either histologically or clinically. 
Some studies report histological diagnoses including lichenoid, granulomatous and 
pseudolymphomatous and less frequently spongiotic reactions, however a clear definite 
diagnosis is frequently missing. The situation is further complicated as one clinical 
pattern can have different histological patterns. Furthermore, it is possible that several 
histopathological pattern can be present in one tattoo complication.
1. Lichenoid reactions
Lichenoid reactions are mainly reported to red ink. Lichenoid reactions can be either caused 
by an allergy or by lichen planus (LP). LP clinically presents with slightly elevated polygonal 
papules and plaques. A local flare of LP is generally due to the Koebner phenomenon 
and therefore not necessarily confined to one colour. However, LP can be clinically and 
histologically indistinguishable from allergic reactions with lichenoid infiltrate. Allergic 
reactions are generally confined to one colour, mainly red. The reason why remains unclear, 
as ink compositions are highly diverse.
Thorough physical examination, i.e. oral and nail examination should be performed 
to rule out LP. Progression of localized lichenoid reaction of the tattooed skin towards 
a generalized lichenoid reaction has also been described in literature.63 In most cases 
the question remains whether the lichenoid reaction is caused by the Koebner phenomenon 
in an (undiagnosed) LP patient or the lichenoid reaction is caused by the tattoo ink in an 
allergic patient, as aetiology remains unknown.
2. Granulomatous reactions
Besides lichenoid reactions, granulomatous reactions also occur frequently. In the literature 
the term ‘granulomatous reaction’ is commonly used as a diagnosis. However, the term is 
solely histological and there are different possible underlying diagnoses. The differential 
diagnosis of non-infectious granulomatous reactions includes allergic reactions, foreign 
body reactions and sarcoidosis. Also, few cases of granulomatous tattoo reactions and 
associated uveitis have been reported. In these cases, chronic inflammation is limited 
to the tattooed skin and eyes and no other features of systemic disease, especially 
sarcoidosis, can be found.64
Differentiation between the above-mentioned conditions is difficult. Allergic reactions 




body reactions often occur in the borders or corners of a tattoo, where the density of 
pigment is higher than in other parts of the tattoo. Tattooing over an existing tattoo, also 
named ‘touch-ups’, are thought to enhance the risk of pigment overload and thereby 
a foreign body reaction. As granulomatous skin reactions may be the initial presentation 
of systemic disease, a comprehensive anamnesis and further investigations (i.e. chest 
x-ray and laboratory tests) for sarcoidosis are recommended. Sarcoidal tattoo reactions 
often present in black tattoos and can present months to years after placement. The exact 
aetiology and pathogenesis of sarcoidosis is unknown.66 Chronic exposure of the immune 
system to the ink may stimulate the development of granulomas and might ultimately 
lead to granulomatous inflammation in an individual who is genetically sensitive to 
the development of sarcoidosis. This would explain the often long latency period between 
the placement of the tattoo and the onset of clinical symptoms.
3. Pseudolymphomatous reactions
Next to lichenoid and granulomatous inflammation, adverse reactions to tattoo pigments 
can also show a pseudolymphomatous inflammation. If the reaction is confined to one 
color, an allergic reaction is more likely. If more tattoo colors are affected, differentiation 
between an allergic reaction and a true pseudolymphoma is difficult. The exact 
pathogenesis of pseudolymphoma is unknown. It is theorized that pigment induces 
chronic inflammation, resulting in polyclonal proliferation of lymphoid B- and T-cells. 
Histologically, these reactions can appear as a cutaneous T- or B-cell lymphoma however 
they are clinically benign. Malignant transformation is likely to be rare. However, one case 
described evolvement into a histologically malignant and immunologically monoclonal 
B-cell large cell lymphoma in a tattoo.67
NEOPLASMS
In the past decades several cases of malignant melanoma (MM), basal-cell carcinoma 
(BCC), squamous-cell carcinoma (SCC) and keratoacanthoma of uncertain malignancy (KA) 
in tattoos have been reported.68,69 Moreover tattoo ink can contain potential carcinogenic 
substances, such as aromatic amines and polycyclic aromatic hydrocarbons.17 This raises 
the question whether there is an association between tattooing and the development 
of neoplasms (fig. 6). Besides MM, BCC, SCC and KA, isolated cases of rare cutaneous 
malignancies, including dermatofibrosarcoma protuberans, cutaneous leiomyosarcoma 
and cutaneous lymphoma, have been reported.  Kluger and Koljonen showed that 
melanoma and BCC are more prevalent on dark coloured tattoos while SCC, KA and 
pseudo-epitheliomatous hyperplasia mainly appeared on red tattoos.70
Carcinogenesis is in general a multifactorial process. Numerous factors have been 
identified to contribute to neoplasms occurring in tattooed areas. Among them are 
the injection of potential carcinogenic substances, trauma induced by the tattooing 




especially genetic predisposition.68 Furthermore a delay in diagnosing can occur. A tattoo 
can mask the appearance of skin lesions and the development of neoplasms, thereby 
complicating thorough clinical evaluation of the skin. This potentially may cause a delay 
in diagnosing. Moreover, tattooing over a nevus might induce a trauma and has been 
thought to induce dysplasia or potentially mask signs of atypical nevi. 
So far, in light of the few reported cases of cutaneous malignancies in tattoos compared 
to all tattooed individuals worldwide, the association has to be interpreted as coincidental. 
However large-scale studies are needed to assess whether tattooing is an independent risk 
factor for cutaneous malignancies. This may be difficult because the long latency period of 
developing cancer would require a big cohort to proof a causal correlation. Considering 
the abovementioned considerations, it is reasonable to refrain from tattooing on nevi. 
Certainly, when it comes to larger or congenital melanocytic nevi.
Benign neoplasms, like dermatofibroma, seborrheic keratosis, epidermal cysts, milia 
and pseudo-epitheliomatous hyperplasia have also been reported. However, cases are 
only rarely published. Histological changes seen in pseudo-epitheliomatous hyperplasia 
are often difficult to distinguish from SCC and KA.70 The number of reported benign 
neoplasm in tattoos is likely to be an underrepresentation. 
MISCELLANEOUS CUTANEOUS COMPLICATIONS
Misapplication, pigment migration and pigment fanning
Other common adverse events in tattoos, frequently causing dissatisfaction, include 
misapplication (form and color), pigment migration, fading or fanning.71,72 These adverse 




events are more frequently seen in permanent make-up and may distort the appearance.  
Pigment migration has also been reported after local injection with anesthetics prior to 
laser tattoo removal. This may be caused by numerous injections in the skin creating 
tunnels in which the ink could spread into the surrounding skin.73
Tattoo blow-out
A tattoo blow-out is rarely described in the literature.74,75 It describes an adverse reaction 
in which the tattoo pigment disperses outside the borders of the original tattoo caused 
by too deeply injected ink into subcutaneous tissue (fig. 7). It may rapidly appear around 
the tattoo after its completion. Likewise, natural aging of a tattoo will result in blurry outer 
lines of the tattoo, however should not be confused with a tattoo blow-out which occurs 
much faster. 31





Hypertrophic scars and keloids
Tattooing could be considered as a massive trauma to the skin which could result in 
hypertrophic scars or keloids, however surprisingly this is rarely reported.76 Nonetheless, 
one of the patients in our clinic was consulted because of keloid on the back of an 
individual who had a multicolored tattoo that was set in Brazil (fig. 8). This patient did not 
have a history of keloid or wound healing disorders. Keloids are more frequent in patients 
with darker skin type and predilection sites include sternum, neck and earlobes.
Neuro-sensory complications
Sometimes patients develop uncomprehended pain or itch in a tattoo. In these cases, 
generally, no clinical or histological abnormalities are found. 
One case of complex regional pain syndrome in an individual with a tattoo on the wrist 
has been reported. Possibly the location of the tattoo in this case is crucial as the cutaneous 
branch of the median nerve is superficial at the wrist. It is presumed that substances of 
the ink affected the C-fibers of the sensory nerves.77 However, coincidence cannot be ruled 
out in these rare cases.




Cutaneous complications during magnetic resonance imaging
Several case reports describe individuals with tattoos or permanent-make up experiencing 
cutaneous reactions after undergoing magnetic resonance imaging (MRI), such as skin 
irritation, swelling and burning.78 Furthermore, tattoos, especially permanent make-up 
containing metallic pigments, may interfere with the quality of MRI and may cause image 
artifacts. There is a tendency for these problems to occur whenever pigments that contain 
magneto-ferrous compounds are used. The exact causative mechanism is unknown. 
However, as symptoms are transient and relatively minor, individuals should not be 
restrained from undergoing MRI. 
Photo-induced reactions
Reactions to ultraviolet(UV)-light are mainly described in tattoos containing cadmium 
sulfide. This metal salt is present in traditional yellow and red pigments. Photo-induced 
reactions to cadmium sulfide manifest as erythematous and edematous lesions. Little is 
known about the exact pathomechanism. These reactions are thought to be photo-toxic 
and should be treated as such.20  
However, tattoo inks and pigments underwent a major change from the use of inorganic 
pigments to organic pigments that are mainly composed out of azo-dyes. Due to the less 
frequent use of cadmium sulfide in tattoo ink, the abovementioned phototoxic reactions 
are expected to occur less frequently nowadays.
Hutton Carlsen and Serup performed a study on the beach, directly interviewing 
sunbathing tattooed individuals. Remarkably, 52% of all surveyed individuals mentioned 
sun as the triggering factor of tattoo irritation. Reactions to sunlight were mainly reported 
in red tattoos and could switch on and off in seconds. The causative mechanism of these 
photo-toxic reaction is thought to be the induction of reactive oxygen species (ROS) due 
to a photochemical reaction to pigment. ROS may interact with DNA, proteins or lipids, 
thereby compromising their normal function and mediate symptoms such as pain, itch or 
even cell death. Preventive measures include covering the tattoos from UV-light or the use 
of sunscreen. 
Incidental cases of granulomatous reactions to ‘invisible’ blacklight or UV-light 
accentuated tattoos have been reported. ‘Invisible’ tattoo ink is composed of substances, 
which fluorescence under the exposure to UV-light. The differential diagnosis of non-
infectious granulomatous reactions consists of allergic reactions, foreign body reactions 
and sarcoidosis, as mentioned above.79,80 Likewise, in our Academic Tattoo Clinic we 
encountered a patient with swelling and pruritis in an ‘invisible’ blacklight tattoo after sun 
exposure. Symptoms resolved after the use of sunscreen and coverage of the affected 
skin area.
In conclusion, this overview illustrates the wide range of morphological changes and 
histological patterns related to cutaneous adverse reactions that may occur after tattooing. 




conditions can occur. Adverse reactions can be divided into four categories: infections, 
inflammatory reactions, neoplasms and miscellaneous complications. It is difficult to 
estimate the true incidence of tattoo related adverse reactions, as no registry is available. 
The classification of the clinical signs and histopathological patterns into all-embracing 
entities is still unclear and challenging. However, this overview gives clinicians tools to 
recognize short- and long-term tattoo adverse reactions. It is important for tattoo artists 
and clients to be well informed about potential complications. More research should be 
performed to classify tattoo reactions, reveal its pathomechanisms and study potential 
treatment options. As the popularity of tattoos is broad and rising, new studies of adverse 
events are important, especially in high-risk groups such as patients with auto-immune 
diseases. This research is not only important for clinicians, but also for also for non-clinicians 
such as tattoo ink producers and regulatory authorities when it comes to production and 
legislation of tattoo inks.
In the end, all of this research should lead to enhanced safety of tattooing. 
Note: all photographs were published with written informed consent of the patients.
GENERAL INTRODUCTION
29
1AIMS AND OUTLINE OF THIS THESISTattoos are a broad subject, and main subtopics to discuss are: dermatological and 
systemic complications, tattoo technique and craftmanship, cultural heritage, history of 
tattooing, contra-indications of tattooing, regulation and law, ingredients and production 
of tattoo inks, tattoo removal etc. However, the primary goal of this thesis is to gain 
more clinical knowledge about tattoo complications, resulting in a more efficient and 
high-quality dermatologic care for these patients. Therefore, this thesis will focus on 
the dermatological complications of tattoos.
In the General introduction an overview of tattoo adverse events is presented. 
In the first three chapters the clinical aspects of tattoo complications are discussed. 
Chapter 2 deals with the clinical aspects of red tattoo reactions and Chapter 3 
investigates the prevalence of tattoos in sarcoidosis patients and associated adverse 
events. Granulomatous reactions in permanent makeup are discussed in Chapter 4. 
The Chapters 5-7 focus on diagnostics and pathomechanisms of tattoo complications. 
The histopathology of red tattoo reactions is presented in Chapter 5, followed by research 
on the skin sensitization potential of five tattoo inks in vitro by using reconstructed human 
skin (RHS) and the contact sensitization biomarker interleukin (IL)-18 in reconstructed 
human skin model in Chapter 6. Chapter 7 investigates the quantification of cutaneous 
allergic tattoo reactions using 3D optical imaging. The last Chapters focus on the treatment 
and course of tattoo complications. Chapter 8 concerns a retrospective study about 
ablative laser therapy of allergic red tattoo reactions and other treatment options will 
also be discussed. In Chapter 9 A-C, cases of treatment and course of respectively tattoo 
associated uveitis, allergic reaction to permanent makeup of the lips and mycobacterial 
tattoo infection are presented.
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Tattooing has become increasingly popular across the globe. In 2016, 12% of Europeans 
were tattooed.1 However, complications of tattooing can occur in which mainly red tattoo 
pigments are involved.2 These reactions to red tattoos are chronic, cause itch and lead 
to a reduced quality of life.3 The clinical presentation includes thickening, hyperkeratosis 
or ulceration, confined to the red tattooed skin.4,5 Nonetheless, little is known about its 
aetiology, eliciting factors and clinical aspects. 
A prospective study was conducted in patients with cutaneous reactions to red tattoos 
at the Department of Dermatology of the VU University Medical Center during 2014-2018. 
Institutional Review Board approval was obtained. A red tattoo reaction was defined as 
a chronic reaction, affecting one or more tattoos, and restricted to red or nuances of 
red. The study focused on eliciting factors and clinical aspects. Data were obtained by 
medical history and physical examination. In the categorization of the clinical presentation 
of the tattoo reactions the classification of Serup et al. was used.2 Histopathology was 
obtained to exclude other diagnoses such as scarring, infections or sarcoidosis. No routine 
patch testing was performed.
Overall, 101 patients were included (Table 1). The most frequently affected tattoo 
locations were the distal extremities (77%). Other affected locations were the face (5%) 
and proximal extremities. Patients reported itch in 94% and pain in 17%. All patients had 
symptoms for more than 3 months. Worsening of symptoms was self-reported in 32% 
after sun exposure,  defined as unprotected exposure of the tattoo in the outdoor sun 
for a nonspecified time period . Forty-three percent of the patients developed symptoms 
within 1 month of getting the tattoo and 24% after 1 year up to 7 years. The average 
time of developing symptoms was 12 months. In 23% of the 43 patients with other older 
red tattoos, simultaneously symptoms occurred in the older red tattoos suggesting ‘cross 
reactivity’. Clinically, we observed a plaque, hyperkeratotic, and ulcero-necrotic pattern 
in 92%, 3% and 5% respectively (Figure 1) of all patients . In 87 patients histopathology 
was obtained. A skin biopsy was refused in 14 patients. Histology included lichenoid, 
pseudolymphomatous or granulomatous inflammation. In 12 patients a granulomatous 
inflammation was found but chest X-ray and serum angiotensin-converting enzyme 
revealed no signs of sarcoidosis.
Currently little is known about the aetiology of red tattoo reactions. As these reactions are 
sharply confined to exclusively the red tattooed area, an allergy to the injected tattoo pigments 
is thought to be the underlying cause. Furthermore, an in vitro study showed that tattoo inks 
were able to cause an inflammatory IL-18 response.6 In this study we observed a substantial 
time span between tattooing and onset of symptoms. Together with the emergence of 
cross reactive red tattoo reactions, these findings suggest a delayed type allergic reaction. 
In our study we remarkably found that allergic tattoo reactions were mainly present in 
tattoos localized on the extremities (91%). In comparison, in a nation-wide survey in 
Germany, they found that tattoos were located on the extremities in only 41%.7 Moreover, 
we found a relatively high percentage of reactions on sun exposed areas: the distal 




Table 1. Clinical patient characteristics.
Parameter
Patients, N 101




Tattoo location, n (%)*
Distal upper extremities 36 (35.0)
Proximal upper extremities 13 (12.6)
Distal lower extremities 43 (41.7)
Proximal lower extremities 2 (1.9)
Trunk 4 (3.9)
Face 5 (4.9)
Tattoo setting, n (%)
Amateur 4 (4.0)
Professional 97 (96.0)
Cross reactivity, n (%)
Other red tattoos 43 (42.6)













Fusion ink 2 (2.0)
Intenze and Eternal 3 (3.0)
Unretrievable 62 (61.4)
Time onset of symptoms, n (%)
< 1 months 43 (42.6)
1-3 months 12 (11.9)
3-6 months 14 (13.9)
6-12 months 8 (7.9)
1-2 years 6 (5.9)
2-5 years 14 (13.9)
>5 years 4 (4.0)
Clinical presentation, n (%)
Plaque elevation 93 (92.1)
Excessive hyperkeratotic 3 (3.0)










Combined granulomatous and lichenoid











* Two patients had a tattoo reaction on a tattoo set at the same time but in different anatomical area (distal lower 
and distal upper extremities, distal upper and proximal upper extremities).
Figure 1.  Clinical reaction types of allergic reactions to red tattoos.
A. Plaque elevation reaction in a red tattoo on the right upper leg. 
B. Plaque elevation in red tattooed lip liner (permanent makeup). 
C. Excessive hyperkeratotic reaction in a red tattoo on the right lower arm. 




report sunlight as a trigger. These findings suggest that sunlight may play a role in forming 
the allergen. Light is known to cause photochemical cleavage of tattoo pigments in 
vitro, and new cases of a tattoo allergy following treatment with a Q-switch laser have 
been reported. 8,9
Altogether, these clinical findings support the hypothesis that red tattoo reactions are 
caused by a delayed type allergy where the allergen is formed in the dermis through 
a slow process of haptenization.10 The tattoo pigments may undergo enzymatic processes 
in a substantial time period in the dermis. As a result, compounds of the tattoo pigments 
form the allergen that induces a T-cell-mediated reaction. This could explain the great 
variation in time of onset and the reason why patch testing is generally negative.
Although this study has limitations (monocenter, no photopatch testing) our findings 
provide more information about the aetiology, eliciting factors and clinical aspects 
of red tattoo reactions. Further research, such as identification of potential pigments 
and photopatch testing, should be performed to reveal more about its aetiology and 
possible allergens.
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Tattoos are currently popular worldwide. However, complications can occur, such as 
allergic reactions, infections and auto-immune diseases such as sarcoidosis.1 Sarcoidosis 
is frequently reported in tattoos and sometimes as its first manifestation.2 This could 
be explained by the Köbner phenomenon or the prevailing theory on the etiology of 
sarcoidosis: environmental factors, such as tattoo pigments, acting as an antigen in people 
with a genetic predisposition causing cutaneous sarcoidosis. The practical use of tattoos is 
broad and its demand is high. However, little is known about the prevalence of tattoos and 
tattoo complications in sarcoidosis patients, as no previous studies have been performed. 
Furthermore, there is no consensus in the literature about what to advise patients in this 
matter.3 The aim of this study is to gather more information about the prevalence of tattoos 
and tattoo adverse events in sarcoidosis patients.
We conducted a multicenter cross-sectional study, using an online survey among 
sarcoidosis patients from December 2018 to April 2019 in two academic centers. We 
included patients, 18-75 years-old, who consulted a dermatologist or pulmonologist 
at least once in the last two years. By chart, the Sarcoidosis Diagnostic Score was used 
for diagnose confirmation.4 Exclusion criteria included an uncertain diagnosis, clinical 
remission, non-proficiency in the Dutch language and unavailable contact information. 
The study outcomes were gathered by questionnaire including presence of tattoos, 
skin type following Fitzpatrick’s classification and occurrence of adverse events and 
its characteristics. Data was collected in Castor EDC and analyzed in SPSS version 25. 
Approval was obtained of the medical ethical committee. 
The database search revealed 638 possible sarcoidosis patients. 295 Patients were 
excluded. 343 patients received and finally 212 completed the survey (61.8%). Patient 
characteristics are shown in table 1. In total, 47 (22.2%) were tattooed, mainly on the upper 
extremities (62.2%). Most patients had one to three tattoos (40.5%) and 54.1% was tattooed 
before being diagnosed with sarcoidosis. Tattoo adverse events were reported in 21.3 % 
(table 2) of which 70% developed after a year and persisted for more than three months 
in 40%. Half of the patients consulted a physician. Black ink, and papules and nodules 
were most frequently reported in 90% respectively 70%. Skin type VI was substantially 
more reported than other skin types (N=7; 70%, p=0.007) (table 2). Of people with tattoos 
and sarcoidosis with skin types I-III and IV-VI, adverse events were reported in 1/20 (5%) 
respectively 9/26 (35%). Of people with tattoos and sarcoidosis with skin type VI, 7/15 
(47%) reported adverse events. 
Our study shows that nearly a quarter of the sarcoidosis patients are tattooed and 
tattoo adverse events are common (21.3%). In comparison, a recent self-reported study 
amongst dermatologic patients showed only 10.3% tattoo adverse events.5  In another 
study, 27% tattoo adverse events was reported in a random population.6 Remarkably, 
60% reported being tattooed both before and after diagnosed with sarcoidosis, assuming 
adverse events occurred in people who were predisposed for sarcoidosis. 
The exact nature of the reported adverse events could not be identified. However, 




Table 2. Characteristics of total sample, tattooed no AE and tattooed with AE.
Parameter Total Sample
Tattooed patients
Tattooed no AE Tattooed with AE
Patients, N 212 37 10
Age, y, mean (SD) 52.6 (11.0) 47 (11.2) 40 (8.4)
Sex, n (%)
Men 120 (56.6) 16 (43.2) 5 (50.0)
Women 92   (43.4) 21 (56.8) 5 (50.0)
Self-reported skin type, n (%)
I 7     (3.3) 2   (5.4) 0 (0)
II 56   (26.4) 8   (21.6) 1 (10.0)
III 62   (29.2) 10 (27.0) 0 (0)
IV 28   (13.2) 7  (18.9) 2 (20.0)
V 14   (6.6) 2   (5.4) 0 (0)
VI 45   (21.2) 8 (21.6) 7 (70.0)
Correlation of skin type VI and tattoo adverse events




Values in parentheses are percentages
the majority of the tattoo adverse events found are sarcoid.7 Hence, 70% reported papules 
and nodules in their tattoo. Clinically, papulo-nodular tattoo reactions are suspect for 
sarcoidosis. A recent study describes systemic sarcoidosis in 8% of these reactions.8
Skin type is strongly correlated with adverse events in our study. Whereas 15/47 (31%) 
of the patients with tattoos and sarcoidosis had type VI skin, these patients experienced 
70% of the reported adverse events. Despite the fact that the incidence of sarcoidosis is 
threefold higher in Afro-Americans than in Caucasians, the occurrence of tattoo adverse 
events in skin type VI patients is remarkable.9 In addition, more frequent cutaneous 
involvement amongst Afro-Americans with sarcoidosis is previously reported.10 
Strengths of this study are the multicenter approach, no previous similar studies and 
the large sarcoidosis population with a high response rate. Limitations include selection 
bias due to our academic patient population, patient recall bias and the adverse events 
and skin type are self-reported. 
Concluding, patients (pre)diagnosed with sarcoidosis have a moderate risk of tattoo 
adverse events, particularly papulo-nodular reactions. Patients with darker skin color seem 
to be more at risk for developing complications.
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Table 2. Outcomes of the tattooed with AE.
Parameter
Patients, N 10
Number of affected tattoos, n (%)  
1 4  (40.0) 
2-3 3  (30.0) 
4-5 1  (10.0) 
6-9 1  (10.0) 
>10 1  (10.0) 
Affected tattoo location, n (%)
Trunk 4  (40.0)
Upper extremities 8  (80.0)
Lower extremities 4  (40.0)
Other1
Body surface area2, n (%)  
1% 6 (60.0) 
2-3 % 2  (20.0) 
4-5 % 2  (20.0) 
   Other3
Time onset of symptoms, n (%)  
 <4 weeks  1  (10.0) 
 >3 months  2  (20.0) 
 >1 year  7  (70.0) 
Symptoms, n (%)  
Papules and nodules 7  (70.0) 
Itch 4  (40.0) 
Redness (erythema) 2  (20.0) 
Swelling 2  (20.0) 
Elevation of one tattoo or specific tattoo color  3  (30.0) 
Elevation of multiple tattoos or all tattoos  2  (20.0) 
Crusts 1  (10.0) 
Scaling 2  (20.0) 
Scars 1  (10.0) 
Other4
Tattoo color, n (%)  
Black 9  (90.0) 
Blue 2  (20.0) 
Green 2  (20.0) 
Red 2  (20.0) 
Purple, pink 2  (20.0) 
White 1  (10.0) 
Other5
Values in parentheses are percentages
1 Others included: face, neck or genital region. 2 Body surface area of the largest affected tattoo was self-reported 
as one palm presenting 1% of the body surface. 3 No tattoo sizes >5% of the body surface area were reported.  4 
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Permanent make-up has become very popular over the last decade(s). Permanent 
make-up, also named cosmetic tattoos, is used for different indications, such as tattooing 
eyebrows, eyeliner or the lining of the lips. It offers a solution to individuals with allergies 
to cosmetic products or physical incapability’s such as arthrosis or visual impairment.1 
Although permanent make-up is common and regarded safe, it may still cause adverse 
skin reactions, including infections, allergic reactions, and auto-immune diseases such as 
sarcoidosis. Regardless of the size of the affected area, tattoo reactions cause a reduced 
quality of life. 2
Here, we report 5 patients referred to the Academic Tattoo Clinic Amsterdam because 
of a skin reaction in their tattooed eyebrows. 
The clinical presentation in these patients include elevated and frequently yellowish 
plaques, sharply demarcated around the tattooed skin. Figure 1. Remarkably, all patients 
got their permanent make-up of their eyebrows several times during the last 4 to 15 years. 
Table 1. Time between last placement of the cosmetic tattoo and onset of complaints 
varied between 1 to 18 months. Dyes used were in the red, brown and black spectrum. 
No triggering factors could be identified and there was no history of systemic complaints. 
Figure 1.
a) Patient 1: Elevated plaques in the tattooed eyebrow area. 
b) Patient 1: Close up, marked are the biopsy locations.  
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Histopathological evaluation revealed granulomatous inflammation in all patients and 
additional stains were negative for fungi and acid-resistant mycobacteria.  In patient 1 an 
elevated level of angiotensin-converting enzyme (ACE) of 126 (range 20-70 U/L) was found. 
In the same patient high-resolution computed tomography (HRCT) revealed mediastinal 
lymphadenopathy, concluding systemic sarcoidosis. In patient 4 chest x-ray revealed 
hilar adenopathy and dubious nodules. In the other patients we did not find any signs of 
systemic sarcoidosis. Patients were treated with topical or intralaesional corticosteroids, 
resulting in almost complete resolution of the skin manifestation.
The differential diagnosis of non-infectious reactions in cosmetic tattoos includes 
allergic reactions, foreign body reactions and sarcoidosis. Differentiation between these 
conditions is challenging as allergic reactions to tattoo pigment are difficult to confirm 
by patch testing, as results are mainly negative.3 In addition to foreign body reactions 
and sarcoidosis, allergic reactions can cause granulomatous inflammation as well.4  If 
a granulomatous reaction is found, further investigation into sarcoidosis is advised. 
The percentage of underlying sarcoidosis in individuals presenting with a granulomatous 
reaction is unknown, however one-third of patients with systemic sarcoidosis have cutaneous 
lesions.5 Sepehri et al. confirmed that sarcoidosis is common in non-infectious cosmetic 
tattoo reactions. They reported in 29% of their patient’s sarcoidosis with a papulo-nodular 
pattern at clinical examination.6
The exact pathological mechanism of sarcoidosis remains unclear.5 Chronic minor 
exposure of the immune system to the ink may stimulate the development of granulomas 
and might ultimately lead to granulomatous inflammation in an individual who is genetically 
sensitive to the development of sarcoidosis.6 The above would elucidate the long latency 
period between the placement of the permanent make-up and clinical manifestation in our 
presented cases. Remarkably, as stated in table 1, our presented cases had set permanent 
make-up 2 to 15 times before developing adverse reactions. In theory, repeated tattooing 
and reintroducing foreign material in the skin may trigger autoimmune activation.
Many patients with clinical granulomatous reactions are, eventually, not diagnosed 
with cutaneous sarcoidosis. Sepehri et al. suggest that these patients might be subclinical 
cases or cases predisposed to sarcoidosis later in life and therefore must be monitored.6
Although the differential diagnosis is challenging, the treatment of choice for 
granulomatous reaction can be similar. All above presented cases were successfully treated 
with potent topical or intralaesional corticosteroids. Quint et al. also reported a patient 
in which all lesions had been resolved after the injection of potent corticosteroids.7 Even 
spontaneous resolution of a granulomatous reaction to a cosmetic lip tattoo after punch 
biopsy is described.8 In associated systemic disease oral prednisone, methotrexate or 
other immunosuppressant are preferred. Martin et al. reported allopurinol as an effective 
treatment in a patient, with a granulomatous reaction to a cosmetic tattoo of the lips, not 
responding to topical steroids.9 Alternatives are surgical excision or laser therapy, however 




In conclusion, clinicians should be aware of the fact that granulomatous reactions in 
tattoos may be a marker of sarcoidosis and therefore, screening and follow-up for other 
manifestations of sarcoidosis should be performed. The cutaneous lesion may be the only 
manifestation of the systemic disease.  For the treatment we recommend topical or 
intralaesional corticosteroids.  
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Despite popularity of tattoos, complications might occur. In particular, red tattoo reactions 
due to allergic reactions are the most frequent chronic tattoo reactions.  However, little is 
known about its histopathology and underlying pathomechanisms.
Objective
The aim of this article is to analyse the histopathology of red tattoo reactions for diagnostic 
purposes and to acquire more insight into pathogenesis. 
Methods
A retrospective cross-sectional study was conducted by reviewing the histopathology of 
74 skin biopsies of patients with allergic red tattoo reactions. Histopathological findings, 
such as inflammation patterns, inflammatory cells and pigment depth and colour, 
were semi-quantified with an in-house validated scoring system by two independent 
senior investigators.
results
Histiocytes and lymphocytes were both present in >93%. Histiocytes were the predominant 
inflammatory cells in 74.3%, but well-defined granulomas were mostly absent (78,0%). 
Eosinophils were uncommon (8,1%) The predominantly histiocytic reaction combined with 
interface dermatitis was the main inflammation pattern (37,9%). Most biopsies showed 
more than one reaction pattern. Interface involvement was observed in 64,8%, despite 
the intended depth of standard tattoo procedures, in which pigment is placed deeper, in 
the upper and mid dermis. Statistical analyses showed a significant association between 
inflammation severity and pigment depth (p = 0.024). In six cases (8,1%) pigments could 
not be retrieved histologically. 
Conclusion 
In this cohort we demonstrated that cutaneous reactions to red tattoo ink are frequently 
characterized by the combination of dermal predominantly histiocytic infiltrates and 
epidermal interface dermatitis. Allergic reactions to red tattoo pigments probably 
represent a combination of a subtype IVa and IVc allergic reaction. Clinicians should be 
aware of the specific histopathology of these reactions and therefore the importance of 
taking a diagnostic skin biopsy.  




The prevalence of Europeans with one or more tattoos has increased from 5-10% in 2003 
up to 12% in 2016.1, 2 Tattoos respond to an apparently need to beautify or decorate 
the skin and are sometimes used for medical purposes as scar camouflage, nipple 
reconstruction after breast cancer and implants or marking for radiotherapy. However, 
tattoos can be complicated by infections, allergic reactions and induction of cutaneous 
autoimmune diseases.3-5 Although complications of green and blue tattoos are frequently 
reported, red tattoo reactions are the most frequent chronic tattoo reactions.6, 7 These 
tattoo reactions can cause itch, pain and swelling, which may be experienced as highly 
bothersome and alter the quality of life.8, 9 Clinically, these reactions present as an 
elevated plaque in the tattooed skin, sharply confined to the areas coloured red, or 
nuances of red [Figs 1a-1b]. Less frequently there is hyperkeratosis [Fig. 1c] and rarely 
ulceration and necrosis.10, 11 Reactions can develop days, months or even years after 
tattooing, with an average time of occurrence of 12 months after the tattoo was placed.12 
Histological examination is crucial in the diagnosis of an allergic red tattoo reaction, 
to exclude other causes of inflammation at the tattoo site, such as infection (including 
mycobacterial infections) or autoimmune skin diseases such as sarcoidosis, psoriasis, 
Figure 1. Clinical manifestations.
Tattoo on the left under arm (1a) and the left lower leg (1b), both showing elevation and scaling in 
the red tattooed area: ‘plaque-type allergic reaction’.  Tattoo on the left lower leg (1c) with prominent 




and also atopic dermatitis,  or contact dermatitis due to ingredients used in local tattoo 
aftercare products. Even if the affected skin is limited to one tattoo colour, cutaneous 
sarcoidosis can occur.13 A great variety of reaction patterns in tattoo complications 
have been reported, yet little is published about the association between clinical and 
histopathological aspects.5,14,15
To study the histology of allergic red tattoo reactions is important, as the exact aetiology 
of these reactions is still unknown. However, little is known about its histopathology: only 
case series or small studies have been reported so far.11, 16 Histological analysis of the reaction 
patterns may contribute to the understanding of the underlying pathomechanisms. 
Clinical studies suggest type IV (delayed type) hypersensitivity as the basic mechanism of 
tattoo reactions 12, nevertheless patch testing was shown to be negative in the majority 
of  patients.17 Hogsberg et al. also suggested an allergic pathomechanism, based on 
the finding of increased epidermal and dermal inflammatory cells, such as T-lymphocytes 
and Langerhans cells in a microscopical study of tattoo reactions.16 Furthermore,  Forbat et 
al. underlined that the majority of  the available literature on this subject consists of case 
series.18 In our present study we analysed a large cohort of patients with tattoo reactions 
to red pigments histologically, with focus on the inflammation pattern and the contribution 
of different inflammatory cell types, in relation to the pigment and its depth. Our data may 
aid in understanding the immunological events that cause red tattoo reactions. 
MATErIALS AND METHODS
In this retrospective cross-sectional designed study, a search was performed using 
the database of the Academic Tattoo Clinic Amsterdam of the Department of Dermatology 
for all patients who visited the clinic between January 2008 and April 2019. Patients 
clinically diagnosed with an allergic red tattoo reaction, from whom a punch biopsy was 
taken from a representable affected area within the macroscopically red part of the tattoo, 
were included. An allergic red tattoo reaction was defined as a chronic tattoo reaction, 
sharply confined to the red (or nuances of red: pink, purple, brown) tattooed skin only, 
with symptoms being present for at least 3 months, using the same criteria as previously 
used by Serup et al. and Van der Bent et al.3, 7, 12 Patients were excluded based on 
the following reasons: other diagnoses such as sarcoidosis; other ink colours involved 
in the reaction than nuances of red; no biopsy taken in the diagnostic process or biopsy 
taken elsewhere. Whenever sarcoid granulomas were observed histologically, further 
investigation was performed by chest X-ray and serum angiotensin-converting enzyme 
for exclusion of systemic sarcoidosis. Clinical information, such as tattoo location, colour 
and photosensitivity was gathered by medical file review. Photosensitivity was defined 
as worsening of symptoms at the site of the tattoo reaction, after a variable exposure to 
outdoor sun. Informed consent was obtained from all participants.
Skin biopsies from tattoo reactions were formalin-fixed, four-micrometer sections 
were stained with haematoxylin/eosin (HE) and examined by conventional microscopy. 
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Two independent researchers, a senior dermatologist with expertise in the field of 
dermatopathology and a pathologist specialized in dermatopathology, reviewed 
the biopsies individually, blinded for any patient information. A third independent 
researcher observed the microscopic slides together with both reviewers and filled in 
the database. In case inter-observer discrepancies existed, re-assessment of the slides 
took place with both researchers until consensus was achieved.  
For data analysis an in-house validated scoring method was used. This method was 
based on the semi-quantitative method of Hogsberg et al.16 General histologic features 
(epidermal acanthosis, -spongiosis, interface activity, dermal fibrosis), types of inflammatory 
cells (lymphocytes, histiocytes, eosinophilic granulocytes, plasma cells) and pigment 
colour shades and depth were assessed on a 3-point scale: 0 None; 1 Some/Moderate; 
2 Many/Severe. Pigment and inflammation depth were divided into: 0. None; 1. Papillary 
dermis; 2. Upper reticular dermis; 3. Lower reticular dermis; 4. Subcutis. The predominant 
subtype(s) group(s) were: Predominantly histiocytic (with or without granulomas); Interface 
dermatitis; Pseudo-lymphomatous; Spongiotic dermatitis; Perivascular infiltrate and 
Other/Atypical infiltrate. 
Descriptive statistics were generated for all variables. Crosstabs, the Fisher’s exact 
test with p-values (p<0.05) were used to compare categories and check for statistical 
significance. Statistical analysis was performed using SPSS software (version 25). 
rESULTS
Of the total of 267 patients with tattoo complications, 121 met the criteria for allergic red 
tattoo reactions. Of these, 74 patients were eligible and gave informed consent, after 
which their clinical information and skin biopsies were analysed. 
The majority of the biopsies were obtained within the last 3 years. Table 1 shows that 
the majority of participants were women (77,0%); distal lower extremities was the most 
common tattooed site (50,0%) and plaque elevation was the main clinical manifestation 
(90,5%). Histological characteristics in Table 2 show that inflammation was scored as 
severe in 75,7%. Epidermal acanthosis was variable (absent in 44,6% some in 33,8%) and 
spongiosis was mostly absent (73,0%). Interface activity at the epidermal-dermal junction 
was present in the majority of biopsies (64,8%), as was dermal fibrosis (91,9%). Both 
histiocytes and lymphocytes were present in more than 93%. Plasma cells were observed 
in 37,9% and eosinophils in only 8,1%. 
Biopsies showed more than one reaction pattern in 77%. A predominantly histiocytic 
infiltrate was present in 74,3% (55 cases), sometimes as solitary inflammatory pattern 
(10,8%, 8 cases) and in most cases combined with other reaction patterns (i.e. together 
with interface-, spongiotic- or perivascular dermatitis: 63,5%, 47 cases). Interestingly, 
a predominantly histiocytic dermal reaction combined with the presence of interface 
dermatitis was the main histopathological combination, observed in 37,9%, with a variable 








Mean age [SD] 47 (20-74) [12] 
Gender, N (%) 
Male
Female 
17 (23,0)  
56 (77,0)
Tattoos 74
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When we studied the epidermal-dermal junction at high magnification in cases with distinct 
interface dermatitis and superficial dermal tattoo pigment, we encountered apoptotic 
keratinocytes with adjacent lymphocytes, apparently undergoing ‘satellite cell necrosis’. 
Pigment particles appeared to be present in close proximity or on the surface of these 
apoptotic keratinocytes. [Figs 2c-2d]. We noticed that most biopsies (78%) did not contain 
well-defined granulomas. If present, granulomas frequently appeared to be poorly defined 
(‘fuzzy’ granulomas) [Fig 2e] or were merely present as undefined collections of histiocytes. 
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INFLAMMATION SEVERITY 3 (4,1%) 15 (20,3%) 56 (75,7%)
HISTOLOGICAL FEATURES
Acanthosis 33 (44,6%) 25 (33,8%) 16 (21,6%)
Spongiosis 54 (73,0%) 18 (24,3%) 2 (2,7%)
Interface Activity 26 (35,1%) 24 (32,4%) 24 (32,4%)
Fibrosis 6 (8,1%) 42 (56,8%) 26 (35,1%)
INFLAMMATORY CELLS
Lymphocytes 4 (5,4%) 27 (36,5%) 43 (58,1%)
Histiocytes 3 (4,1%) 13 (17,6%) 58 (78,4%)
Eosinophils 68 (91,9%) 6 (8,1%) 0 (0,0%)
However, in some cases, well-defined sarcoid granulomas were encountered, reminiscent 
of cutaneous sarcoidosis. [Fig 2f] [Figs 2e-2f] We did not observe a pseudolymphomatous 
pattern in any of the biopsies.
In determining the depth of inflammation and tattoo pigment, as shown in table 3, 
inflammatory infiltrates and pigment particles were mainly confined to the upper and lower 
reticular dermis. Yet, in some biopsies both pigment particles and inflammatory infiltrates 
extended into the subcutis. Although all biopsies had been taken from macroscopically 
red tattoos, microscopic colour shades of tattoo pigment particles varied significantly: 
cherry red in 24,3% and dark red in 28,4%, purple in 5,4%, brown in 14,9%, up to even 
black coloured pigment particles in 8,1%. In eight cases (10,8%) overlap between red and 
dark brown/black pigment particles was visible within the same biopsy. In six cases (8,1%) 
we were unable to detect any tattoo pigment particles microscopically. Statistical analyses 
showed a significant correlation between the severity of inflammation and pigment depth 
with p < 0.024. (alpha<0.05). No associations were found between pigment depth and 
inflammation depth, photosensitivity and interface activity, visible pigment and interface 
activity, or tattoo location and interface activity. 
DISCUSSION 
In this study, the histopathological features of red tattoo reactions generally included 
the presence of histiocytes as the predominant inflammatory cells (74,3%), indicating 
a central role for histiocytes in hypersensitivity reactions to red ink. Unexpectedly, interface 
activity was present in 64,8% [Table 2.] of the biopsies. The combination of a histiocytic 
pattern and interface dermatitis may point to a specific immunologically mediated red 
tattoo reaction. It is not exactly clear why this typical reaction, involving the interface 
between epidermis and dermis, occurs. Interestingly, biopsies with interface dermatitis 




Figure 2 a-f. Histopathological features of red tattoo reactions.
a) example of epidermal interface dermatitis, with dermal predominantly histiocytic infiltrate and 
‘fuzzy’ granulomas (HE x100); b) follicular interface dermatitis and diffuse lymphohistiocytic infiltrate 
(HE x100); c) detail of epidermal interface dermatitis, with dark tattoo pigment and lymphocytes 
directly adjacent to a Civatte body (arrow)(HE x400); d) another example of an epidermal apoptotic 
keratinocyte, with red pigment particles on its surface and an attached lymphocyte (arrow)(HE x400); 
e) ill-defined ‘fuzzy’ granuloma, with abundant red tattoo pigment present (HE x200); f) well-developed 
sarcoid granulomas, with dark-brown tattoo pigment present (arrow)(HE x100).
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This phenomenon, highly suggestive of ‘satellite cell necrosis’, i.e. the process of 
cytotoxic lymphocytes inducing apoptosis in basal keratinocytes, was observed in several 
biopsies, in some cases with tattoo pigment particles visible on the surface of the involved 
keratinocytes [Figs. 2c-2d]. Although reported before 16, 18, 19, the pathomechanism for 
interface reactions to red tattoo pigment remains unclear. It could be hypothesized that 
pigment particles, after binding to certain cell surface molecules on basal keratinocytes, 
form neo-antigens that are recognized by cytotoxic T cells, Natural Killer (NK) cells or 
NK-T cells. This could subsequently lead to apoptosis of the (neo)antigen-expressing 
keratinocytes, causing the release of pro-inflammatory cytokines and the attraction of 
histiocytes and other inflammatory cells. However, the sequence of events remains to be 
established: it is also possible that attraction and activation of histiocytes by accumulated 
red tattoo pigment in the dermis is the initial event and that the observed interface 
dermatitis is a secondary reaction to the formation of dermal inflammatory infiltrates. In our 
Tattoo Clinic, tattoo reactions to other colours are also observed, mainly in black tattoos. 
We studied the histopathology of these black tattoo reactions (data to be published) and, 
in contrast to red tattoo reactions, these were mainly granulomatous and no interface 







Predominantly histiocytic 8 (10,8%) 3 (4,1%) 5 (6,8%)






Predominantly histiocytic + interface dermatitis 28 (37,8%) 7 (9,5%) 21 (28,4%)
Predominantly histiocytic + perivascular infiltrate 16 (21,6%) 2 (2,7%) 14 (18,9%)
Interface dermatitis + perivascular infiltrate 9 (12,2%)
Predominantly histiocytic + spongiotic dermatitis 3 (4,1%) 0 3 (4,1%)
Spongiotic dermatitis + perivascular infiltrate 1 (1,4%)
















Inflammation depth (%) 3 (4,1%) 0 20 (27,1%)* 46 (62,1%)* 5 (6,8%)
Tattoo pigment depth (%) 6 (8,1%) 2 (2,7%) 29 (39,2%)* 34 (48,6%)* 1 (1,4%)




dermatitis was rarely observed. The distinct presence of histiocytes could be explained 
by their role as major component of the innate immune system: they can phagocytose 
and degrade tattoo ink particles and activate the adaptive immune system by presenting 
ink antigens to lymphocytes and by cytokine signaling.20 Indeed, the significant numbers 
of lymphocytes present in the majority of biopsies with severe inflammation in our study 
suggest a contribution of antigen-specific cell-mediated immunity, but to confirm this 
antigen-specific T-cell activation assays are required. The presence of either poorly- or 
well-defined granulomas (16.3%) may also indicate delayed type hypersensitivity reactions. 
[Figure 2e;2f] However, in previous studies “dermatitis” or “lichenoid” reactions seemed 
to be dominant.21 
We did not observe a pseudolymphomatous reaction pattern in any of the 74 biopsies, 
which differs from cases reported by others, although they categorised this pattern 
as uncommon.22-24 
Tattoo pigments: presence and colours
Histology of uncomplicated tattoos usually shows pigment particles in the upper and 
mid dermis. Particles can be seen captured inside macrophages and also freely between 
collagen bundles.20, 25 In our study, tattoo pigments were found in all layers of the skin, 
tended to be smaller in the deeper skin layers and were not visible histopathologically in 
six cases. This was remarkable, since all biopsies were taken from macroscopically visible 
affected red tattooed skin. Possibly, macrophages had eliminated most pigments by 
phagocytosis and degradation in these cases. This finding is in line with a recent study, in 
which 104 red tattoo reactions were studied and no pigments could be identified in 22%.26 
Pigment depth was associated with inflammation severity, which could be explained by 
a stronger inflammatory stimulus if pigment depositions are more abundant throughout 
the skin. Also, histiocytes may have ‘dragged’ pigment particles, bound to cell surface 
receptors or phagocytosed, deeper into the reticular dermis during the course of 
the expanding inflammatory infiltrate. Whether deeper situated tattoo pigment itself 
provokes a stronger inflammatory response in the immediate environment remains to be 
established. In 3 cases (4,1%) no microscopic inflammation was observed at all, despite 
the clinical presence of an elevated plaque in the red tattoo. This could indicate that these 
clinical plaque elevations were merely based on dermal oedema rather than inflammatory 
infiltrates. As tattoo pigments are permanently located in the dermis, treatment is 
difficult.4, 27 The depth of tattoo pigments cannot be established clinically. Histologically, 
we observed ample variety in pigment depth. Pigment depth may also vary within a single 
tattoo. These findings suggest that the treatment and removal of these pigments requires 
an individual approach in which the treatment depth can vary, for example with ablative 
laser therapy or dermatome shaving.28 The variation in pigment colours that we observed 
microscopically may have been due to differences in the composition of the red ink used 
during tattooing. Mercury, formerly frequently used as a red tattoo pigment, is known 
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to induce epithelial alterations.29 However, since mercury is much less frequently used in 
tattoo pigments nowadays, still most chronic reactions are caused by red pigments.20, 30, 31 
In their search for the identity of the culprit allergen, Serup. et al suggested that azo 
pigment breakdown products, serving as haptens, may cause the allergic reaction.26  
Allergy 
Eosinophils were found in only 6 biopsies (8,1%), in contrast to what is expected in 
cutaneous allergic reactions 20, 32, yet similar to a previous study on red tattoo reactions 
(11,11% eosinophils).16 This raises the question whether these red tattoo reactions are truly 
caused by an allergy. However, previous reports showed multiple clues for pathomechanism 
that involve type IV hypersensitivity reactions: i) these reactions are sharply confined to 
the exclusively red tattooed area; ii) tattoo pigments can cause an inflammatory IL-18 
response (pro-inflammatory cytokine, facilitates Th1 lymphocyte responses); iii) red 
tattoo reactions may show cross reactivity; iv) the delayed onset of symptoms, and v) 
the reported role of sunlight (photosensitivity) as a trigger.12 On the other hand, systematic 
patch testing in red tattoo reactions were merely negative.17, 33 The amended Gell and 
Coomb’s classification suggests that type IV hypersensitivity reactions can be divided into 
4 subtypes: type IVa (Th1 lymphocyte-mediated with activation of macrophages, with 
or without granuloma formation), type IVb (Th2 lymphocyte-mediated with eosinophilic 
involvement), type IVc (mediated by cytotoxic lymphocytes causing apoptosis) and type 
IVd (T lymphocyte-driven neutrophilic inflammation).34 According to this subclassification 
of type IV reactions, our results suggest that in allergic reactions to red tattoo pigments, 
mainly subtypes IVa and IVc are involved. Decomposition products of tattoo pigments can 
migrate throughout the body and have been found in the regional lymph nodes, where 
they can be presented to the adaptive immune system, resulting in an antigen-specific 
immune response.35 Binding of small fragments from ink particles to certain host proteins 
(haptenization) and photochemical alteration of tattoo pigment may be attributive factors 
contributing to allergen formation and antigenicity.17,33
Strengths and limitations 
Strengths of this study are the number of patients with a specific reaction to red tattoo 
ink and the semi-quantified method used to detect different reaction patterns. Limitations 
include possible interference by other dermatoses, especially in the 37 (50%) biopsies 
taken from a distal lower extremity: pre-existing stasis dermatitis caused by chronic 
venous insufficiency may have been responsible for the epidermal spongiosis and/or 
dermal fibrosis observed in certain cases. Also, treatment effects were not considered 
in our analysis of the biopsies. Furthermore, the histopathological term ‘granuloma’ is 
imprecise and debatable, since there is no strict definition (‘relatively discrete collection of 




observed. Although signs of cutaneous or systemic sarcoidosis were absent, it cannot be 
ruled out that sarcoidosis will develop later in these patients.36
CONCLUSION 
Histologically, reactions to red tattoo ink are presented as predominantly histiocytic 
hypersensitivity reactions, frequently in combination with interface dermatitis. Red pigment 
particles were encountered throughout the different skin layers, including the basal 
epidermis, where they may have contributed to the interface dermatitis by formation 
of neo-antigens.   
Clinically, red tattoo reactions are thought to be an allergic reaction. As very few 
eosinophilic and neutrophilic granulocytes were observed, we conclude that specific 
allergic reactions to red tattoo pigments most likely represent a combination of a subtype 
IVa and IVc hypersensitivity reaction. In order to reveal the exact pathomechanism, 
patch testing and photo-patch testing with single ingredients from red tattoo pigments 
and their breakdown products should be performed, as well as antigen-specific T cell 
activation assays. 
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During the last decade, the number of people with one or more tattoos has increased 
noticeably within the European population. Despite this, safety assessment is limited for 
tattoo inks. 
Objectives
To test the skin sensitization potential of five tattoo inks in vitro using reconstructed human 
skin (RhS) and the contact sensitizer biomarker IL-18. 
Methods
Two red and three black tattoo inks, one additive (Hamamelis Virginiana extract), and 
one irritant control (lactic acid) were tested. The culture medium of RhS (reconstructed 
epidermis on a fibroblast populated collagen hydrogel) was supplemented with test 
substances in a dose-dependent manner for 24 hours, after which cytotoxicity (histology, 
MTT assay) and sensitizing potential (IL-18 secretion, ELISA) was assessed. 
results
All but one ink demonstrated cytotoxicity. Notably, one red ink and one black ink were able 
to cause an inflammatory response, indicated by substantial release of IL-18 suggesting 
that these inks may be contact sensitizers. 
Conclusions
The in vitro RhS model showed that four tattoo inks were cytotoxic and two were able 
to cause an inflammatory IL-18 response, indicating that an individual may be prone to 
develop allergic contact dermatitis when exposed to these tattoo inks. 
Key words
allergic contact dermatitis, human reconstructed skin, IL-18, in vitro, safety assessment, 
skin sensitization, tattoo ink.
Abbreviations
AOP, adverse outcome pathway; C.I., color index; EC50, effective chemical concentration 
to reduce cell viability by 50%;; HPLC, high-performance liquid chromatography; IL-18, 
interleukin 18;; LC, Langerhans cell; NA, not available; PAAs, primary aromatic amines; 
PAHs, polycyclic aromatic hydrocarbons; RhE, reconstructed human epidermis; RhS, 
reconstructed human skin; SEM, standard error of the mean; SI, stimulation index.




During the last decade, the percentage of Europeans with one tattoo or more increased 
noticeably from 5-10% in 2003 to 12% in 2016.1 Simultaneously, the number of patients 
with tattoo-related complications visiting the dermatologist indicates a real health risk. 
Allergic reactions are reported to be mostly associated with red-pigmented tattoos, in 
which an itching, plaque-like elevation may be observed, confined to one uniformly colored 
site of the tattoo.6, 7 A strong allergy occurring in a tattoo can ultimately manifest itself in 
hyperkeratosis, or even ulceration and necrosis of the skin.7-9 The onset of complications 
may differ substantially, from straight after placement of the tattoo up to years or decades 
afterwards.1 Occasionally, the allergic reaction can manifest simultaneously in older-, 
similarly colored tattoos.7 The disease burden of a chronic allergic reaction in a tattoo is 
high and significantly reduces the quality of life.10 Therefore generation of in vitro toxicity 
data is of utmost importance if we are to gain a better understanding of safety regarding 
tattoo inks.  Recent publications concerning the health hazard of tattoo inks provided 
insight into cytotoxicity, genotoxicity and reactive oxygen species production following 
tattoo ink exposure in the skin.2-5 However, in vitro data on sensitization potential of tattoo 
inks is scarce.
The pigments in tattoo ink are not strictly intended for intradermal use but are prepared 
for other (industrial) uses as well, such as application in textiles, lacquer, inks, or plastics. 
Therefore these pigments are not specifically assessed for the injection and permanent 
application into the human body.11, 12 Currently, azo dyes are the class of chemicals most 
commonly used as colorant in tattoo inks. They replace the traditional pigments such as 
cinnabar (red), chromium (green), cobalt (blue), cadmium (yellow), or manganese (purple) 
1. Azo dyes are present in many consumer products, such as textiles and leather clothing, 
and are associated with allergy.13-15. Metabolism or chemical degradation of the azo bond 
may result in Primary Aromatic Amines (PAAs), some of which have been proven to possess 
mutagenic and carcinogenic-, or sensitizing properties.11 
Black inks usually contain pigments from natural origin, such as Carbon Black (Pigment 
Black 6/7). This pigment consists mainly out of elemental carbon (>97%). The Scientific 
Committee for Consumer Safety (SCCS, formerly SCCP) concluded in their scientific 
opinion that this Carbon Black pigment, when considered in its nano-structured form, 
can be regarded as safe at concentrations up to 10% in consumer products.16 However, 
polycyclic aromatic hydrocarbons (PAHs) may be present as contaminants in this pigment, 
of which several have been classified as carcinogenic by the International Agency for 
Research on Cancer (IARC).3, 17
The Adverse Outcome Pathway (AOP) for the process of skin sensitization defines one 
Molecular Initiating Event and a number of Key Events.18 Key  Event 1 (initial event) – 
covalent binding of a xenobiotic chemical to a skin protein, forming a hapten, and 
penetration of the hapten through the skin’s stratum corneum into the viable layers of 




secretion e.g. IL1a, IL-18, TNF-α; Key Event 3 - Langerhans cell (LC) activation (migration and 
maturation) directly or by a hapten-carrier protein complex; and Key Event 4 - presentation 
of the antigen by matured LC to antigen-responsive T-Lymphocytes in the draining lymph 
nodes resulting in primed effector and memory T-Lymphocytes.18, 19
It has been observed that sensitizer potency is related to the irritant properties of 
the chemical, and that this irritancy results in an innate immune inflammatory response 
(i.e. xenoinflammation).20 New insights into the mechanism of xenoinflammation have 
identified IL-18 (amongst other cytokines) as playing a pivotal role in Key Event 2 of skin 
sensitization and allergic contact dermatitis, but surprisingly not in respiratory sensitization 
or irritant contact dermatitis.20-22 IL-18  is therefore considered to be the key between 
xenoinflammation, which may be caused by irritants as well as contact allergens, and 
migration of the dendritic cells.20 Hence, this cytokine can be considered as a specific 
biomarker which is upregulated by chemicals which have the potential to be skin sensitizers.
We have previously developed an in vitro assay to distinguish contact sensitizers from 
irritants based on the release of IL-18 from reconstructed human epidermis (RhE).23, 24 
The assay is currently undergoing validation in Europe, Asia, and America and can use 
commercially available RhE as well as in house academic RhE. An IL-18 stimulation index 
(SI) equal to or above a threshold value (to be defined for each type of RhE) is strongly 
indicative of a skin sensitizer. For our in house RhE, an SI ≥ 5 could predict skin sensitizers 
from non-sensitizers with 95% accuracy.23 Of note, in the RhE model, chemicals were 
applied topically to the stratum corneum, thus mimicking topical exposure in humans. 
The aim of this research was to determine whether an organotypic 3D Reconstructed 
human Skin (RhS) model could serve as a screening tool for determining the skin sensitizing 
potential of tattoo inks. RhS consists of a reconstructed differentiated epidermis grown on 
a fibroblast populated collagen hydrogel at the air-liquid interface.25 Since tattoo inks 
are permanently injected into the dermis, a topical application was considered not to be 
the best application method. Therefore, instead of a topical exposure, tattoo dyes were 
supplemented into the culture medium to achieve an intradermal exposure. IL-18 release 
and cytotoxicity were determined in vitro for two red- and three black tattoo inks in order 
to obtain information on sensitization potential. These red inks in particular were chosen 
since they were associated with allergic reactions in patients visiting the tattoo outpatient 
clinic of VU University Medical Center.  
MATErIALS AND METHODS
reconstructed human skin culture
Human foreskin was obtained from healthy human donors and was used in anonymous 
fashion in compliance with the VU University Medical Center’s ethical guidelines and 
the “Code for Proper Use of Human Tissues” as formulated by the Dutch Federation of 
Medical Scientific Organizations (see www.fmwv.nl).
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RhS were constructed as described previously.26 In short, dermal fibroblasts and 
epidermal keratinocytes were isolated from foreskins and cultured until 90% confluent. 
Passage 1 cells were used to construct RhS in 2.5 cm diameter transwells (pore size of 
0.4 µm; Corning, NY, USA). Keratinocytes (5 x 104 cells) were seeded on top of the fibroblast 
populated collagen hydrogels (1 x 105 fibroblasts per gel).
RhS were cultured initially submerged for 3 days and then a further 14 days at 
the air liquid interface, with the culture medium only in contact with the underside of 
RhS via the porous transwell membrane, in order to promote epidermal differentiation 
in Dulbecco’s Modified Eagle Medium (DMEM; Lonza, Basel, Switzerland) and Ham-F12 
(Gibco, Grand Island, USA) (3:1) containing 0.2% UltroserG (BioSepra S.A. Cergy-Saint-
Christophe, France), 1% penicillin-streptomycin, 1 µM hydrocortisone, 1 µM isoproterenol, 
0.1 µM insulin, 2 ng/mL Keratinocyte Growth Factor, 0.5 ng/mL Epidermal Growth Factor, 
1.0 x 10-5 M L-carnitine, 1.0 x 10-2 M L-serine,  and supplemented with a lipid-mixture (25 
µM palmitic acid, 15 µM linoleic acid, and 7 µM arachidonic acid), 50 µg/mL ascorbic 
acid, and Vitamin E. Medium was changed twice a week. For the exposure, cultures were 
incubated overnight in the above mentioned medium, in the absence of hydrocortisone.25 
All substances were derived from Sigma Chemical Co. (St. Lewis, MO, USA) unless stated 
otherwise. 
Chemical exposure
Two red inks and three black inks which are commercially available from Intenze (Intenze 
Products, Kalsdorf, Austria), Eternal Ink (Eternal Ink, Brighton, UK) and Carbon Black 
(H-A-N GmbH, Esslingen, Germany) were selected for testing in the RhS model (Table 1). 
Hamamelis Virginiana extract was also tested, as it is an anti-inflammatory agent added to 
2 of the 5 tattoo inks investigated in this study (Table 1).Isopropanol (1% w/w) was used as 
vehicle for diluting Eternal Ink Light Red and Carbon Black No. 13 as this is a component 
of the undiluted ink and glycerol (1 % w/w) was used as vehicle for the other inks as 
glycerin (not isopropanol) was a component of these inks (see Table 1). Furthermore, 
a non-sensitizing irritant control was tested in order to obtain a sensitizer threshold level 
for the SI IL-18 parameter: lactic acid (Table 2). 
The culture medium of RhS was supplemented with test substances at final 
concentrations of 10%, 1%, 0.1%, and 0.01%, or as stated otherwise, for 24 hours. Lactic 
acid and Hamamelis Virginiana water were diluted in culture medium to the required 
concentrations. Hereafter RhS were harvested. RhS biopsies were taken and processed 
immediately i) using the MTT assay to determine mitochondrial activity and ii) for 
histology. In addition, culture supernatant obtained from underneath the air-exposed RhS 
was harvested and stored at -20 °C until further ELISA analysis. 
MTT assay
Mitochondrial activity, an indicator for cell viability, was determined using the MTT 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2. The hazard identification of the vehicles, additive, and irritant according to CLP a.
Chemical name CAS nr. Hazard identification
Isopropanol 67-63-0 Eye irrit. 2
Glycerol 56-81-5 NA
Hamamelis Virginiana extract 84696-19-5 NA
Lactic acid 79-33-4 Eye Dam. 1b, Skin Irrit. 2b, Eye Irrit. 2b, Skin Corr. 1Bb
NA =  Not available
a Classification, Labelling and Packaging of Substances and Mixtures Regulation (CLP, Regulation (EC) 
No. 1272/2008)
b Self-classified by the registrant under REACH (Registration, Evaluation, Authorisation, and Restriction of Chemicals 
Regulation (EC) No. 1907/2006). 
any excess ink from the underside of the culture, and transferred to a 96 wells culture plate 
containing 200 µL thiazolyl blue tetrazolium bromide (MTT) diluted in PBS (2 mg/mL) and 
further processed as described in Gibbs, Corsini, Spiekstra, Galbiati, Fuchs, Degeorge, 
Troese, Hayden, Deng and Roggen.23 To determine whether the tattoo inks were able to 
interfere with the MTT assay, 10 % of each tattoo ink was tested in the absence of RhS. 
No colour change measured at 570 nm was observed and therefore it was concluded that 
the inks did not interfere with the MTT assay at concentrations used for RhS exposure. This 
is the method recommended in the OECD TG 431 and 439 for in vitro skin corrosion test 
(epiCS 2012). 
Hematoxylin/eosin paraffin staining assay
For light microscopic examination, RhS samples were fixed in 4% paraformaldehyde and 
embedded in paraffin. Subsequently, thin sections (5 µm) were cut and stained using 
hematoxylin and eosin. 
IL-18 ELISA
After exposure, the amount of IL-18 in the culture supernatant was measured using 
a commercially available specific sandwich ELISA kit according to manufacturer’s 
instructions (MBL, Nagoya, Japan). Cytokine levels determined in the exposed RhS were 
transformed into a stimulation index (SI) relative to the vehicle (fold increase), according to 
the procedure described in Gibbs, Corsini, Spiekstra, Galbiati, Fuchs, Degeorge, Troese, 
Hayden, Deng and Roggen 23.
High-performance liquid chromatography (HPLC)
RP-HPLC (Jasco, Japan) was performed using aSymmetry C18 column, 100Å, 5 µm, 
3.9 x 150 mm (Waters, Milford, MA, USA), containing dimethyloctadecylsilyl bonded 
amorphous silica. to detect the presence of PAHs in the black inks. A PAH identification 
mixture and a benzo[a]pyrene standard were obtained from Sigma Chemical Co. (St. 
Lewis, MO, USA). To prepare the benzo[a]pyrene standard, the chemical was dissolved 
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in methanol to a concentration of 10 ug/mL.  Each black ink (1 mL) was extracted 
overnight using 5 mL dinitrochloromethane (Biosolve, The Netherlands), and dried in 
a vacuum concentrator RVC-2-25 Co plus (CHRIST, Germany). Subsequently, ink samples 
were dissolved in methanol. Samples were filtered over a PTFE 0.2m membrane filter 
and elution was performed with a linear gradient from 40-85% acetonitrile (Actu-ALL 
chemicals, The Netherlands) containing 0.1% TFA (Biosolve, The Netherlands) for 45 
minutes at a flowrate of 1 mL/min.  The PAH identification mixture was used to compare 
with peaks obtained from the tattoo inks. For identification of benzo[a]pyrene, 20 µl of 
10 µg/ml benzo[a]pyrene standard was analyzed separately and then 90 µl of 100 µg/ml 
benzo[a]pyrene standard was spiked with 10 ul of the extracted Intenze Sculpting Black 
tattoo ink fraction.
Data analysis
Data represents at least three independent experiments with an intra-experiment duplicate. 
Each experiment used RhS constructed from a different skin donor. Results of cell viability 
and IL-18 secretion were analyzed using one-way ANOVA followed by Dunn’s multiple 
comparison test (GraphPad Prism, version 7.0). Difference was considered significant when 
p < 0.05, compared to the vehicle-exposed control for IL-18 SI and the negative control 
for cell viability.
rESULTS 
Tattoo inks exhibit irritant properties when exposed to reconstructed 
human skin
Five tattoo inks were selected for testing in the RhS model in order to determine their skin 
irritant- and sensitizing potency. Furthermore, two vehicles (glycerol and isopropanol), one 
tattoo ink additive (Hamamelis Virginiana extract), and one irritant (lactic acid) were tested 
(Table 1; Table 2). The substances were added to the culture medium of RhS and tested in 
a dose-dependent manner for 24 hours.
Clear deleterious effects were observed in the tissue architecture of the RhS exposed to 
the tattoo inks Eternal Ink Light Red, Intenze Gold Label Bright Red, and Intenze Sculpting 
Black at a concentration of 10% (Fig. 1). Cytotoxicity was indicated by an increase in 
the number of vacuoles, nuclei shrinkage, and detachment of the epidermis. Carbon 
Black No. 13 Blackout and Intenze True Black had no visible effects on tissue histology. As 
expected, the irritant control (lactic acid) was clearly cytotoxic at a concentration of 0.06%, 
and Hamamelis Virginiana extract had no effect on tissue architecture. 
The MTT assay was performed in order to determine the test substance concentration 
which reduces RhS viability by 50% (EC50 value). This value relates to the cytotoxic/irritant 
potential of the substances (a low EC50 value corresponds to strong irritant potency). 
With the exception of Intenze True Black and Hamamelis Virginia extract, RhS viability 
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Figure 1. Histology of RhS exposed to tattoo inks, Hamamelis Virginiana extract, vehicles glycerol 
and isopropanol, and lactic acid. Test substances were added to the culture medium for 24 hours. For 
Eternal Ink Light Red and Carbon Black No. 13 Blackout isopropanol (1% w/w) was used as vehicle, 
and for all other substances the vehicle was  glycerol (1% w/w). Representative hematoxylin and eosin 
staining of 5-um paraffin-embedded RhS tissue sections is shown. 200 x magnification; scale bar 
represents 50 µm. 
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and irritant in order of most-toxic to non-toxic based on their EC50 value provides: 
Eternal Ink Light Red (0.04% w/w) > lactic acid (0.05% w/w) > Intenze Sculpting Black 
(0.09% w/w) > Intenze Gold Label Bright Red (6.3% w/w) > Carbon Black No.13 Blackout 
(12% w/w) > Intenze True Black (not reached) > Hamamelis Virginiana extract (100% w/w). 
Clearly, four of the five inks have cytotoxic/irritant in vitro properties with Eternal Ink Light 
Red and Intenze Sculpting Black, being highly cytotoxic/ in the same order of magnitude as 
lactic acid.
Exposure to Eternal Ink Light red and Intenze Sculpting Black 
increases release of sensitization biomarker IL-18 from reconstructed 
human skin
Having determined the cytotoxic/irritant potential of the five tattoo inks, we next determined 
whether the dyes could also result in an increase in the sensitization biomarker IL-18 release 
from RhS. Two dyes in particular, Eternal Ink Light Red (SI: 88 ± 45) and Intenze Sculpting 
Black (SI: 62 ± 15) resulted in a substantial release of IL-18 into the culture supernatant 
of RhS compared to the other three tattoo dyes, indicating that these dyes may have 
sensitizing potential (Fig. 2; Table 3). The tattoo dye vehicles (glycerol and isopropanol), 
Hamamelis Virginiana extract, and lactic acid did not increase IL-18 release as expected. 
The extremely strong sensitizer benzo[a]pyrene is present in Intenze 
Sculpting Black
To explain the differences in IL-18 release and cytotoxicity observed between Intenze 
Sculpting Black and the other two black inks, HPLC was performed to screen for PAHs 
(Fig. 3.). Special attention was paid to benzo[a]pyrene since this compound is classified as 
extremely strong sensitizer in the Local Lymph Node Assay.28 HPLC analysis indicated that 
Intenze Sculpting Black contains three major compounds that co-eluted with peaks 1, 3 
and 11 from the PAH identification mixture. Intenze True Black contains mainly compounds 
that co-eluted with  peaks 4 and 13 while Carbon Black mainly contains compound 4. 
Interestingly, Compound 11 being benzo(a)pyrene (as determined by spiking the ink with 
a benzo[a]pyrene standard) was only present in Intenze Sculpting Black.
DISCUSSION
From our clinical experience as well as scientific literature it can be concluded that tattoo 
inks may cause deleterious health effects in the skin.1, 7 This finding therefore calls for much 
stricter safety assessment of tattoo inks in the future. In this study, using the 3D organotypic 
RhS model and the sensitization biomarker IL-18, we clearly demonstrate that four of  five 
tested inks were cytotoxic (and therefore have irritant properties) and that two inks may 
have sensitizing potential. Currently, in vitro analysis regarding the toxicity of tattoo inks 





Figure 2. Tattoo inks are cytotoxic and result in IL-18 release from RhS. RhS were exposed to test 
substances for 24 hours, culture supernatants were then analyzed using a specific IL-18 ELISA, and 
RhS cell viability was determined using the MTT assay. IL-18 stimulation index (grey bars) and cell 
viability (black bars) are shown as mean ± SEM with each experiment (n) representing a different batch 
of RhS constructed from a different donor skin for Eternal Ink Light Red (n = 5),  Intenze Gold Label 
Bright Red (n = 5),  Intenze Sculpting Black (n = 5), Carbon Black No. 13 Blackout (n = 4), Intenze 
True Black (n = 4), Hamamelis Virginiana extract (n = 4), and lactic acid (n = 3). Statistical significance 
was determined using one-way ANOVA followed by Dunn’s multiple comparison test. * p < 0.05; 
** p < 0.01 compared to the vehicle-exposed RhS.
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Table 3. Summary results of cell viability and IL-18 secretion for inks, additives, and irritants. 
Tattoo Ink Conc.
Cell viability  
± SEM (%) EC50
IL-18 SI  
± SEM N
Eternal Ink 0.01 % 57 16 0.04% 11 7.6 5
Light Red 0.1% 33 13 31 17
1% 12 3.0 88 45
10% 6.4 2.2 50 13
Intenze Gold Label Bright Red 0.01 % 110 6.1 6.3% 1.2 0.48 5
0.1% 103 8.5 0.9 0.15
1% 80 11 4.1 1.3
10% 6.4 1.6 4.1 1.4
Intenze 0.01 % 78 7.7 0.09% 1.9 0.37 5
Sculpting Black 0.1% 47 10 29 14
1% 15 4.0 41 16
10% 5.8 1.0 62 15
Carbon Black 0.01 % 90 5.0 12% 1.4 0.23 4
No.13 Blackout 0.1% 99 4.6 1.5 0.23
1% 86 9.4 1.5 0.28
10% 57 14 1.3 0.56
Intenze True 0.01 % 85 11  NR 1.1 0.19 4
Black 0.1% 88 13 0.8 0.18
1% 94 13 1.4 0.50





0.01 % 105 10 100% 1.6 0.35 4
0.1% 82 11 2.5 0.39
1% 80 13 2.8 1.12
10% 79 3.8 1.2 0.25
Control Irritant:
Lactic Acid 0.03% 84 7.4 0.05% 1.4 0.24 3
0.06% 11 1.9 8.3 3.9
0.1% 9 1.0 0.1 0.02
0.3% 12 2.7 0.0 0.01
N = Number of experiments; NR = Not reached; SEM = Standard Error of the Mean; SI = Stimulation Index.
Eternal Ink Light Red and Carbon Black No. 13 Blackout are expressed relative to the vehicle isopropanol (1% w/w), 
all other exposure conditions are expressed relative to the vehicle glycerol (1% w/w).. IL-18 SI ≥10 is indicated in 
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Figure 3. Black tattoo inks contain PAHs. Comparative HPLC analysis was performed on the black 
tattoo inks. (A) shows the PAH identification mixture. Peaks correspond to the following substances: 
(1) naphthalene; (2) acenaphthylene; (3) fluorene; (4) phenanthrene; (5) anthracene; (6) fluoranthene; 
(7) pyrene; (8) benz[a]anthracene/chrysene; (9) benzo[b]fluoranthene; (10) benzo[k]fluoranthene; 
(11) benzo[a]pyrene; (12) dibenz[a,h]anthracene; (13) benzo[ghi]perylene; (14) indeno(1,2,3-C,D)
pyrene. (B) Intenze Sculpting Black contains naphthalene, fluorene, and benzo[a]pyrene; (C) Intenze 
True Black contains phenanthrene and benzo[ghi]perylene; and (D) Carbon Black No. 13 Blackout 
contains phenanthrene. 
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research is thereby the first to use an advanced in vitro RhS model to study tattoo ink-
induced complications observed in patients. 
It is now generally accepted that skin sensitization will not be established without 
xenoinflammation, which involves triggering the inflammasome and the innate immune 
system (Key Events 2 and 3 in the AOP).20 Furthermore, the irritant potency of a chemical 
has been shown in vivo and in vitro to be directly related to sensitizing potency, and it also 
has been shown that skin irritation conditions the development and severity of allergic 
contact dermatitis.29-32 In this study we demonstrate that the inks varied considerably 
in their irritant potency as illustrated by the broad range of EC50 values obtained after 
supplementation of  inks into the culture medium of RhS (EC50: 0.04% - EC50: not 
reached). Notably, Eternal Ink Light Red and Intenze Sculpting Black had an EC50 value 
in the same range as lactic acid (EC50 < 0.1 %) suggesting that both inks have strong skin 
irritant and corrosive properties. Furthermore these two inks were able to cause significant 
IL-18 secretion, a key biomarker for the onset of skin sensitization (Key Event 2). 
In our RhS (as well as our RhE) assay, cytotoxicity is required as this results in cell 
membrane permeability which ensures the release of all intracellularly accumulated IL-18 
into the culture supernatant.23 A background level of IL-18 can be measured after exposure 
to irritants as well as contact sensitizers. However, only upon exposure to a contact 
sensitizer, can neosynthesis and intracellular accumulation of IL-18 occur in the cell. 
Therefore, an increase in IL-18 concentration is indicative of a skin sensitizer in the RhS 
as well as the RhE model.23 Since our previous studies used RhE (rather than RhS) we 
cannot directly use the same prediction model for labeling and classifying sensitizers. 22, 23 
The current results indicate that the threshold to distinguish between sensitizers and 
irritants is slightly higher with RhS compared to the RhE IL-18 SI threshold of 5, since lactic 
acid in RhS has an IL-18 SI of 8.3 ± 3.9. This may be due to the presence of fibroblasts in 
RhS and the different method of chemical exposure (dermal rather than topical epidermal). 
However, it should be noted that even for commercially available and in house RhE, each 
model needs to define its own threshold.23 Notably, in comparison to the other tattoo 
inks and lactic acid, Eternal Ink Light Red and Intenze Sculpting Black had very high RhS 
SI IL-18 values (SI:88 ±  45 and SI:62 ± 15 respectively), indicating that these inks were 
activating Key Event 2 of the sensitization AOP. Further investigation with a standard panel 
of chemicals, as was used in the RhE model 23 is now required to validate the RhS dermal 
exposure model for comparing sensitizer and irritant potency. However, the assessment of 
tattoo inks in the RhS model will remain a semi-quantitative assay as it will not be possible 
to extrapolate the EC50 and SI IL-18 values to the in vivo tattoo ink concentrations, as we 
have done in the past for chemical sensitizers, as currently no tattoo ink human or animal 
(LLNA) chemical concentration data is available for such correlations.23 The importance of 
developing a model which includes a dermal exposure route is illustrated by the clinical 
study performed by Serup and Hutten Carlsen who patch tested seventy nine patients with 
suspected allergy to red inks with nine red pigments. Only one ink was able to score as 




in patch testing with the red pigments not being able to penetrate the stratum corneum 
to trigger an immune response or it may be due to pigments used in the study not being 
present in the red tattoos which showed the allergic symptoms. For these reasons, in 
our study we chose to expose RhS via the more relevant dermal route and to investigate 
the complete tattoo inks as obtained from the suppliers. 
As shown in Table 1, Eternal Ink Light Red contains the skin sensitizer Pigment Red 
170. Therefore it was expected that this ink would score positive as a skin sensitizer in our 
RhS model (high IL-18 SI: 88 ± 45). In comparison, Intenze Gold Label Bright Red, which 
also causes clinical allergy, does not contain any substances with skin sensitizing potential 
according to its label. However, based on chemical composition of both the preservative 
Diazolidinyl Urea and the pigment Orange 13 present in Intenze Gold Label Bright Red, 
one may expect release of oxidation products with skin sensitizing capacity over time (i.e. 
formaldehyde and 3,3’-chlorobenzidine). This may explain the difference which we found 
between Eternal Ink Light Red (positive score as skin sensitizer) and Gold Label Bright Red 
(negative score as skin sensitizer) in our RhS model. We are aware of the fact that 24 hours 
of exposure is a current limitation of our RhS model, since this excludes possible toxic 
effects of red ink pro-electrophiles and pre-electrophiles (OECD 2012). These processes 
can be studied in the RhS model in the future by extending the exposure time, or by co-
exposure with UV-light. 
In order to investigate the black inks further, HPLC was used to screen for PAHs. 
The black inks contained a number of compounds correlating to PAHs with Intenze 
Sculpting Black containing one compound (peak 11) which was confirmed as being 
benzo[a]pyrene Considering the sensitizing (and carcinogenic) properties of PAHs, and in 
particular of benzo[a]pyrene,17, 28 these PAHs may be related to the cytotoxicity and high 
IL-18 release observed after RhS exposure to Intenze Sculpting Black. Although reactions 
to black inks are reported, such as papulo-nodular reactions and phototoxic reactions, 
allergic reactions to black tattoo ink rarely occur.1, 6, 33, 34 One possible explanation for this 
may be that the PAHs are removed from the skin with time, in contrast to the encapsulated 
ink pigments.35, 36 Also, whereas a substantial increase in IL-18 secretion was observed in 
the RhS after exposure to Intenze Sculpting Black, our RhS–IL18 assay only represents 
keratinocyte activation (Key Event 2) of the sensitization AOP and further downstream key 
events such as dendritic cell activation and T cell priming may possibly not occur. This will 
be a subject for further investigation. 
CONCLUSION
Our results contribute to a better understanding of the tattoo induced complications 
observed in our outpatient tattoo clinic, where we observed most allergic reactions in red 
pigmented tattoos.8, 9 The substantial increase of IL-18 which we observed in RhS exposed 
to Eternal Ink Light Red supports the clinical data that this ink may be responsible for 
chronic allergic reactions. As the number of people with a tattoo has been increasing 
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significantly during the past decade, it is important that adequate  safety assessment 
of tattoo inks takes place. Tattoo inks currently do not fall under European harmonized 
legislation, but under national regulations based on resolution CoE ResAP (2008)1.12 
These regulatory frameworks differ between countries: some EU countries do not 
have specific legislation regarding tattoo safety; some countries do regulate tattooing 
practices but do not transpose the CoE ResAP into the national legislation; and some 
countries have adopted either CoE ResAP (2003)2 or CoE ResAP (2008)1.37 The European 
Chemicals Agency (ECHA) is therefore preparing a dossier for restriction of hazardous 
chemicals in tattoo inks under the Registration, Evaluation, Authorisation, and Restriction 
of Chemicals Regulation (REACH, Regulation (EC) No. 1907/2006). This document will 
provide information on all the required toxicology end-points, based on the tonnages of 
the substances currently used on the European market. 
ACKNOWLEDGEMENTS
The authors want to acknowledge Dr J.G.M Bolscher for critically reading this manuscript 
and discussions.
The authors have no conflicts to declare. This study was financed by VU University 
Medical Center.
AUTHOr CONTrIBUTIONS
S. Gibbs, S.W. Spiekstra, T. Rustemeyer, S.A.S. van der Bent, and W. Bil designed 
the research; W. Bil, S.W. Spiekstra, and K. Nazmi performed the research; W. Bil, S.W. 
Spiekstra and S. Gibbs analyzed the data;, W. Bil, S. Gibbs, K. Nazmi, and S.A.S. van der 
Bent drafted the paper, and W. Bil, S. Gibbs, K. Nazmi, S.W. Spiekstra, S.A.S. van der Bent, 





1. Piccinini P, Pakalin S, Contor L, Bianchi L, Senaldi C. Safety of tattoos and permanent 
make-up: Final report. EUR27947, 2016.
2. Falconi M, Teti G, Zago M, Galanzi A, Breschi L, Pelotti S, Ruggeri A, Mazzotti G. Influence 
of a commercial tattoo ink on protein production in human fibroblasts. Arch Dermatol 
Res 2009: 301: 539-47.
3. Regensburger J, Lehner K, Maisch T, Vasold R, Santarelli F, Engel E, Gollmer A, Konig 
B, Landthaler M, Baumler W. Tattoo inks contain polycyclic aromatic hydrocarbons that 
additionally generate deleterious singlet oxygen. Exp Dermatol 2010: 19: e275-81.
4. Neale P A, Stalter D, Tang J Y M, Escher B I. Bioanalytical evidence that chemicals in tattoo 
ink can induce adaptive stress responses. J Hazard Mater 2015: 296: 192-200.
5. Wamer W G, Yin J J. Photocytotoxicity in human dermal fibroblasts elicited by permanent 
makeup inks containing titanium dioxide. J Cosmet Sci 2011: 62: 535-47.
6. Serup J, Carlsen K H. Patch test study of 90 patients with tattoo reactions: negative 
outcome of allergy patch test to baseline batteries and culprit inks suggests allergen(s) are 
generated in the skin through haptenization. Contact Dermatitis 2014: 71: 255-63.
7. Serup J, Carlsen K H, Sepehri M. Tattoo complaints and complications: diagnosis and 
clinical spectrum. Curr Probl Dermatol 2015: 48: 48-60.
8. Van Der Bent S A S, Maijer K I, Rustemeyer T. Image Gallery: Hyperkeratotic hypersensitivity 
reaction to red pigment tattoo. Br J Dermatol 2017: 177: e350.
9. Van Der Bent S A S, Wolkerstorfer A, Rustemeyer T.  Cutaneous Adverse Reactions to 
Tattoos. Ned Tijdschr Geneeskd 2016: 160: A9808.
10. Carlsen K H, Serup J. Chronic tattoo reactions cause reduced quality of life equaling 
cumbersome skin diseases. Curr Probl Dermatol 2015: 48: 71-5.
11. Piccinini P, Contor L, Pakalin S, Raemaekers T, Senaldi C. Safety of tattoos and permanent 
make-up. State of play and trends in tattoo practices. EUR27528, 2015.
12. Laux P, Tralau T, Tentschert J, Blume A, Dahouk S A, Bäumler W, Bernstein E, Bocca B, 
Alimonti A, Colebrook H, De Cuyper C, Dähne L, Hauri U, Howard P C, Janssen P, Katz L, 
Klitzman B, Kluger N, Krutak L, Platzek T, Scott-Lang V, Serup J, Teubner W, Schreiver I, 
Wilkniß E, Luch A. A medical-toxicological view of tattooing. The Lancet 2016: 387: 395-402.
13. Wijnhoven S W P, Ezendam J, Schuur A G, Loveren H V, Engelen J G M V. Allergens in 
consumer products. In: RIVM Report 320025001/2008, 2008.
14. Ryberg K, Agner T, Andersen K E, Bircher A, Diepgen T, Foti C, Gimenez-Arnau A, Goncalo 
M, Goossens A, Johansen J D, Le Coz C, Maibach H I, Bruze M. Patch testing with a textile 
dye mix--a multicentre study. Contact Dermatitis 2014: 71: 215-23.
15. Isaksson M, Ale I, Andersen K E, Diepgen T, Goh C L, Goossens R A, Jerajani H, Maibach 
H I, Sasseville D, Bruze M. Patch testing to a textile dye mix by the international contact 
dermatitis research group. Dermatitis 2015: 26: 170-6.
16. SCCS. Opinion on Carbon Black (nano-form). In: SCCS/1515/13, 2013.
17. IARC. Carbon black, titanium dioxide, and talc. In: Monographs on the evaluation of 
Carcinogenic Risk to Humans, 2010.
18. OECD. The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding 
to Proteins. Part 1: Scientific Evidence. Paris OECD Publishing 2012.
SKIN SENSITIZATION POTENCY OF FIVE TATTOO INKS
99
6
19. Rovida C, Alepee N, Api A M, Basketter D A, Bois F Y, Caloni F, Corsini E, Daneshian M, 
Eskes C, Ezendam J, Fuchs H, Hayden P, Hegele-Hartung C, Hoffmann S, Hubesch B, 
Jacobs M N, Jaworska J, Kleensang A, Kleinstreuer N, Lalko J, Landsiedel R, Lebreux F, 
Luechtefeld T, Locatelli M, Mehling A, Natsch A, Pitchford J W, Prater D, Prieto P, Schepky 
A, Schuurmann G, Smirnova L, Toole C, Van Vliet E, Weisensee D, Hartung T. Integrated 
Testing Strategies (ITS) for safety assessment. ALTEX 2015: 32: 25-40.
20. Martin S F, Esser P R, Weber F C, Jakob T, Freudenberg M A, Schmidt M, Goebeler 
M. Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. 
Allergy 2011: 66: 1152-63.
21. Corsini E, Galbiati V, Mitjans M, Galli C L, Marinovich M. NCTC 2544 and IL-18 production: 
a tool for the identification of contact allergens. Toxicol In Vitro 2013: 27: 1127-34.
22. Galbiati V, Papale A, Marinovich M, Gibbs S, Roggen E, Corsini E. Development of an in 
vitro method to estimate the sensitization induction level of contact allergens. Toxicology 
Letters 2017: 271: 1-11.
23. Gibbs S, Corsini E, Spiekstra S W, Galbiati V, Fuchs H W, Degeorge G, Troese M, Hayden P, 
Deng W, Roggen E. An epidermal equivalent assay for identification and ranking potency 
of contact sensitizers. Toxicol Appl Pharmacol 2013: 272: 529-41.
24. Teunis M, Corsini E, Smits M, Madsen C B, Eltze T, Ezendam J, Galbiati V, Gremmer E, 
Krul C, Landin A, Landsiedel R, Pieters R, Rasmussen T F, Reinders J, Roggen E, Spiekstra 
S, Gibbs S. Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 
to determine the skin sensitizing capacity and epidermal equivalent assay to determine 
sensitizer potency. Toxicol In Vitro 2013: 27: 1135-50.
25. Spiekstra S W, Toebak M J, Sampat-Sardjoepersad S, Van Beek P J, Boorsma D M, 
Stoof T J, Von Blomberg B M, Scheper R J, Bruynzeel D P, Rustemeyer T, Gibbs S. 
Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine 
(CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure. Exp 
Dermatol 2005: 14: 109-16.
26. Kosten I J, Buskermolen J K, Spiekstra S W, De Gruijl T D, Gibbs S. Gingiva Equivalents 
Secrete Negligible Amounts of Key Chemokines Involved in Langerhans Cell Migration 
Compared to Skin Equivalents. J Immunol Res 2015: 2015: 627125.
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to 
proliferation and cytotoxicity assays. J Immunol Methods 1983: 65: 55-63.
28. Gerberick G F, Ryan C A, Kern P S, Schlatter H, Dearman R J, Kimber I, Patlewicz G Y, 
Basketter D A. Compilation of historical local lymph node data for evaluation of skin 
sensitization alternative methods. Dermatitis 2005: 16: 157-202.
29. Basketter D A, Kan-King-Yu D, Dierkes P, Jowsey I R. Does irritation potency contribute to 
the skin sensitization potency of contact allergens? Cutan Ocul Toxicol 2007: 26: 279-86.
30. Bonneville M, Chavagnac C, Vocanson M, Rozieres A, Benetiere J, Pernet I, Denis A, 
Nicolas J F, Hennino A. Skin contact irritation conditions the development and severity of 
allergic contact dermatitis. J Invest Dermatol 2007: 127: 1430-5.
31. Grabbe S, Steinert M, Mahnke K, Schwartz A, Luger T A, Schwarz T. Dissection of 
antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence 
that not the antigenic component but nonspecific proinflammatory effects of haptens 
determine the concentration-dependent elicitation of allergic contact dermatitis. J Clin 




32. Mclelland J, Shuster S, Matthews J N. ‘Irritants’ increase the response to an allergen in 
allergic contact dermatitis. Arch Dermatol 1991: 127: 1016-9.
33. Sepehri M, Hutton Carlsen K, Serup J. Papulo-Nodular Reactions in Black Tattoos 
as Markers of Sarcoidosis: Study of 92 Tattoo Reactions from a Hospital Material. 
Dermatology 2016: 232: 679-686.
34. Carlsen K H, Serup J. Photosensitivity and photodynamic events in black, red and blue 
tattoos are common: A ‘Beach Study’. J Eur Acad Dermatol 2014: 28: 231-237.
35. Lehner K, Santarelli F, Vasold R, Penning R, Sidoroff A, Konig B, Landthaler M, Baumler W. 
Black tattoos entail substantial uptake of genotoxicpolycyclic aromatic hydrocarbons (PAH) 
in human skin and regional lymph nodes. PLoS One 2014: 9: e92787.
36. Kaur R R, Kirby W, Maibach H. Cutaneous allergic reactions to tattoo ink. J Cosmet 
Dermatol 2009: 8: 295-300.
37. Piccinini P, Bianchi L, Pakalin S, Senaldi C. Safety of tattoos and permanent make-up. 





rEACTIONS USING 3D OPTICAL 
IMAGING: A FEASIBILITY STUDY
Mark D. den Blanken, Sebastiaan A.S. van der Bent, Niels 
Liberton, Matthijs Grimbergen, Mark B.M. Hofman, Ruud 
Verdaasdonk, Thomas Rustemeyer






User independent quantitative measures of cutaneous allergic reactions can help 
the physicians manage and evaluate the treatment of cutaneous allergic reactions. In this 
paper we present and validate a method to quantify the elevation, volume and area of 
cutaneous allergic reactions to red tattoos.
Methods
The skin surface of allergic tattoo reactions was imaged using an optical 3D scanner. 
The in-house developed analysis tool measured the elevation, volume and area of 
the lesions, compared to a reference surface. This reference surface was created by 3D 
interpolation of the skin after manual removal of the lesions. The error of the interpolation 
tool was validated using a digital arm model. The error of our optical scanner was 
determined using a 3D printed lesion phantom. The clinical feasibility of the method was 
tested in 83 lesions in 17 patients.
results
The method showed clear potential to assess skin elevation, volume change and area of an 
allergic reaction. The validation measurements revealed that the error due to interpolation 
increases for larger interpolation areas, and largely determined the error in the clinical 
measurements. Lesions with a width ≥4 mm, and an elevation ≥0.4 mm could be measured 
with an error below 26%. Patient measurements showed that lesions up to 600 mm2 
could be measured accurately, and elevation and volume changes could be assessed 
at follow-up. 
Conclusion
Quantification of cutaneous allergic reactions to red tattoos using 3D optical scanning is 
feasible and may objectify skin elevation and improve management of the allergic reaction.




The measurement and quantification of cutaneous allergic reactions is important for 
treatment management and evaluation, since it provides an objective measure free off 
inter-observer variation, and enables the medical specialist to compare the cutaneous 
allergic reactions before and after treatment. In current clinical practice the evaluation of 
the skin is generally performed in a qualitative manner, such as a description of visible signs 
of inflammation and structure evaluation by touching the skin.1 Quantitative measurements 
such as measuring tape or a caliper are used less frequently. Medical photography might 
be used as a reference in follow-up, however medical photography only provides a relative 
quantification. These measurements are user dependent, and therefore the reliability 
and reproducibility are subject to the skill of the investigator. A frequently used semi 
invasive method is a skin patch test;2 a diagnostic tool to determine sensitization or an 
allergic reaction. However, this test only provides a subjective measure for the severity of 
the allergic reaction. A user-independent quantitative method to evaluate allergic lesions 
can be an improvement. Ultrasound 3 is a user-independent quantitative method, however 
this method is not commonly used in the clinic for the assessment of allergic reactions.
Since handheld 3-dimensional (3D) scanners can produce high resolution 3D surfaces 
and have become portable, inexpensive and require little training, they are increasingly 
used in clinical setting. These scanners typically use structured light to measure surfaces.4 
They have been applied to measure body volumes,5 to compare BMI with 3D,6 to study 
growth defects, to design patient-specific prosthetics,7 as well as measuring wounds 8 and 
scar height.9 But up to now they have not been applied to quantify cutaneous allergic 
reactions. 3D optical scanning techniques may offer an user-independent, non-invasive, 
quantitative method for the management or evaluation of skin treatment.
Allergic tattoo reactions are suitable to study the feasibility of 3D optical 
scanning as the allergic area is chronic, well defined and frequently causing a plaque 
elevation.10 Chronic allergic tattoo reactions are predominantly caused by red tattoo 
ink, and the number of allergic tattoo reactions correlate with the increasing number of 
aesthetic tattoos.11
The purpose of this study is to show the feasibility of 3D optical scanning as a tool to 
quantify allergic reactions of the skin. Therefore, we developed an analysis tool of the 3D 
images, and tested the method for accuracy and in patients with one or more allergic 
tattoo reactions.
METHODS
Handheld optical 3D scanner
For this study a handheld optical 3D scanner (Artec Spider, Artec 3D, Luxembourg), 
henceforth called optical scanner, was used, see figure 1. The optical scanner has a 3D 
resolution of 0.1 mm and 3D point accuracy of 0.05 mm, which is smaller than the smallest 




from 90x70 mm (at 0.17 m) to 180x140 mm (at 0.35 m), so even allergic reactions with 
a diameter up to 100 mm can be assessed. The frame rate of the optical scanner is 7.5 
frames per second, while the exposure time of one frame is 0.5 ms 12. Thus, the typical scan 
time to obtain a scan of one side of the fore-arm is about 60 seconds, generating 92-338 
images. The optical scanner was operated using a regular laptop (HP ZBook 15, Intel 
Core i7-4700 MQ CPU @ 2.40 GHz, 24 GB RAM, 64-bit OS) running 3D image acquisition 
software (Artec Studio v.12 professional, Artec 3D, Luxembourg).
The optical scanner generates data when making a 3D scan. This raw scan data is 
polygonised, and exported as an Surface Tessellation Language (STL) model, using the 3D 
image acquisition software of the optical scanner, see figure 2.
Figure 1. Handheld optical 3D scanner: Artec Spider, Artec 3D, Luxembourg.
Figure 2. The top panel shows raw 3D scan data of an allergic tattoo reaction on a leg in the 3D 
image acquisition software. The bottom panel shows a polygonised surface of the raw 3D scan data. 




The analysis algorithm consists of an interpolation tool, which is required to create 
a reference surface which is used in the analysis tool , which calculates the elevation, 
volume and area of the lesions on the STL model.
Interpolation tool
The scanned skin surface, presented by an STL model, is further processed in a software 
package (GOM Inspect metrology software, Braunschweig, Germany). The surface model 
is manually positioned such that the z-axis is set perpendicular to the skin surface at 
the location of the allergic reaction. This is a requirement for the analysis tool. This model 
is henceforth called original surface model.
A reference surface model is required to determine the elevation and volume in 
the analysis tool, see figure 3. The reference surface model represents the shape of 
the skin without the lesions. To create the reference surface model, regions of interest 
(ROI’s) are selected around the lesions in a duplicate of the original surface model, and 
removed to create a hole surface model, see figure 4. These ROI´s are selected manually 
closely around the allergic reaction. Subsequently, the surface in the hole surface model 
is interpolated over the holes using a standard algorithm of the GOM Inspect software 
(Close Holes Interactively, type Normal, while neighboring polygons were not deleted) 
to create the reference model. The algorithm interpolates the existing surface based 
continuity of the surface normal vectors of the surrounding triangles. Both original and 
reference surface model were exported as ASCII-files containing space coordinates.
Analysis tool
The analysis tool calculates the elevation, volume and area of lesions from the original 
surface model and the reference surface model. This tool is in-house developed software 
within MATLAB (Release 2015b,The MathWorks, Inc., Natick, Massachusetts, United 
Figure 3. The analysis tool calculates the elevation and the volume of the lesions from the original 
surface model and the reference surface model. The elevation is given as the maximum distance 




States). The Matlab functions meshgrid (resolution of 0.1 mm in x- and y-direction) and 
griddata (linear fit) were used to convert the surface models to a measurable grid (of 
0.1x0.1 mm in x- and y-direction), with respective interpolated z-coordinates.
The elevation is assessed by calculating the maximum distance between the two 
surfaces, see figure 3, based on the normal vector of the reference surface model. 
The volume is calculated by integrating the volume between the two surfaces. Each 
gridpoint has a surface area depending on the normal of the surface. The interpolated area 
is calculated by summation of the areas of all gridpoints in which the original surface model 
is elevated from the reference surface model. The lesion area is calculated by summation 
of the areas of all gridpoints in which the elevation (difference between the reference 
surface model and the original surface model) exceeds a threshold of 0.1 mm.
Validation
In this section the methods are described for assessing the induced errors by the analysis 
algorithm and the optical scanner.
Interpolation induced errors
The interpolation tool creates a reference surface. The accuracy of this algorithm together 
with the shape of the original surface determines the accuracy of the elevation and volume 
measurements. The errors induced by the interpolation tool are estimated by applying 
Figure 4. Flow scheme of the interpolation tool. The tool duplicates the original surface model. 
ROI’s are manually selected around the lesions on the duplicate original surface model, which are 
subsequently removed to create a hole surface model. The surface is interpolated over the holes to 
create the reference surface model. The original surface model and the reference surface model are 
then used to calculate the elevation, volume and area in the analysis tool.
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the analysis tool to a surface model of a lower arm without any lesions, see figure 5. 
The lower arm of a volunteer was scanned with the optical scanner. From this data a digital 
3D model, henceforth called arm model, was created. The volunteer had no visible lesions 
on the arm, only a few small naevi.
Duplicates of the arm model were created. In each duplicate an ROI was selected 
to be removed from the model, in order to create hole surface models. The holes were 
interpolated to create reference surface models, as described by the interpolation tool. 
Since the original surface model of the arm had no lesions, the reference surface models 
intents to be similar to the original surface model. Any deviations between the two surfaces 
is due to induced errors by the interpolation tool. Using the analysis tool, these errors in 
the elevation and volume were determined. 
ROI´s with variable size and position were applied; on 32 positions (8 positions 
transversally, 4 positions axially) and sizes ranging from 25 to 1200 mm2. The ROI´s were 
rectangular for practical reasons. To calculate the standard deviation of the induced error, 
the results were grouped based on the intended size of the ROI’s. The actual size of 
the ROI’s increased somewhat due to the 3D nature of the surfaces, while the selection 
of the ROI’s was performed in a 2D view. The intended sizes of the ROI’s were: 5x5mm 
(25 mm2), 10x10 mm (100 mm2), 15x15 mm (225 mm2), 20x20 mm (400 mm2), 20x40 mm 
(800 mm2) and 30x30 mm (900 mm2).
The elevation error was measured as the largest distance between the original surface 
model of the arm and a reference surface per ROI. A positive value was given if the original 
surface was above the reference surface, and vise versa for a negative value. The same 
holds for the measurements of the volume error. 
Scanning induced errors
Secondly, the accuracy of the optical scanner in combination with the analysis tool was 
tested. The measurement errors were quantified using a 3D printed lesion phantom, see 
figure 6, which was created using MATLAB. The phantom consists of a flat surface with 
Gaussian shaped lesions. Due to the flat surface, interpolation errors do not contribute. 
The lesions vary in diameter and in elevation; elevation ranges from 0.1 to 5 mm, and 
4  |     den BLAnKen et AL.
by	the	interpolation	tool.	Using	the	analysis	tool,	these	errors	in	the	









10	 ×	 10	 mm	 (100	 mm2),	 15	 ×	 15	 mm	 (225	 mm2),	 20	 ×	 20	 mm	
(400	mm2),	20	×	40	mm	(800	mm2)	and	30	×	30	mm	(900	mm2).






Secondly,	 the	accuracy	of	 the	optical	 scanner	 in	combination	with	
the	analysis	 tool	was	 tested.	The	measurement	errors	were	quan‐
tified	using	a	3D	printed	 lesion	phantom,	see	Figure	6,	which	was	
created	 using	 MATLAB.	 The	 phantom	 consists	 of	 a	 flat	 surface	
with	Gaussian‐shaped	lesions.	Due	to	the	flat	surface,	interpolation	









ner,	 and	 the	 analysis	 algorithm	 (interpolation	 tool	 and	 analysis	 tool)	
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F I G U R E  4  Flow	scheme	of	the	
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F I G U R E  5  Arm	model	without	any	lesions,	as	applied	to	
quantify	the	errors	induced	by	the	interpolation	tool








the base diameter of the lesion ranges from 0.5 to 16 mm. The standard deviations (SD) 
defining the Gaussian shaped lesions were chosen such that the height of the Gaussian at 
the edge of the base area equals the print resolution of the 3D printer (0.1 mm), resulting 
in a SD ranging from 0.08 to 2.64 mm. The subsequent Gaussian shaped lesions had 
volumes ranging from 0.004 to 217 mm3.
The 3D printed lesion phantom was scanned with the optical scanner, and the analysis 
algorithm (interpolation tool and analysis tool) was applied to measure the elevation, 
volume and area of each lesion separately. The 3D printed lesion phantom was scanned 
6 times, and the resulting elevation and volume were averaged for each original lesion.
To estimate a total error of a lesion measurement with a specific lesion size, elevation 
and hole area, the variances (the square of SD’s) of the two errors (induced by interpolation 
and scanning) are added to calculate the combined SD. This total error is shown as the error 
in the in-vivo results for elevation and volume. The error in the area measurements due to 
the interpolation tool is not determined in this study.
In-vivo feasibility evaluation
The feasibility of quantification of allergic reactions using the optical 3D scanning 
method was evaluated in patients with allergic tattoo reactions. Patients were included 
at The Academic Tattoo Clinic Amsterdam in the period of September 2017 until July 
Figure 6. Photo of the 3D printed lesion phantom to quantify the errors induced by using the optical 
scanner and the analysis tool. The lesion phantom contains Gaussian shaped lesions ranging from 0.1 
to 5 mm in elevation and 0.5 to 16 mm in diameter.
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2018. Patients with a constant, chronic cutaneous tattoo reaction, confined to the red area, 
were included.
After diagnosis was made by the dermatologist, informed consent of the patient was 
obtained to participate in the study to collaborate voluntarily in the study. If complied, 
a 3D scan was obtained by moving the optical scanner around the lesion at a skin distance 
in the range of 17 to 35 cm. Patients with follow-up appointments in the inclusion period 
were scanned multiple times, typically 2-6 months later.
Patients with allergic tattoo reactions were treated with superpotent topical 
corticosteroids for several weeks.
The Medical Ethics Review committee of the VU University Medical Center judged 
that the Medical Research Involving Human Subjects Act did not apply for this study, this 
is registered at ‘Centraal Meldpunt Gegevensverwerking’: VUmc_2017-2434. All patients 
and the volunteer gave informed consent.
The described analysis algorithm was used to assess elevation, volume and area of 
lesions caused by allergic tattoo reactions, before and after treatment. In case of multiple 
distinguishable lesions in a patient, each was measured separately. To evaluate whether 
individual lesions could be measured accurately, the elevation and volume of each individual 
lesion are plotted against the lesion area. To evaluate whether changes in elevation and 
volume of lesions during treatment could be measured significantly, the elevation and 
volume of individual lesions were plotted for each visit to the outpatient department.
rESULTS
Interpolation induced errors
Figure 7 shows the determined error in elevation and volume due to interpolation algorithm 
in the arm model. The mean error in both elevation and volume enlarges with increasing 
interpolation area, as also presented in table 1. At large holes, especially rectangular 
shapes, the interpolation induces large errors. 
Table 1. Mean error and standard deviations in elevation and volume due to interpolation errors for 
different size ranges of the interpolation area, as determined from the data of figure 7. 
Interpolation area [mm2]
Elevation Volume
Mean [mm] SD [mm] Mean [mm3] SD [mm3]
25 – 100 0.03 0.06 0.02 0.4
100 – 225 -0.03 0.10 -0.5 1.5
225 – 400 -0.02 0.14 -1 3
400 – 800 -0.1 0.2 -4 11
>800 (rectangle) 0.1 0.5 27 83





The 3D printed lesion phantom was used to quantify the measurement error induced by 
the scanning method. Figure 8 shows the average error over 6 measurements of elevation, 
volume and area for each lesion on the phantom, against the original lesion elevation and 
diameter. Lesions with a diameter of 4.0 mm and larger, and an elevation 0.2 mm and 
larger, have a mean error in elevation of ≤26% (SD ≤±12%). Lesions with a diameter of 4.0 
mm and larger, and an elevation of 0.5 mm and larger, have a mean error in volume of 
≤22% (SD ≤±17%). 
In-vivo feasibility evaluation
17 patients were scanned with the optical scanner. In total 83 lesions were assessed and 
analyzed. Scanning and analysis was successful in all cases. Making a 3D scan of a lesion 
using the optical scanner took approximately 60 seconds. The majority of the lesions were 
on arms (33) and legs (34), others were on the back (10) or elsewhere (6). 6 patients (18 
Figure 7. The error in elevation (bottom panel) and the volume (top panel) due to the interpolation 
tool, plotted against the interpolation area, as assessed in the arm model. 
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lesions: 7 on arms, 10 on legs, 1 on the back) were scanned during follow-up, 2 patients (8 
lesions: 7 on legs, 1 on the back) were scanned during a second follow-up.
The 3D optical scanning method is capable of visualizing the skin elevation effectively 
as shown in a typical example of a tattoo allergy in figure 9. Especially by removal of 
the skin and tattoo colors in the 3D surface (in the middle panel) the elevations become 
clear, as well as the treatment effect in the right panel.
Figure 8. The averaged error over 6 measurements in elevation (top panel), volume (middle panel) 
and area (bottom panel) due to the optical scanner and analysis tool, plotted against the width and 




Figure 9. The images show an allergic tattoo reaction on the lower arm skin of a patient. Shown are 
the raw 3D scan data the original allergic tattoo reaction (top panel), the 3D surface model prior to 
treatment (left panel) and the 3D surface at follow-up, after treatment (right panel). Our analysis showed 
an elevation of 1.2 mm, volume of 390 mm3, and area of 1100 mm2 for this lesion prior to treatment, 
and an elevation of 0.7 mm, volume of 30 mm3, and an area of 380 mm2 after on follow-up.
The elevation and volume of all measured lesions against the lesion area is presented 
in figure 10. The lesions had an elevation between 0.2 and 4.9 mm, a volume between 0.6 
and 1600 mm3, and an area between 7 and 2600 mm2. In this figure the total error due 
to interpolation and scanning method, as assessed by the validation described above, 
is shown. Clear is that lesions on arms and legs with an area up to 600 mm2 can be 
measured accurately. The total error for in-vivo lesions is dominated by the interpolation 
induced error.
Figure 11 shows the elevation, volume and area for lesions of patients that had one or 
more follow-up scans. It shows that changes in elevation, volume and lesion area can be 
measured significantly.
DISCUSSION
This paper presents an analysis method to quantify lesions of allergic tattoo reactions 
using a 3D optical scanner, in terms of elevation, volume and area of a lesion. The method 
showed to be feasible in a clinical setting, with changes observed in follow-up above 
the estimated error range. 
The results show the interpolation algorithm works accurately for arms and legs, 
with an interpolation area smaller than 600 mm2. The shape of skin is determined 
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Figure 10. The measured elevation (top panel) and volume (bottom panel) are plotted against the lesion 
area for all measured in-vivo lesions. The error bars show the total error due to the interpolation tool 
and the optical scanning method.
by the underlying structures, such as bone, veins, muscle and fat. If these underlying 
structures express themselves in the ROI, and are smaller or of a similar size of the ROI, 
the interpolation tool will not be able to take these into account perfectly, and therefore 
introduces larger errors. The interpolation tool is able to reconstruct the skin surface 
as long as all ‘information’ about the ROI is present in the surrounding skin. Therefore 
the analysis algorithm worked well on most lesions of the arms and legs, and it showed 
more difficulties for lesions of an ankle or back (due to the shoulder blades). Therefore 
the location of lesions in allergic reactions should be researched in the future to minimize 
the errors made by the interpolation tool. The interpolation tool also seemed vulnerable 
to physiological skin surface anomalies such as underlying veins and tendons on the edge 
of the ROI. ROI’s were chosen as such to minimize these problems. Patients could be asked 
to take certain stance to minimize this effect.
The interpolation tool showed a larger SD for rectangular holes compared to square 




tattoos appear in all kind of shapes and sizes, no default shape could be used. Therefore, 
in the future the dependence of the interpolation tool on shape of the tattoo should be 
further studied. In the evaluation in patients (figures 7-10) the SD as assessed with ROI’s 
over the whole fore-arm is applied, which is an overestimation of the error in case of 
lesions in less irregular shaped parts of the skin.
As shown by the results, the optical scanner works accurately for lesions with a diameter 
of 4 mm and larger. We expect the error for lesions smaller than 4 mm to be caused by 
the combination of the optical scanner and the analysis algorithm. Lesions with a diameter 
smaller than 4 mm, typically have an elevation of 0.1-0.2 mm, and 0.1 mm is the resolution 
of the applied optical scanner.12
Figure 11. The measured elevation (top panel), volume (middle panel) and area (bottom panel) for 
lesions of patients with follow-up 3D scans. The error bars show the total error due to the interpolation 
tool and the optical scanning method.
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Most of the evaluated lesions had a diameter above 3 mm and an interpolation area 
below 600 mm2, see figure 10. This study shows that the method is relevant for most, but 
not all allergic tattoo reactions.13
The 3D optical scan method shows in follow-up significant changes in elevation and 
volume, as can be seen in figure 11. These results were not compared to the clinical 
outcome of the treatment as assessed by the dermatologist, since the clinical outcome is 
greatly dependent on the subjective parameter itch,13 and itch is not measured using our 
method. However, the quantification of lesions could be used as an objective marker in 
the evaluation of treatment. This should be further studied in a larger patient cohort. This 
technique could also be promising as a marker in evaluation of new treatments. This 3D 
optical scanning method will also be useful for the quantification of allergic reactions in 
skin patch and prick tests, since the size these lesions are within the limits of the optical 
scanner and the analysis algorithm.
The acquisition of the 3D data takes approximately 60 seconds. 3D scanning is 
therefore workable in a clinical setting. However the post processing of the data and 
the analysis algorithm were applied partial manually in this study, taking about 1 to 2 
hours per patient. For clinical use the time for post-processing and the analysis algorithm 
needs to be reduced to a few minutes. This can be done by combining the analysis in one 
software environment and further automation. 
The optical scanner we applied in this study is an industrial scanner with high 
specifications. The optical scanner showed potential to quantify measures such as 
elevation and volume for allergic reactions. Since optical 3D scanners are currently rapidly 
developing and are becoming more widely available, this technique shows great promise 
to become a commonly used application.
Follow-up of this work should include a test of reproducibility and inter- or intra-observer 
variability. Also the clinical value should be studied in a larger patient cohort. Furthermore, 
the diagnostic value of 3D scanning can be explored in other dermatological fields. All 
skin lesions with an altered skin surface such as psoriasis, skin tumors, hemangioma, 
hypertrophic scars9 and keloids might be assessed and followed in time by this 
new technology.
CONCLUSIONS
In this study we developed a method to quantify lesions of allergic tattoo reactions in 
terms of elevation, volume and area using a 3D optical scanner. The measurement error 
was quantified using an arm model and a lesion phantom, showing good measurement for 
lesion with diameters above 2.5 mm and areas smaller than 600 mm2. Significant changes 
in elevation and volume of lesions on arms and legs could be measured over time.
Therefore, we conclude that quantification of lesions of allergic reactions using a 3D 
optical scanner is feasible. 3D optical scanning is a promising technique for the evaluation 
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Patients with allergic tattoo reactions are burdened with itch and have a reduced quality of 
life. Conservative treatment is often insufficient and little is known about treatment options 
to remove the responsible allergen.
We aimed to address the effectiveness and safety of ablative laser therapy including 
measurement of patient’s satisfaction, in patients with allergic reactions to tattoos.
Methods
A retrospective study was conducted including patients with allergic tattoo reactions who 
were treated with a 10600 nm ablative CO2 laser, either by full surface ablation or fractional 
ablation. Clinical information originated from medical files and a 25-item questionnaire.
results
Sixteen tattoo allergy patients were treated with a CO2 laser between January 2010 and 
January 2018. Fourteen patients completed the questionnaire. Ten patients were satisfied 
with laser treatment. On a visual analogue scale, pruritus and burning improved with 
a median of 5,5 and 4 points in the full surface ablation group and 3 points on both 
parameters in the fractional ablation group. 
Conclusion
Despite the relatively small group of patients, our results suggest that CO2 laser ablation 
improves itching, burning and impact on daily life in tattoo allergy.
Key words: red tattoo, contact dermatitis, ablative laser, CO2 laser, patient reported outcome




Tattooing is a worldwide popular form of body art with an overall prevalence in Europe 
and the USA of approximately 10-20%.1 Although it is regarded safe, adverse reactions 
may occur, including allergic reactions. Many dyes are used for tattooing, but the red 
dye is most frequently associated with allergic reactions.2,3 These reactions are chronic 
and persistent, characterized by itch, burning and pain and can develop months to many 
years after getting a tattoo. Regardless of size and location of the affected area, allergic 
reactions can result in a significantly reduced quality of life.4 Several clinical subtypes can 
be recognized of which the ‘plaque type’ is most common. Other, less common types 
are the ‘excessive hyperkeratotic reaction’ or the ‘ulcero-necrotic reaction’.5,6 Thus far, 
the responsible allergens have not been identified and the exact patho-mechanism 
remains unknown.7-9
Treatment of these allergic reactions is difficult, as tattoo pigments are permanently 
stored in the dermis. Topical or intralesional corticosteroids are indicated as first line 
treatment but effects are often temporary and unsatisfactory.10 Allopurinol was reported 
to be effective in one patient, however symptoms recurred after withdrawal of the drug.11 
Likewise, hydroxychloroquine caused complete regression of pseudolymphomatous 
tattoo reaction on the trunk and a granulomatous reaction to a red cosmetic tattoo.12,13 
To achieve permanent remission, the causative allergen needs to be removed. However, 
the best treatment option to remove the responsible allergen is unknown. Surgical 
excision, dermatome shaving, Q-switched lasers and ablative CO2 lasers are reported as 
treatment options with permanent results.14,15 Nevertheless, each treatment option has its 
disadvantages, such as possible scarring, infection, risk of generalized allergic reactions 
and treatment imprecision. 
Millán Cayetano et al. considered the continuous wave CO2 laser as an effective, safe 
and precise treatment for improving red tattoo reactions in six patients.16. Fractional 
ablation was effectively and safely used for removal of allergic tattoo reactions in three 
patients.17,18 Apart from these small studies, clinical efficacy has been studied insufficiently. 
Furthermore, patient reported outcome measures (PROMs) have not been thoroughly 
investigated in this field. PROMs are crucial as quality of life and symptom reduction are 
best assessed by patients themselves.19 The aim of this study was to report real life data 
using ablative laser treatment and to asses PROMs regarding the effectiveness and safety 
of ablative CO2 laser treatment for allergic tattoo reactions. 
MATErIAL AND METHODS
We performed a retrospective study in which we included patients with allergic tattoo 
reactions treated with the 10600 nm ablative CO2 laser (Lumenis Ultrapulse Encore, 
Lumenis Ltd., Santa Clara, CA, USA) using a handpiece for full surface ablation (2 mm 
true spot) and/or a handpiece for fractional ablation (DeepFx handpiece, 120 µm beam 




Patients were eligible for inclusion if clinically an allergic reaction was diagnosed and 
if they were treated with the ablative CO2 laser. Allergic tattoo reactions were defined as 
chronic inflammatory reactions, manifesting in one single colour and persisting for at least 
3 months.5,19 As there are currently no routine patch tests, the distinction between an 
allergic tattoo reaction, sarcoidosis and foreign body reaction is mostly clinical (the allergic 
tattoo reaction is localized to one specific color).21,22 Furthermore, the histopathology of 
allergic tattoo reactions is frequently granulomatous as well20. Nevertheless, if histologically 
a granulomatous reaction was observed, laboratory test (including ACE and in some cases 
sIL-2R) and chest X-ray were performed to exclude sarcoidosis. However, as there is no 
routine patch test, the distinction between an allergic tattoo reaction, sarcoidosis and 
foreign body reactions is mostly clinical. 
Based on the clinical information provided by the physician, patients and physician 
made a shared decision about the preferred treatment, either fractional of full 
surface ablation. 
All patients received a test treatment 3 months before the full treatment was started to 
assess effectiveness and cosmetic outcomes on a small test area. 
All patients received infiltration anaesthesia (lidocaine 2% + adrenaline 1:80000). 
Fractional ablation settings ranged from 25-40 mJ/microbeam and 15-25% density. 
Full surface ablation was performed with a 2 mm spot, 225 mJ and 10-30W combined with 
wet gauzes to remove carbonized tissue between laser passes. The clinical endpoint of 
the full surface ablation was the complete removal of red pigments. 
After fractional ablation, patients received fucidic acid 20mg/g cream twice daily for 
1 week. After full surface ablation, patients received silver sulfadiazine 10 mg/g cream 
under hydrofiber absorbent dressings for 1 week. After 1 week when the dressings were 
removed, patients applied silver sulfadiazine 10 mg/g cream twice daily until healing of 
the wound was observed. In the case of large areas treated with full surface ablation, 
systemic antibiotics were used.
Clinical information was obtained from patient’s records and a 25-question questionnaire, 
addressing 3 topics. The questionnaire was performed retrospectively in December 2017 
and January 2018. Overall primary end point was patient satisfaction. The questionnaire 
focused on 3 topics; clinical baseline information, symptoms and outcomes. 
Clinical baseline information: time interval between placement of tattoo and 
complaints, previous treatments. The time interval was based on an ordinal scale. Previous 
treatment options were given and could either be answered with yes or no. If patients 
received previous treatment, effects were analysed on an ordinal scale (from no effect to 
excellent effect). 
Symptoms: subjective symptoms before and after laser therapy, such as itch and 
burning. These questions were based on a visual analogue scale (VAS, 0-10), with 0 
meaning no itch or burning and 10 meaning the worst itch or burning.
Outcomes: overall satisfaction, cosmetic outcome and satisfaction with improvement 
of pruritus, burning, inflammation and influence on daily life were based on an ordinal 
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scale (from highly unsatisfied to highly satisfied). Evaluation of pain and discomfort during 
treatment was based on a VAS (0-10), with 0 meaning no pain or discomfort and 10 
meaning the worst pain or discomfort. Scar formation and pigment variation could be 
answered with either yes or no. If present, the burden of scars and pigment variation were 
based on a VAS (0-10), with 0 meaning no burden and 10 meaning the worst burden. 
A statistical analysis was performed. Outcomes between groups were compared using 
the student’s t-test, Mann-Whitney-U test or Kruskall-Wallis test depending on distribution 
and the number of groups. Categorical data was compared using the Chi2 test or 
the Fisher’s exact test depending on group sizes. 
rESULTS
Patient characteristics
Sixteen patients (11 women, 5 men) were treated with an ablative CO2 laser. Two patients 
were first treated with the fractional CO2 laser without clinical improvement and were 
therefore also treated with full surface ablation. Therefore, 10 patients were treated with 
the fractional CO2 laser and 8 patients were treated with the full-surface CO2 laser. 
The median age was 44.5 years. Red or nuances of red made up for 94% of all 
responsible pigments. Other patient characteristics are shown in Table 1. 
All patients had received prior treatment, such as topical and/or intralesional 
corticosteroids and Q-switched laser therapy. Prior treatment either failed or patients 
desired a more permanent solution. 
The number of sessions needed varied between both groups, with a median of 1 
in the full-surface CO2 laser group and a median of 4 in the fractional CO2 laser group 
(P < 0,01). 
results from medical files
The medical files indicated complete remission of symptoms, such as itching, burning 
or swelling, in six patients (33,3%), which was maintained until the last follow-up. Nine 
patients had partial remission (50%) and maintained occasional itching or burning. 
Potent topical corticosteroids were prescribed in some patients to control these residual 
symptoms. Results of medical files are shown in table 2.
Two adverse events were reported. One patient with skin type 4 developed a keloidal 
scar after full surface ablation on his upper arm. The other patient developed a generalized 
allergic reaction one day after the fifth fractional CO2 laser treatment. Eczema developed 
around the tattoo, on arms, face and knees. She was treated with oral antihistamines 
and topical potent corticosteroids resulting in gradual improvement of the eczematous 




Table 1. Baseline characteristics of 18 treatments in 16 patients.
All (n=18)
GrOUP A  






Median [Q1 - Q3] 44,5 [36 - 52,25] 44,5 [36,25 – 57,75] 44,5 [35,75 - 52,25]
Gender, n
Male 6 5 7 
Female 12 3 3 
Time between placement of tattoo and complaints, n
<2 weeks 7 2 5 
> 2 - < 4 weeks 3 2 1
> 1 - < 3 months 3 2 1 
> 3 - < 6 months 4 2 2 
>6  - < 12 months 0 0 0
> 12 months 1 0 1 
Histopathological pattern, n
Pseudolymphomatous 4 4 0




Not avalaible 9 1 8
Location, n
Lower leg/ankle 12 6 6 
Upper leg 1 0 1 
Forearm 3 1 2 
Upper arm 2 1 1 
Colour, n 
Red 17 7 10 
Black 1 1 0
Previous treatment, n
Potent topical corticosteroids 6 1 5 
Potent topical and intralaesional 
corticosteroids
7 5 2 
Intralesional corticosteroids 3 1 2 
Potent topical corticosteroids 
and other laser treatment 
2 1 1 
Q1-Q3 = interquartile range
Patient reported outcomes
Two patients did not complete the questionnaire. Thus, 16 patients responded (88%). 
PROMs are shown in table 3. From the responding patients, ten patients reported to 
be either satisfied or highly satisfied with ablative laser treatment (62,5%). Six patients 
reported to be satisfied with the cosmetic aspect after ablative laser treatment (37,5%), 4 
patients were neutral (25%), 6 patients were unsatisfied or highly unsatisfied (37,5%). 
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Table 2. Results from medical files, not patient reported.
All (n=18)
GrOUP A  
(Full surface ablation) 
n = 8
GrOUP B  
(Fractional ablation)  
n=10
Number of sessions
Median [Q1 - Q3] 2,5 [1 – 4,25] 1 [1 – 1,75] 4 [3 – 6,25]
Follow-up (months)  
Median [Q1 - Q3] 14 [9,25 – 39,75] 8,5 [4,75 – 11,75] 31 [20,5 - 60]
Result after treatment, n (%)
Complete remission 6 (33,3) 3 (37,5)  3 (30) 
Partial remission 9 (50) 4 (50) 5 (50) 
































Figure 2. Before and after treatment of a red tattoo reaction treated with fractional ablation. 
Figure 1. Before and during treatment of a tattoo reaction (‘plaque type’) to red dye in a multi-




Patients rated pain and discomfort of ablative laser therapy with a median VAS score of 
3 on both parameters (P = 0,67 and 0,83, respectively for pain and discomfort). 
Scar formation was reported in 6 patients in the full surface ablation group and 5 
patients in the fractional ablation group (P = 1,00). Variation in pigment was reported in 7 
patients in the full surface ablation group and 4 patients in the fractional ablation group 
(P = 0,28).
Common complaints before starting laser treatment were a burning sensation (93%) 
and pruritis (100%). Improvement on a VAS scale (0-10) was found, for both, burning 























Figure 4. Before and after of a red tattoo reaction (‘plaque type’) on the wrist treated with full 
surface ablation.
Figure 3. A red tattoo reaction (‘plaque type’) during treatment with fractional ablation. 
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Table 3. Patient reported outcome of 16 treated tattoos in 14 patients. 
All (N=16)




GrOUP B  
(Fractional 
ablation)  
N = 8 P value
Satisfaction with
Laser treatment, n (%) 0,45
Highly satisfied 3 (18,8) 2 (25) 1 (12,5)
Satisfied 7 (43,8) 4 (50) 3 (37,5)
Neutral 3 (12,5) 0 3 (37,5)
Unsatisfied 2 (12,5) 1 (12,5) 1 (12,5)
Highly unsatisfied 1 (6,3) 1 (12,5) 0
Cosmetic aspect, n (%) 0,59
Highly satisfied 0 0 0
Satisfied 6 (37,5) 4 (50) 2 (25)
Neutral 4 (25) 1 (12,5) 3 (37,5)
Unsatisfied 3 (18,8) 2 (25) 1 (12,5)
Highly unsatisfied 3 (18,8) 1 (12,5) 2 (25)
Improvement itch and burning, n (%) 0,93
Highly satisfied 4 (25) 3 (37,5) 1 (12,5)
Satisfied 2 (12,5) 1 (12,5) 1 (12,5)
Neutral 2 (12,5) 1 (12,5) 1 (12,5)
Unsatisfied 4 (25) 1 (12,5) 3 (37,5)
Highly unsatisfied 4 (25) 2 (25) 2 (25) 
Improvement inflammation, n (%) 0,52
Highly satisfied 3 (18,8) 2 (25) 1 (12,5)
Satisfied 6 (37,5) 3 (37,5) 3 (37,5)
Neutral 2 (12,5) 0 2 (25)
Unsatisfied 3 (18,8) 1 (12,5) 2 (25)
Highly unsatisfied 2 (12,5) 2 (25) 0
Evaluation of laser therapy
Pain (median [Q1-Q3])* 3 [1,25 - 5] 3 [2,25-4,5] 3,5 [0,25-5] 0,67
Discomfort (median [Q1-Q3])* 3 [1- 5] 2,5 [1,25-3,75] 3,5 [0,25–5,75] 0,83
Adverse effects
Scars, n (%) 11 (68,8) 6 (75) 5 (62.5) 1,00
Level of inconvenience  
(median [Q1-Q3])*
2,5 [1–6,75] 2,5 [0,75–7,75] 5 [0,5-7] 1,00
Variation in pigment, n (%) 11 (68,8) 7 (87,5) 4 (50) 0,28
Level of inconvenience  
(median [Q1-Q3])*
4 [1-5] 4 [0 - 7] 4,5 [1,75-5] 0,92
Improvement of symptoms
Itch (median [Q1 - Q3]) * 4.5 [7,75–0,25] 5,5 [8 - 0] 3 [7,25–0,25] 0,71
Burning (median [Q1 - Q3]) * 4 [7-0] 4 [7 - 0] 3 [7,75–0,75] 0,91
Influence on daily life (median [Q1 - Q3]) * 2 [4 - 0] 3 [4 - 0] 2 [3,75 – 0,25] 1,00
Recommendation, n (%) 11 (68,8) 7 (87,5) 4  (50) 0,28




surface ablation group (median of 5.5 for itch and 4 for burning) and fractional ablation 
group (median of 3 for both itch and burning), it should be noted that more improvement 
was observed in full surface ablation. However, the difference is not statistically significant 
(P = 0,71 and 0,91, respectively for itch and burning).
The vast majority of the full surface ablation group would recommend this therapy to 
others (87.5%), in the fractional ablation group 4 patients (50%) gave a recommendation 
(P = 0,28)
DISCUSSION
Patients suffering from allergic tattoo reactions are burdened with chronic itch and 
discomfort.4 Treatment is challenging. Topical or intralesional corticosteroids are convenient 
options, however effectiveness varies and is frequently temporary or insufficient. A safe 
treatment modality with permanent results is needed. Removal of all culprit pigment by 
surgery or laser ablation is thought to be the best approach. However, there are variable 
techniques to remove the pigments and little is known about efficacy, side effects and 
PROMs. In our study, we found that CO2 laser therapy can improve the symptoms of allergic 
tattoo reactions when topical or intralesional corticosteroids are insufficiently effective. Six 
allergic tattoo reactions showed complete remission (33,3%), 9 showed partial remission 
(50%) and 3 lesions showed no improvement (16,7%) after a median follow-up of 14 
months. Remarkably, in some cases with satisfactory outcome, we observed some residual 
red pigment questioning the necessity of complete removal of pigment. 
Fractional and full surface ablation
Patients were overall satisfied with the treatment and reported marked improvement of 
their symptoms. When comparing our treatment groups, more improvement was reported 
in the full surface ablation group. Fractional ablation is less invasive with less side effects 
in comparison to full surface ablation, however at the cost of multiple treatments and 
possibly lower efficacy. The difference could not be significantly confirmed. Because of 
this, the study design and the relatively small group of patients, it cannot be concluded 
that full surface ablation is superior in effectiveness to fractional ablation. 
Adverse events
It should be noted that adverse effects, such as scarring and allergic reactions, may occur. 
Full surface ablation has a higher risk of scarring compared to fractional ablation.16 This 
could be explained by the fact that conventional CO2 lasers ablate the full surface of 
the skin, while fractional CO2 lasers ablate a fraction of the skin at a time by emitting 
microbeams that create microthermal ablation and coagulation zones leaving unaffected 
tissue around these zones. In our study, no significant difference in scarring between both 
groups were observed. 
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In one patient a generalized eczematous allergic reaction was observed after fractional 
ablation, treated in our Academic Tattoo Clinic. More cases of generalized allergic reactions 
after fractional laser therapy to treat allergic tattoo reactions have been reported.18,23 We 
assume that full surface ablation completely eliminates pigment containing cells, thereby 
preventing systematic uptake. However, in fractional ablation the ablative channels are 
small and surrounded by coagulation zones which may be responsible for systemic uptake 
of allergens.18 In addition, dyspigmentation is reported several times. 
Other treatment options
Other surgical treatment options are conventional full-thickness excision and dermatome 
shaving. Conventional excision is only favourable in certain anatomical locations and 
small size tattoos. In addition, scarring is inevitable. Dermatome shaving is an excellent 
permanent treatment option. However, in this procedure an experienced plastic surgeon 
or dermatologist is crucial. Furthermore, in our opinion, CO2 lasers have the possibility 
of treating more accurately in a horizontal plane, resulting in better preservation of 
the original tattoo design. The pigment-loaded tissue can be removed layer by layer until 
the desired endpoint, removal of pigment, is achieved. As the depth of the tattoo inks in 
the skin differs, it is an advantage that de depth of laser treatment can be adjusted. 
Dermatome shaving may also elicit complications such as scarring, hyper- and hypo-
pigmentation, which required additional treatments with intralesional corticosteroids in 
almost 20% to control scarring.14 Furthermore, in contrary to dermatome shaving, ablative 
laser therapy is not a bloody procedure due to surrounding coagulation. Experienced laser 
surgeons can take advantage of this phenomenon and vary the ratio between ablation and 
coagulation by adjusting the pulse energy. Therefore, the risk of post-procedure bleeding 
is smaller. 
Another treatment option for allergic tattoo reactions is the Q-switched laser. Unlike 
ablative lasers, Q-switched lasers are the gold standard for removal of uncomplicated 
tattoos.24 Q-switched lasers selectively damage pigment containing cells, after which 
pigment particles are released into systemic circulation. The photomechanical breakdown 
of pigments may also produce and systemically spread new allergens and harmful chemicals. 
Several cases of localized, generalized and even anaphylactic allergic reactions have been 
reported following Q-switched laser tattoo removal in patients with a pre-existent allergic 
reaction to tattoo pigments or even in prior non-allergic patients.25-28 Besides the risk of 
inducing systemic allergic reactions, treatment efficacy for allergic tattoo reactions to red 
pigment with a Q-switched-laser is compromised because of the limited penetration depth 
at 532 nm, whilst in ‘plaque reactions’ an evident thickening arises with deeply located 
pigments. Moreover, Q-switched lasers may require more than ten treatments. 
Thus far this is the largest study of ablative laser therapy in allergic tattoo reactions. 
Another strength of this study is the long follow-up and the presence of real life data. 




and the descriptive analysis. Also, patients were not laser-naïve. The response rate of 
the questionnaire was 88%, which is high. However, it should be noted that some patients 
had to assess their clinical symptoms years after the initial diagnosis and treatment. 
Unfortunately, two patients were lost to follow-up. Furthermore, no validated outcome 
measures could be used due to a lack of research in this field. Future research should be 
prospective and include an objective evaluation of improvement of skin inflammation.
Despite the relatively small group of patients, our results suggest that CO2 laser 
ablation (either fractional or full surface ablation) improves itching, burning and impact 
on daily life in tattoo allergy. It may be implemented as third line treatment, when topical 
or intralesional corticosteroids are insufficiently effective. Patients seem to prefer the full 
surface ablation above fractional ablation, which may result from higher effectiveness and 
less treatment sessions. However, this could not be statistically confirmed. Patients should 
be thoroughly informed about the possible risks, especially scar and keloid formation. 
More evidence is needed before final recommendations can be given.
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Few reports describe tattoo granulomas with the simultaneous development of intraocular 
inflammation without any evidence of systemic sarcoidosis at the time of presentation.1–4 
Here, we present a patient with no prior diagnosis of sarcoidosis who developed 
inflammation of the tattooed skin and shortly after bilateral uveitis. 
A 52-year-old previously healthy woman presented with an 8-month history of swelling 
and itching located in all of her 11 black tattoos. Approximately 5 months later, she 
developed complaints of blurred vision, diagnosed as recurrent uveitis anterior by an 
ophthalmologist. The last tattoo was performed 8 years ago. On physical examination, she 
presented with confluent papules and nodules in all black tattoos (Fig. 1). Histopathologic 
evaluation of a skin biopsy from a black tattoo on the left shoulder revealed a non-
necrotizing granulomatous giant cell reaction with black tattoo pigment in the dermis 
(Fig. 2). The patient was referred to the rheumatologist, who could not find any evidence 
for other uveitis-associated diseases, such as sarcoidosis or spondyloarthritis, both on 
clinical and serological or imaging findings; C-reactive protein, comprehensive chemistry 
panel, HLA-B27, serum ACE/ANA/ANCA, chest X-ray and X-rays of spine and sacroiliac 
joints all showed results interpreted as normal. The patient was treated with high-dose oral 
prednisone and with methotrexate that led to the simultaneous improvement of the ocular 
inflammation and complete resolution of the skin lesions. 
Figure 1. In (a) initial presentation of the skin reaction; papulonodular reaction in all black tattoos. In 




We describe a patient who presented with granulomatous inflammation of the tattooed 
skin and the onset of bilateral uveitis shortly thereafter. No additional evidence of 
sarcoidosis or other uveitis-associated diseases on examination, serological tests or 
imaging was found. Other studies found similar results.1–4 The majority of those reports 
showed that inflammation of tattooed skin coincided with the onset of uveitis. However, 
few reports showed delayed ocular involvement, the same as in our case.2 
Tattoo granulomas and uveitis, or tattoo-associated uveitis, are increasingly 
recognized phenomena, in which inflammation is limited to tattooed skin and the uveal 
tract. The underlying pathophysiology remains unclear, although several hypotheses 
have been described. First, it has been suggested that this condition represents 
a specific granulomatous-delayed type of hypersensitivity reaction to ink.2 Moreover, 
the manufacturing of black tattoo ink is based on soot, which may contain toxic, mutagenic 
or carcinogenic compounds.5 The injection of tattoo pigments into the skin results 
in a relatively large antigenic and/ or toxic load, initiating a local cutaneous response 
that in some way seems to be involved in the later development of ocular inflammation. 
Identification of the specific tattoo pigments that may trigger such a condition in susceptible 
ndividuals is therefore of interest. Secondly, another hypothesis suggested that chronic, 
mild antigenic stimulation from the tattoo in genetically predisposed individuals may 
lead to a systemic  ranulomatous reaction, consistent with sarcoidosis.6 Many cases have 
been attributed to sarcoidosis because non-necrotizing granulomas are often seen on 
Figure 2. Histopathologic evaluation of a skin biopsy from a black tattoo on the left shoulder 
revealed a non-necrotizing granulomatous giant cell reaction with black tattoo pigment in the dermis. 
Magnification 100x.
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skin biopsy.7 However, pulmonary involvement is uncommon, and in many cases, no other 
clinical, serological or imaging features are found. 
The first line of treatment includes topical corticosteroids and intraocular pressure 
lowering drops. However, in many cases systemic treatment with oral prednisone 
is needed, generally leading to simultaneous improvement of the ocular as well as 
the skin inflammation. To enable successful tapering of oral prednisone, initiation of 
immunosuppressive therapy, such as methotrexate or mycophenolate mofetil, has been 
described, just as in our case.1 
Greater alertness among tattoo artists of the potential complications of certain inks 
may reduce the number of tattoo associated uveitis. For the dermatologist treating 
granulomatous inflammation of the tattooed skin, we would emphasize the importance of 
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We present a case of a patient with a cutaneous allergic reaction to red tattoo pigments in 
a cosmetic lip tattoo, successfully treated with hydroxychloroquine.
DISCUSSION
A 73-year old woman visited the dermatology department with painful and itching skin 
lesions and a discoloration of the lips since 6 months. Two years earlier, both her entire 
lips were tattooed with red tattoo ink, for cosmetic reasons. Her eyebrows, tattooed with 
black tattoo ink simultaneously, were unproblematic. She had no further medical history. 
On physical examination we observed a slightly elevated plaque, confined to the red 
tattooed area, with yellow acneiform-like inclusions (Figure 1A & 1B). There was no 
lymphadenopathy. Skin biopsy showed a lymphohistiocytic, granulomatous inflammation 
surrounding the red tattoo pigment. Ziehl-Neelsen and PAS-D staining were negative. 
A chest X-ray and serum angiotensin converting enzyme were performed, which showed 
no abnormalities, especially no signs of sarcoidosis. The used tattoo ink could not be 
retrieved and patch testing was not performed. Based on the clinical and histological 
findings we diagnosed a delayed allergic reaction to the red tattoo pigment. 
Because of potential cutaneous atrophy and limited penetration depth, therapy with 
topical or intralesional corticosteroids was not considered. Surgical procedures, such as 
dermatome shaving, were rejected because of potential scarring. Therefore, treatment 
with hydroxychloroquine 200 mg twice daily was initiated. After 3 months, we noticed 
a significant clinical improvement. After 18 months, there was a complete remission of all 
symptoms (Figure 2). The dosage of the hydroxychloroquine was slowly tapered and finally 







Figure 1A and 1B. Pictures of the patient before treatment with hydroxychloroquine: showing 
slightly elevated plaque and yellowish papules on both the upper and lower lip, sharply confined to 
the tattooed area. The location of skip biopsy is marked. 
Figure 2. Picture of the patient after 18 months of treatment with hydroxychloroquine: showing 
complete resolution of the reaction.
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Cosmetic tattoos, when applied facially sometimes referred to as permanent makeup 
(PMU), are used to enhance facial appearance.1 Frequently eyebrows, eyelids and lips are 
tattooed. Furthermore, these tattoos can camouflage lesions of skin diseases, such as 
alopecia of the eyebrows, hypopigmentation and vitiligo. Potential complications include 
infections, allergic reactions, autoimmune skin diseases, scarring, pigment migration and 
fanning/fading of the tattoo.1 
In allergic reactions to tattoo pigments, red pigments are most frequently involved.2 
These reactions are chronic and can cause tenderness, pain, swelling and severe itch.3 
Onset of symptoms may vary, ranging from days to several years after tattooing.4 These 
reactions can lead to a reduced quality of life.5 Clinical patterns observed are: plaque 
elevation, ulcero-necrotic and hyperkeratotic pattern.6 In allergic reactions to tattoo 
pigments occluded epidermal cysts can occur, as in our case. Patch testing was not 
performed because the tattoo ink was not retrievable and it would not have influenced 
treatment in our patient. In addition, patch testing results are generally negative and 
the diagnose is generally made clinically.7
During the past decennia, the composition of inks has changed. Inks are less likely 
than before to contain mainly inorganic pigments, such as mercury salt as a red pigment. 
Modern inks mostly contain organic pigments such as azo-pigments. In reactions to red 
tattoo ink, red azo pigments are the suspected sensitizers.
Treatment of allergic reactions to tattoo pigments is difficult because the pigments 
are permanently located in the dermis. In most cases, first line treatment consists 
of topical or intralesional corticosteroids. However, frequently a temporary effect is 
observed. Systemic corticosteroids can be used to treat more severe allergic reactions 
in red tattoos. Furthermore, allopurinol is reported as a successful treatment option for 
a granulomatous reaction to red tattoo pigment.8,9 More permanent treatment options 
include dermatome shaving, surgical excision or treatment with carbon dioxide laser.6 
Until now, little is known about the optimal treatment modality in allergic reactions to 
tattoo pigments located facially. In some cases, spontaneous resolution of the lesions 
is reported. Because of physical complaints and cosmetic reasons, treatment is desired. 
In this case, hydroxychloroquine was used, as it is reported to be a successful treatment 
in granulomatous skin reactions.10 In addition, it was reported previously as an effective 
option in the treatment of a pseudolymphomatous reaction to a green pigment tattoo 
on the trunk.11 To our knowledge, this is the first reported case of the successful 
treatment of a granulomatous allergic reaction to a red pigment cosmetic tattoo 
with hydroxychloroquine.
PEArL 
In granulomatous allergic tattoo reactions on the lips, hydroxychloroquine can be 
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A 56-year-old, otherwise healthy, man was referred to the Academic Tattoo Clinic Amsterdam 
because of pain and itch in a multicoloured tattoo on his right arm since 1-month. Two 
weeks before the start of the complaints the tattoo had been placed on Bali, Indonesia. 
The patient had no fever or other physical complaints. Physical examination revealed 
multiple erythematosquamous papules and pustules, especially in the black and white 
coloured parts of the tattoo (Fig. 1). The red, orange and green parts of the tattoo were not 
affected. He had no axillary or cervical lymphadenopathy. Histopathology of a skin biopsy 
in the black part of the tattoo showed a purulent granulomatous inflammation. Auramine 
stain of the punch biopsy showed acid-fast rods. Chest X-Ray showed no abnormalities, 
serum C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were not elevated. 
Culture of another biopsy of the affected skin was positive for Mycobacterium abscessus. 
Cutaneous Mycobacterium abscessus infection after tattooing was diagnosed. Treatment 
options were limited, as in-vitro resistance was shown for ciprofloxacin and moxifloxacin, 
clarithromycin, co-trimoxazole, doxycycline, imipenem, and linezolid . Tigecyclin MIC was 
2 mg/liter, clofazimine MIC was  2 mg/liter. The strain tested susceptible to amikacin, and 
intermediate susceptible to cefoxitin using Sensititre RAPMYCO (ThermoFischer Scientific, 
Waltham, MA, USA). The patient was planned for admission to the hospital, to start 
treatment with oral clarithromycin and intravenous amikacin and cefoxitin. However, in 
the meantime, the patient reported significant improvement of symptoms. He experienced 
less pain, itch and the skin manifestations abated. Therefore, antibiotic treatment was put 
on hold and a watchful waiting policy implemented. After 1,5 months, total clearance of 
the symptoms and skin manifestation was observed (Fig. 2). Follow-up 8 months later 
showed no clinical signs of recurrence of the infection.
Tattoos are currently one the most popular forms of body art worldwide. Despite its 
popularity, complications such as infections, allergic reaction, auto-immune skin disease 
and scarring can occur.1 Although bacterial tattoo infections such as Staphylococcus 
aureus induced impetigo occur frequently, they are generally mild, superficial and self-
limiting. Other reported pathogens inducing tattoo infections include herpes simplex 
virus, Streptococcus pyogenes and Pseudomonas aeruginosa. Mycobacterial infection 
located in a tattoo is rare. However, Mycobacterium chelonae, Mycobacterium abscessus 
subspecies massiliense  and Mycobacterium fortuitum infections have been reported.2, 3 
Mycobacterium abscessus, a multidrug-resistant, rapidly growing non-tuberculous species 
consisting of Mycobacterium abscessus subspecies abscessus and subspecies bolletii 
with inducible macrolide resistance via the erm(41) gene, and the macrolide-susceptible 
Mycobacterium abscessus subspecies massiliense, has rarely been reported in tattoos 
before.4-6 Reliable data are lacking but the prevalence of Mycobacterium abscessus 
infections seems to be increasing.5 Transmission occurs through contaminated tattoo 
ink or water used in the tattooing process, and lack of hygiene of the tattoo artist or 
the client. In our opinion, most likely the black tattoo ink or water used during tattooing 
was contaminated. Unfortunately, the ink could not be retrieved and the tattoo artist could 




Figure 1.  Picture of the patient’s right arm showing multiple erythematous and erythematosquamous 
papules and pustules: cutaneous infection with Mycobacterium abscessus. 
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Different regimens of various durations have been tried for Mycobacterium abscessus 
cutaneous infections.4, 7. However, spontaneous remission of tattoo infection has not been 
reported in the literature yet. Our patient had no comorbidities and was immunocompetent 
at the time of being infected, which probably has contributed to an adequate immune 
response resulting in clearance of the infection. The toxicity of the intended treatment, 
the cutaneous limitation of disease and patient’s motivation has driven the decision to 
implement a watchful waiting policy. 
This case demonstrates spontaneous resolution of a Mycobacterium abscessus 
infection in a tattoo of a 56-year old patient.  Clinicians should be aware of the possibility 
of a mycobacterial infection if persistent pustules or erythematosquamous papules are 
observed in a tattoo. Since treatment of these mycobacterial skin infections is difficult 
because of  antibiotic resistance patterns, hygienic standards and regulations for tattoo 
artists are important. Finally, watchful waiting can be considered in immunocompetent 
patients who show clinical improvement and no signs of disseminated disease.
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Tattoos are a popular and growing form of body art. In contrast, the scientific literature 
comprises only few studies regarding tattoo complications and mainly consists of case-
reports and case-series. This might be ascribed to the wide dispersion of these patients 
among healthcare workers: for the same medical tattoo associated problem, patients 
are referred to different healthcare professionals: general practitioners, dermatologists, 
internists, general surgeons, plastic surgeons, municipal health services, skin therapists 
etc. This makes it difficult for an individual researcher to perform large studies. This was 
one of the reasons to found the Academic Tattoo Clinic Amsterdam on January 13th of 
2017.1,2 It was done in the footsteps of the Tattoo Clinic in Bispjeberg, Denmark, founded 
in 2009 and followed by a specialized tattoo consultation in France in 2017.3 By this means, 
patients with tattoo complications can be referred to a highly specialised department, 
aiming at an efficient way to combine high quality dermatological care and research.
As we have experienced in our Tattoo Clinic and as previously reported, the majority 
of patients with tattoo complications visiting a dermatologist, presents with two types 
of reactions: firstly, the most common chronic tattoo complication, an allergic tattoo 
reaction to red pigment. In a large study of 493 tattoo complications, allergic reactions 
accounted for 37% of all tattoo complications and were predominantly associated with 
red pigments (85%) and typically presented with a plaque type elevation (figure 1).4 In our 
clinic, these red allergic tattoo reactions accounted for 53% of all tattoo complications 
(unpublished data). 
Secondly, chronic inflammatory non-allergic reactions to black tattoo account for 
a significant part of all tattoo complications, previously reported to account for 14.3% of 
all tattoo complications. 4 The clinical presentations typically include papules and nodules 
in the black tattooed skin, and are therefore sometimes named papulo-nodular black 
tattoo reactions (figure 2).5 In our clinic, these reactions accounted for around 17% of all 
patients with tattoo complications (unpublished data), the second largest group after red 
tattoo reactions.




In total, these two reactions accounted for the vast majority of tattoo complications 
(70%) in our clinic. Notably, black, followed by red are the most frequently used tattoo 
colours. For these reasons, these two complications will be discussed extensively 
and separately regarding clinical aspects, diagnostics, pathomechanisms and 
treatment options.
rED TATTOO rEACTIONS
Clinical aspects of red tattoo reactions
Red tattoo reactions play a major role in the field of tattoo complications as they are 
the most frequent chronic tattoo reactions and cause persistent symptoms resulting in 
a lowered quality of life.6 However, until today, the exact pathomechanisms of red tattoo 
reactions remain unknown. It is thought to be a delayed allergic reaction, yet the clinical 
differential diagnoses include a phototoxic or irritant reaction, cutaneous sarcoidosis 
and localized lichen planus. Although, as reported in chapter 2, several clinical aspects 
indicate an allergic reaction: confined to exclusively the red tattooed skin, the substantial 
time span between tattooing and onset of symptoms and concomitant occurrence of red 
tattoo reactions in older red tattoos. On the other hand, there are several clinical aspects 
which might not directly correlate with an allergic reaction. For example, in patients with 
a contact dermatitis to p-phenylenediamine (PPD), the severity of the reactions increases 
with repetitive exposure to the allergen by stimulation of memory and effector T cells. In 
severe cases, this may lead to angio-oedema, generalized reactions or even blistering and 
ulceration.7 However, in red tattoo reaction this rarely occurs and ulceration is reported 
in only 5% in our study. This is remarkably, since the allergen (tattoo ink) is permanently 
present in the dermis. However, this continuous type of exposure in tattoos as opposed to 





intermittent exposure may well be responsible for a very different type of clinical course. 
This immunological process of continuous exposure with damping excessive reactions 
is called “hardening” and has been well documented in construction workers sensitized 
to chromium in cement.8 Furthermore, as reported in chapter 2, various red tattoo 
ink brands were used in the studied 101 red tattoo reactions. This could indicate: i) all 
the reported brands contain the identical pigment or its breakdown products or additive; 
ii) multiple allergens are involved or; iii) these reactions are not allergic in nature at all. 
Also, the suggested role of sun exposure in forming the causative allergen is remarkable. 
In the studied cases, tattoos were located on sun exposed areas in 83% and worsening 
of symptoms was reported by patients in 32% after sun exposure. The latter was defined 
as unprotected exposure of the tattoo in the outdoor sun for a non-specified period of 
time. However, this definition is also applicable for phototoxic and other light-induced 
reactions. Furthermore, light-induced reactions are also frequently reported in black 
and blue tattoos.9 On the other hand, a phototoxic reaction seems unlikely because its 
general occurrence is just minutes after sun exposure. This is in contrast to what patients 
with red tattoo reactions reported to us in practice: worsening of symptoms occurring 
hours to days after sun-exposure. Furthermore, cross-reactive red tattoo reactions 
would not fit in the diagnosis of a phototoxic reaction. For example, itch in a patient 
with a recent red tattoo simultaneously occurring with itch in an 8-year-old red tattoo 
without any symptoms in the past, would not fit in the diagnosis of a phototoxic reaction. 
The other two autoimmune skin dermatoses mentioned in the differential diagnosis include 
lichen planus and sarcoidosis. However, it is very unlikely that these dermatoses would 
Köbnerize only in one specific colour in a multi-coloured tattoo. Nevertheless, cases of 
cutaneous sarcoidosis restricted to one colour have been reported.10,11 An irritant reaction 
in a tattoo is also unlikely, since one would expect a direct, instead of a delayed, reaction. 
Furthermore, as in phototoxic reactions, cross-reactive red tattoo reactions, would be 
theoretically inexplicable.
Diagnostics and pathomechanism in red tattoo reactions 
Although the diagnosis of a red tattoo reaction can frequently be made clinically, 
diagnostics such as histopathology can be used to exclude other diagnosis such as 
sarcoidosis, lichen planus, psoriasis or a mycobacterial tattoo infection. Other diagnostics 
such as patch testing can be used to confirm the diagnosis of an allergy and specify 
the culprit allergen. In this way, it is known what tattoo ink not to use for further tattooing, 
for example in medical tattoos. These diagnostics and other analytical methods such as 
the reconstructed human skin model can also be used to gain more knowledge about 
the aetiology of red tattoo reactions. These will be discussed further on. Other recent 
studied diagnostical and analytical methods in human material concerning tattoos will not 
be discussed, such as Raman spectroscopy, micro (μ) and nano (ν) scale X-ray fluorescence 




coupled plasma‐mass spectrometry (MALDI‐MS/MS or LA‐ICP‐MS) and synchrotron-based 
Fourier transform infrared (μ-FTIR) spectroscopy. 12-15 
1) Histopathology and pathomechanism
In the past literature, red tattoo reactions are frequently described and categorized by their 
histological pattern, despite their similar clinical presentation. For example ‘lichenoid red 
tattoo reaction’, ‘pseudolymphomatous reaction on the red pigmented areas of a tattoo’ or 
‘granulomatous tattoo reaction confined to red pigment‘.16-18 This may cause confusion, as 
a clearly defined diagnosis is frequently missing. On the other hand, the number of terms 
describes the great variety in histological patterns; lichenoid, granulomatous, spongiotic 
and pseudolymphomatous are all reported. 
Thus far, only few and small histological studies have been performed regarding allergic 
tattoo reactions.19-21 As we discussed in chapter 5, histiocytes were the predominant 
inflammatory cells in 74.3% of our study population. Interface involvement was observed 
in 64.8%, which is line with a previous study.21 The most frequent inflammatory pattern 
was a predominant histiocytic reaction with interface dermatitis. Remarkably, eosinophils 
were observed in only 8.1%. The abundance of histiocytes could be explained by their 
role as major component of the innate immune system. The combination of a histiocytic 
pattern and interface dermatitis may contribute to find the right diagnosis and indicates 
a specific immunologically mediated red tattoo reaction. Because of the inflammation 
patterns and cells found in this study, it is suggested that these reactions are most likely 
a combination of a subtype IVa and IVc delayed hypersensitivity reaction.22 However, it 
remains remarkable that the variety in histological patterns has no influence on severity of 
symptoms, choice of treatment or prognosis.
2) Patch testing, possible allergens and skin sensitization potential
As previously mentioned, red tattoo reactions are thought to be delayed allergic reactions, 
however the culprit allergens remain unknown. Tattoo inks generally contain a mixture of 
insoluble pigments and soluble ingredients such as solvents, thickeners and preservatives. 
Pigments dominate the analytical focus because of its high concentrations in tattoo inks, in 
contrast to the much lower concentrations of preservatives and impurities.23 Furthermore, 
potential sensitizers such as preservatives, solvents and impurities are more biodegradable 
and therefore will be removed quickly from the tattooed skin after the tattooing procedure. 
Because red tattoo reactions are chronic, these soluble substances are therefore less likely 
to cause the reactions.
In the past, mercury was thought to be the causative allergen, since several cases were 
published with positive patch test results .18,24 However, in the last decades, inorganic 
metallic pigments, such as mercury, chromium and cadmium salts, have largely been 
replaced by organic pigments like azo pigments, quinacridones, and phthalocyanines.25 




the causative allergen.  However, in some inks, these substances are still detected in small 
concentrations, be it as chromophores (appendix), shading additives or contaminants.25 
In the last decade, one large study was performed regarding patch testing in patients 
with allergic tattoo reactions.26 In this study, baseline allergens, disperse dyes/textile 
allergens and a selection of tattoo ink stock products were tested in 90 patients with 
an allergic tattoo reaction. Additionally, in 25 cases the culprit inks could be obtained 
from the tattooist and these patients were tested with their respective ink. Remarkably, 
the majority of all the patch tests were negative. Even in the 25 patients who were tested 
with their individual culprit ink, only 2 patients (8%) reacted. Again, this raises the question 
whether these red tattoo reactions are truly allergic in nature. However, there are several 
possible explanations for the negative patch test results: i) the potential allergens may 
insufficiently penetrate the skin; ii) the potential allergens may have been tested in incorrect 
concentrations; iii) the incorrect ink may have been tested; iv) the declaration of content 
on the label may deviate from its actual content (proven by analysis in several studies) or; 
v) the causative allergen may be a breakdown product from the original pigments and 
therefore not present in the tattoo ink bottle. The latter supports the current hypothesis 
that the allergen is formed in the dermis through a slow process of haptenization.26 
Tattoo pigments may undergo enzymatic processes in the dermis. This may be induced 
by light, as light is known to cause photochemical cleavage of tattoo pigments 
in vitro. Also, cases of a tattoo allergies induced by the use of Q-switched laser are 
reported. 27,28 These degradation products may form the allergen that induces a T cell-
mediated reaction. This hypothesis is further supported by the observation that tattoos 
fade over time, hence the concentration of the original pigment decreases. Also, clinically, 
this could clarify the great variation in time of onset of symptoms. For these reasons, to 
enhance the sensitivity of future patch testing, new patch test series should be developed 
and studied, including all ingredients and breakdown products of the pigments in 
the tattoo inks.
In a recent study, chemical analysis of human skin biopsies from chronic allergic 
reactions in red tattoos was performed to identify pigments and metals.15 In this study, 
mainly azo pigments were found, including Pigment Red 22 (35%), Pigment Red 210 (24%) 
and Pigment Red 170 (12%). These pigments are all naphthol AS azo pigments. Napthol 
AS is an organic compound with the gross formula C10H6(OH)C(O)NHC6H5) and was found 
in more than 55% of the biopsies in this study. As previously mentioned, these pigments 
are known to be cleaved upon sunlight exposure or laser irradiation. These data suggest 
that naphtol AS are potential causative allergens as the majority of the found pigments 
are capable of sensitization. However, it still cannot be concluded what the precise azo 
pigment‐related fragment is that is causing the allergy. 
Further allergic research should be performed for further determination. Of course, 
it would be interesting to inject tattoo dyes into the skin to perform intradermal allergy 
testing, however this might result in permanent skin discolouration (i.e. tattoo) and 




and photo-patchtesting should be performed, with all the ingredients and breakdown 
products of the pigments in the tattoo inks. In this way, the aetiology and causative 
allergens in these red tattoo reactions can be revealed. As a result, these pigments could 
be banned in the tattoo industry and other suggestions for alternative red tattoo pigments 
could be made. Hopefully, in this way, tattooing will cause less complications.
Next to patch testing, in vitro sensitization tests could be used to identify potential 
dermal sensitizers in tattoo inks. In chapter 6, the sensitization potential of 5 tattoo 
inks was investigated by using interleukin-18 as a biomarker in a reconstructed human 
skin model. One of the tested inks was Eternal Ink Light Red, which according to the label 
contains Pigment Red 170, showing significant secretion of IL-18 in comparison to other 
tattoo inks. This confirms the pigment as a skin sensitizer and is in line with the study 
of Schreiver et al. where the specific pigment was found in the affected skin of patients 
with allergic red tattoo reaction. Using a reconstructed human skin (RHS) model would be 
a promising method for screening of sensitizing potential of tattoo inks. However, this is 
the first study where an advanced in vitro RHS model is used to study tattoo ink-induced 
complications. Other limitations include the 24 hours of exposure of the substances and 
no exposure of UV-light is used. Also, although IL-18 secretion is crucial in the adverse 
outcome pathway (AOP) the process of skin sensitization and developing an allergic 
reaction, it includes only one of the several other events such as dendritic cell activation 
and T cell priming. Further validation of the RHS model for its unique type of application 
should be performed, by testing an extended panel of chemicals which exposed via 
the dermal side rather than stratum corneum to precisely set the threshold in the future.
Treatment of red tattoo reactions
Treatment of allergic tattoo reactions is difficult, as tattoo pigments are permanently 
stored in the dermis. Few studies about the treatment of allergic red tattoo reactions are 
published.29-31 Objective and validated outcomes, such as discussed in chapter 7, should 
be used to assess the effectivity of the treatment. Topical or intralesional corticosteroids 
are indicated as a first line treatment and their therapeutic potential should not be 
underestimated. As is illustrated in figure 3, a hyperkeratotic allergic red tattoo reaction 
was intermittently treated with betamethasone 0.05% with salicylic acid 3% ointment pulse 
therapy. After 3-4 months, the excessive hyperkeratosis has disappeared and the typical 
‘pseudo-epidermal cysts’ became visible.32,33 Therapy was continued and complete 
resolution was obtained in 8 months without any adverse events. In general, local 
corticosteroids have to be used for a longer period and sometimes additional occlusion 
is required. 
If topical corticosteroids fail, intralesional corticosteroids can be used.34 As previously 
mentioned, the effect of these therapies is generally temporary and therefore prolonged 
treatment is necessary. The duration of these treatments depends on the treatment 




Namely, if the symptoms persist or the patients prefer long lasting treatment results, other 
treatments that remove the allergen should be considered such as dermatome shaving, 
ablative CO2 laser and surgical excision. In chapter 8, a retrospective study shows that 
CO2 laser ablation improves itching, burning and impact on daily life in tattoo allergy. An 
advantage of the CO2 laser is the possibility of treating more accurately in a horizontal and 
vertical plane which spares the surrounding tissue and results in a better preservation of 
the original tattoo design. Furthermore, in contrary to dermatome shaving, ablative laser 
therapy is not a bloody procedure due to surrounding coagulation. The main downside 
of this treatment, as in dermatome shaving and surgical excision, is the formation of 
scars. Thus far, no safe and scarless treatment is available for removing the ink in red 
tattoo reactions. 
To avoid scarring, one could consider using the fractional CO2 laser or a Q-switched 
laser. The Q-switched laser is the current gold standard for removal of uncomplicated 
tattoos.35 However, the Q-switched lasers can cause a generalized allergic reaction by 
breakdown of tattoo pigments being released into systemic circulation, as shown in several 
case reports.36-39 This reaction can be eczematous, indicating a type IV allergic reaction, or 
urticarial, indication a type I reaction. On the other hand, these laser-induced reactions are 
thought to be temporary and generally well treatable. Moreover, the Q-switched 532 nm 
Nd:YAG laser is the only type of laser that affects red ink, and at this specific wavelength, 
the penetration into tissue is limited to 0.5 mm. Consequently, this type of laser can 
reach only the superficial part of the tattoo. And finally, Q-switched lasers do not remove 
the tattoo ink but result in redistribution of the ink particles in the body. Nevertheless, 
Figure 3. Hyperkeratotic red tattoo reaction on the right lower leg, intermittently treated with 
betamethasone 0.05% with salicylic acid 3% ointment pulse therapy, photographs taken after 0 (left), 




to my knowledge, the Q-switched laser is used frequently by several dermatologists in 
the Netherlands and abroad in the treatment of allergic tattoo reaction. One could discuss 
the effectiveness of the Q-switched laser as its penetration depth is about 0.5-1 mm and, 
an allergic tattoo reaction may show abundant dermal thickening by far more than 1 mm. 
On the other hand, as observed in our study with the fractional laser, not all the pigments 
have to be removed for improvement of the symptoms. Another disadvantage of 
the Q-switched lasers is that it may require more than ten treatments.  
Other therapeutic options could be considered in patients with specific tattoo locations 
or contra-indications for the previously discussed treatments. These alternative treatments 
include allopurinol, cyclosporine and hydroxychloroquine. As described in chapter 9 B, 
complete resolution was achieved in a patient with an allergic tattoo reaction on her lips. 
However, after cessation of these systemic medications, the symptoms may reoccur. In our 
patient, the symptoms did not reoccur. A possible explanation for this could be that, during 
the 18 months treatment with hydroxychloroquine, natural breakdown of the causative pigment 
took place, leading to tissue concentrations below the threshold for a symptomatic allergy. 
Further research has to be performed for assessment of safe and permanent treatment 
options. Ablative CO2 laser is an effective and efficient treatment but can cause scars. 
The Q-switched lasers may have the best aesthetic outcome, but generalized skin reactions 
can occur and multiple treatments are needed. Further research, adopting a split lesion 
randomized comparative study using objective and validated outcomes, should be used 
to assess and compare the different therapeutic options.
BLACK TATTOO rEACTIONS
Clinical aspects of black tattoo reactions
Black is by far the most frequently used tattoo colour. The risk of developing chronic 
symptoms in black tattoos is rather low. Though, due to the large population tattooed with 
black tattoo ink, patients with chronic reactions in black tattoos are frequently observed 
in the dermatology clinic.4 The diagnosed dermatoses generally not include psoriasis, 
infections or phototoxic reactions but rather present a still largely unknown inflammatory 
dermatologic entity. The clinical presentation generally includes papules, nodules or 
larger plaques, confined to the black tattooed skin (chapter 4).5 Remarkably, other parts 
of the similar tattoo, made with the same tattoo in, may appear completely normal. Also, 
generally the itch or pain is mild and evident erythema or secondary infection is rare. 
These clinical aspects differ significantly from previously discussed red tattoo reactions. 
On the other hand, the onset of symptoms after tattoo placement differs widely and can 
go up many years, as in red tattoo reactions. 
It is known for many years that reactions in black tattoos can be a manifestation of 
(systemic) sarcoidosis and can even be the presenting symptom.40 Another peculiar, rarely 
reported, medical entity is ‘tattoo associated uveitis´: i.e. a granulomatous cutaneous 




in the absence of systemic sarcoidosis. Although the skin and eyes are the most common 
extrapulmonary organs to be involved in sarcoidosis, it remains unclear whether this is 
a specific clinical subtype of sarcoidosis or a separate disease entity. 41 
A review of tattoos and sarcoidosis found an association between the male gender and 
sarcoidosis, and black and red tattoos.11 Thus far, only one large clinical study on black 
tattoo reactions has been performed.5 This study shows that papulo-nodular black tattoo 
reactions are an important marker for sarcoidosis: of the total of 72 patients, sarcoidosis 
was diagnosed in 19 patients (26%). Of these 19 patients, 8 (11%) had cutaneous 
sarcoidosis and 11 (15%) systemic sarcoidosis. Moreover, in this study a new clinical clue 
was suggested: the ‘rush phenomenon’. This is the clinical observation when an affected 
papulo-nodular tattoo reaction precedes the development of similar reactions in other 
black tattoos. The authors suggest that this is in favour of sarcoidosis. More studies should 
be performed to evaluate this phenomenon and whether it is possible to differentiate 
between a chronic black tattoo reaction by sarcoidosis or non-sarcoidosis on the basis of 
clinic aspects. Furthermore, in the concerning study, the majority of these patients were 
described as having non-sarcoidosis black tattoo reactions. However, these patients may 
still develop sarcoidosis later in life. Therefore, clinical studies with a longer follow-up 
are essential. 
Diagnostics and pathomechanism in black tattoo reactions 
As described above, a significant part of inflammatory black tattoo reactions is caused by 
sarcoidosis and therefore sarcoidosis has to be excluded. For the screening on sarcoidosis 
a skin biopsy, chest X-ray can be performed and blood testing for, angiotensin-converting 
enzyme (ACE) and soluble interleukin 2 receptor (sIL-2R). Other diagnostic procedures 
include chest computed tomography (CT) and magnetic resonance imaging (MRI) and, 
depending on possible other organs involved, specific diagnostic procedures are needed.42 
If the clinical suspicion of sarcoidosis is high, referral to a pulmonologist is recommended.
A possible explanation for the occurrence of sarcoidosis in tattoos is the Köbner 
phenomenon: the trauma of the tattooing procedure may trigger the autoimmune 
disease. This may even occur many years after the tattoo was placed. However, most 
patients with auto-immune diseases do not experience symptoms in their tattoo, as is 
described in sarcoidosis patients in chapter 3. This is also shown in other studies regarding 
tattoos and other auto-immune diseases such as psoriasis and lupus erythematosus.43,44 
The pathomechanisms of sarcoidosis are unknown but it is believed to be an abnormal 
inflammatory immune response to an antigen or immunological trigger. Likely, genetic and 
environmental factors, such as tattoo pigments, play a role.45 
On the other hand, the majority of patients with chronic inflammatory black tattoo 
reactions has no sarcoidosis.5 The aetiology of these non-sarcoidosis reactions remains 
unknown and differentiation between an allergic reaction, foreign body reaction or 
cutaneous sarcoidosis is difficult. Therefore, in my opinion, these black tattoo reactions 





No large studies have been performed focusing on the histopathology of chronic black 
tattoo reactions. In case reports, mainly granulomatous reactions have been described and 
to a lesser extent, pseudolymphomatous and lichenoid reactions. 46-50 In the study cited 
earlier, histopathology included sarcoid granuloma, ‘inflammation’ and granulomatous 
inflammation.5 However, they did not define the term ‘inflammation’ or elaborate on 
the type of inflammation. Furthermore, cutaneous sarcoidosis was diagnosed in 11% 
of these black tattoo reactions. In my opinion and according to current practice and 
guidelines, it is debatable whether the diagnosis sarcoidosis can be made solely on tattoo 
related dermatological clinical findings and a skin biopsy. Namely, the histopathology of 
a foreign body reaction and cutaneous sarcoidosis can be similar.51-53 In addition, a tattoo 
pigment is a foreign body per definition. Furthermore, for the diagnosis of sarcoidosis, 
the presence of multiorgan involvement enhances the diagnostic certainty.54 This study 
also suggests that the non-sarcoidosis reactions are by aetiology foreign body reactions. It 
suggested that these reactions are elicited by the tendency of carbon black nanoparticles 
to agglomerate, forming large clusters of black pigments resulting in a foreign body 
reactions, although this is still dependent on individual predisposition.5 While pigment 
agglomeration was found in patients with sarcoidosis and tattoo reactions, no comparison 
was made with uncomplicated black tattoos in healthy individuals.55 Furthermore, 
the formation of pigment agglomeration might be due to the inflammation itself, caused 
by sarcoidosis.
Further histological studies should be performed for assessment of the inflammatory 
patterns and cells involved in chronic black tattoo reactions. Preferably, this histopathology 
should be combined with a long-term follow-up with repetitive screening on sarcoidosis. 
It would be interesting to see whether the presence of non-sarcoidal granulomas in a skin 
biopsy can be in found in patients with systemic sarcoidosis presenting with symptomatic 
nodules in the tattooed skin. 
2) Allergy
An allergic pathomechanism is thought to be unlikely, as the main pigment used in black 
tattoo ink, ‘Carbon black’, is inert. Carbon itself has never been reported as an active 
allergen in the medical literature.5 Furthermore, except one case-report, no positive 
patch test results have been reported in the literature in patients with chronic black tattoo 
reactions. 56 Some authors even suggest that allergies to black tattoo pigments are non-
existing. On the other hand, no large patch test studies have been performed in patients 
with these reactions, so evidence is lacking. An immunological mechanism is likely to play 
a role. This is supported by an interesting case report describing a patient with a recurrent 
papulo-nodular black tattoo reactions that disappeared within a weeks after surgical 
removal of metal osteosynthesis implants from his spine.57 Patch testing with extracts 




Nickel, chromium, titanium and aluminum were detected in both the tattooed skin 
biopsy and the implants. These findings suggest that the pigments could play a role in 
the pathogenesis of black tattoo reactions. Moreover, cases of cutaneous sarcoidosis 
restricted to one tattoo colour are reported and therefore raise the question whether 
these reactions are aetiologically a sarcoidal hypersensitivity reaction to a specific tattoo 
pigment or ink additive, or the first manifestation of a systemic disease. 
Till today, the exact pathomechanism of chronic inflammatory black tattoo reactions 
is unknown. It may be a delayed type hypersensitivity reaction or a manifestation of 
sarcoidosis. One could even further debate whether there is a difference between 
sarcoidosis and a granulomatous hypersensitivity reaction to a specific agent. On the other 
hand, there might be distinct diagnoses involved in these chronic black tattoo reactions.
In my opinion, it is indeed possible that black tattoo pigments can elicit an inflammatory 
response. However, the inflammatory response may depend on the individual (genetic) 
predisposition. Different environmental factors may be involved, such as targeted therapies 
and immune checkpoint inhibitors used for advanced cancers. These drugs are known to 
elicit black tattoo reactions.58 These new therapeutic modalities are expected to be used 
more frequently in the future and as a consequence, adverse reactions in tattoos might be 
seen more often. In addition, these immunomodulatory therapies might also shed light on 
underlying immunological pathomechanisms.
Treatment of black tattoo reactions
Except for a few case-reports, no studies have been published regarding the treatment 
of chronic black tattoo reactions.48,59 If sarcoidosis is diagnosed, corticosteroids, 
hydroxychloroquine and methotrexate can be considered as treatment options.60,61 
However, adequate controlled trials of these therapies are lacking.62 In tattoo-associated 
uveitis, the advantage of systemic treatment is that multiple affected organs can 
be treated with one drug. Methotrexate, as discussed in chapter 9 A, is a possible 
treatment option. Other reported treatment options include systemic corticosteroids and 
mycophenolate mofetil.41
Concerning the non-sarcoidosis black tattoo reactions, it is stated that these reactions 
are generally self-limiting and topical or intralesional corticosteroids are generally 
sufficient.63 This is also our experience in the Academic Tattoo Clinic Amsterdam. The self-
limiting aspect supports the theory that pigment concentration might be involved in 
these reactions. 
Based on our experience and the weak evidence from clinical studies, local 
corticosteroids are the first therapy of choice in both the sarcoidosis and non-sarcoidosis 
chronic black tattoo reactions. In case of insufficient effect, the second choice is intralesional 
corticosteroids, followed by hydroxychloroquine and methotrexate. However, the choice 






Tattoos are a popular form of body art with a great variety of potential complications. 
To date, little research has been performed. Allergic red tattoo reactions and chronic 
inflammatory black tattoo reactions are the most frequent chronic tattoo complications. 
Red tattoo reactions are likely to be a delayed type allergic reaction and UV exposure 
seems to play a role. The culprit allergens are still unknown, but azo pigments may be 
involved. Further research should be performed by patch testing and photo-patchtesting 
with the potential causative allergens, including all ingredients and breakdown products of 
the pigments in the tattoo inks. Treatment options with permanent effect include CO2 laser 
ablation, dermatome shaving and surgical excision. Other treatment options should be 
studied for less invasive and safe removal with less downtime and better cosmetic outcomes. 
Chronic black tattoo reactions are an important marker for sarcoidosis, and therefore 
screening should be performed. However, the majority of these chronic inflammatory 
black tattoo reactions are non-sarcoidosis and their exact etiology remains unknown. 
In my opinion, despite all potential complications mentioned in this thesis, we should 
not be fundamentally opposed to tattoos. In fact, tattoos can be beneficial and even 
have several medical purposes as well. Furthermore, in my experience, tattoos can bring 
‘joy’ in the life of people and may contribute to the self-esteem and body image.64-66 
For the future, the development of a ‘hypoallergenic’ tattoo ink would be interesting and 
potential beneficial to all involved in the tattoo industry. In any case, clients always should 





1. NOS. Speciale tattoopoli voor pijnlijke probleemtatoeages. Hilversum, Netherlands: NOS; 
2017 Jan 13. Retrieved from https://nos.nl/artikel/2152776-speciale-tattoopoli-voor-
pijnlijke-probleemtatoeages.html. Accessed January 13, 2018.
2. Boersma EA. Tattoopoli gaat pijnlijke tatoeages verwijderen. Amsterdam, Netherlands: De 
Volkskrant; 2017 Jan 13. Retrieved from https://www.volkskrant.nl/nieuws-achtergrond/
tattoopoli-gaat-pijnlijke-tatoeages-verwijderen~b4aa2c12/. Accessed January 13, 2018.
3. Kluger N, Descamps V. Usefulness of a specialized « tattoo » consultation in a tertiary care 
hospital: a one-year experience. J Eur Acad Dermatol Venereol. 2019;33(4):e182-e183. 
doi:10.1111/jdv.15435
4. Serup J, Sepehri M, Hutton Carlsen K. Classification of Tattoo Complications in 
a Hospital Material of 493 Adverse Events. Dermatology. 2016;232(6):668-678. 
doi:10.1159/000452148
5. Sepehri M, Hutton Carlsen K, Serup J. Papulo-Nodular Reactions in Black Tattoos as 
Markers of Sarcoidosis: Study of 92 Tattoo Reactions from a Hospital Material. Dermatology. 
2016;232(6):679-686. doi:10.1159/000453315
6. Carlsen KH, Serup J. Chronic tattoo reactions cause reduced quality of life equaling 
cumbersome skin diseases. Curr Probl Dermatol. 2015;48:71-75. doi:10.1159/000369644
7. Mukkanna KS, Stone NM, Ingram JR. Para-phenylenediamine allergy: current perspectives 
on diagnosis and management. J Asthma Allergy. 2017;10:9-15. Published 2017 Jan 18. 
doi:10.2147/JAA.S90265
8. Watkins SA, Maibach HI. The hardening phenomenon in irritant contact dermatitis: an interpretative 
update. Contact Dermatitis. 2009;60(3):123-130. doi:10.1111/j.1600-0536.2009.01507.x
9. Hutton Carlsen K, Serup J. Photosensitivity and photodynamic events in black, red and 
blue tattoos are common: A ‘Beach Study’. J Eur Acad Dermatol Venereol. 2014;28(2):231-
237. doi:10.1111/jdv.12093
10. Sowden JM, Cartwright PH, Smith AG, Hiley C, Slater DN. Sarcoidosis presenting with 
a granulomatous reaction confined to red tattoos. Clin Exp Dermatol. 1992;17(6):446-448. 
doi:10.1111/j.1365-2230.1992.tb00257.x
11. Kluger N. Sarcoidosis on tattoos: a review of the literature from 1939 to 2011. Sarcoidosis 
Vasc Diffuse Lung Dis. 2013;30(2):86-102. Published 2013 Aug 1.
12. van der Bent SAS, Berg T, Karst U, Sperling M, Rustemeyer T. Allergic reaction to 
a green tattoo with nickel as a possible allergen. Contact Dermatitis. 2019;81(1):64-66. 
doi:10.1111/cod.13226
13. Hutton Carlsen K, Køcks M, Sepehri M, Serup J. Allergic reactions in red tattoos: Raman 
spectroscopy for ‘fingerprint’ detection of chemical risk spectra in tattooed skin and culprit 
tattoo inks. Skin Res Technol. 2016;22(4):460-469. doi:10.1111/srt.12287
14. Schreiver I, Hesse B, Seim C, et al. Synchrotron-based ν-XRF mapping and μ-FTIR 
microscopy enable to look into the fate and effects of tattoo pigments in human skin. Sci 
Rep. 2017;7(1):11395. Published 2017 Sep 12. doi:10.1038/s41598-017-11721-z
15. Serup J, Hutton Carlsen K, Dommershausen N, et al. Identification of pigments related to 
allergic tattoo reactions in 104 human skin biopsies. Contact Dermatitis. 2020;82(2):73-82. 
doi:10.1111/cod.13423
16. Malki S, Onnis G, Lissia A, Montesu MA, Satta R. Cutaneous T pseudolymphoma on the red 




17. Haber R, Farid S. Réaction granulomateuse confinée à l’encre rouge de tatouage 
[Granulomatous tattoo reaction confined to red pigment]. Ann Dermatol Venereol. 
2016;143(1):79-80. doi:10.1016/j.annder.2015.09.001
18. Taaffe A, Knight AG, Marks R. Lichenoid tattoo hypersensitivity. Br Med J. 1978;1(6113):616-
618. doi:10.1136/bmj.1.6113.616
19. Thum CK, Biswas A. Inflammatory complications related to tattooing: a histopathological 
approach based on pattern analysis. Am J Dermatopathol. 2015;37(1):54-66. 
doi:10.1097/DAD.0b013e3182974558
20. Shinohara MM, Nguyen J, Gardner J, Rosenbach M, Elenitsas R. The histopathologic 
spectrum of decorative tattoo complications. J Cutan Pathol. 2012;39(12):1110-1118. 
doi:10.1111/cup.12023
21. Høgsberg T, Thomsen BM, Serup J. Histopathology and immune histochemistry of red 
tattoo reactions. Interface dermatitis is the lead pathology, with increase in T-lymphocytes 
and Langerhans cells suggesting an allergic pathomechanism. Skin Res Technol. 
2015;21(4):449-458. doi:10.1111/srt.12213
22. Uzzaman A, Cho SH. Chapter 28: Classification of hypersensitivity reactions. Allergy 
Asthma Proc. 2012;33 Suppl 1:96-99. doi:10.2500/aap.2012.33.3561
23. 23. Nederlandse Voedsel- en Warenautoriteit. Resultaten onderzoek van kleurstoffen voor 
tatoeages en permanente make-up in de periode 2008-2013. Utrecht: NVWA; 2014, 16 p.
24. Bhardwaj SS, Brodell RT, Taylor JS. Red tattoo reactions. Contact Dermatitis. 2003;48(4):236-
237. doi:10.1034/j.1600-0536.2003.00090.x
25. Laux P, Tralau T, Tentschert J, et al. A medical-toxicological view of tattooing. Lancet. 
2016;387(10016):395-402. doi:10.1016/S0140-6736(15)60215-X
26. Serup J, Hutton Carlsen K. Patch test study of 90 patients with tattoo reactions: negative 
outcome of allergy patch test to baseline batteries and culprit inks suggests allergen(s) 
are generated in the skin through haptenization. Contact Dermatitis. 2014;71(5):255-263. 
doi:10.1111/cod.12271
27. Engel E, Spannberger A, Vasold R, König B, Landthaler M, Bäumler W. Photochemical 
cleavage of a tattoo pigment by UVB radiation or natural sunlight. J Dtsch Dermatol Ges. 
2007;5(7):583-589. doi:10.1111/j.1610-0387.2007.06333.x
28. Ashinoff R, Levine VJ, Soter NA. Allergic reactions to tattoo pigment after laser treatment. 
Dermatol Surg. 1995;21(4):291-294. doi:10.1111/j.1524-4725.1995.tb00175.x
29. Sepehri M, Jørgensen B, Serup J. Introduction of dermatome shaving as first line treatment of chronic 
tattoo reactions. J Dermatolog Treat. 2015;26(5):451-455. doi:10.3109/09546634.2014.999021
30. Millán-Cayetano JF, Alegre-Sánchez A, Boixeda P. Treatment of red tattoo reaction using 
CO2 laser. Lasers Med Sci. 2018;33(5):1171-1173. doi:10.1007/s10103-017-2229-3
31. Forbat E, Al-Niaimi F. Patterns of Reactions to Red Pigment Tattoo and Treatment Methods. 
Dermatol Ther (Heidelb). 2016;6(1):13-23. doi:10.1007/s13555-016-0104-y
32. van der Bent SAS, Maijer KI, Rustemeyer T. Image Gallery: Hyperkeratotic hypersensitivity 
reaction to red pigment tattoo. Br J Dermatol. 2017;177(6):e350. doi:10.1111/bjd.16040
33. Kluger N. Eruptive milia and acneiform hyperkeratosis with comedones (pseudo-epidermal 
cysts) within tattoos. Ann Dermatol Venereol. 2019;146(12):801-806. doi:10.1016/j.
annder.2019.01.026
34. Wambier CG, Cappel MA, Wambier SPF. Treatment of reaction to red tattoo ink with intralesional 




35. Prinz BM, Vavricka SR, Graf P, Burg G, Dummer R. Efficacy of laser treatment of tattoos 
using lasers emitting wavelengths of 532 nm, 755 nm and 1064 nm. Br J Dermatol. 
2004;150(2):245-251. doi:10.1111/j.1365-2133.2004.05658.x
36. England RW, Vogel P, Hagan L. Immediate cutaneous hypersensitivity after treatment of 
tattoo with Nd:YAG laser: a case report and review of the literature. Ann Allergy Asthma 
Immunol. 2002;89(2):215-217. doi:10.1016/S1081-1206(10)61942-4
37. Harper J, Losch AE, Otto SG, Zirwas M, Delaney KO, Wakelin JK 3rd. New insight into 
the pathophysiology of tattoo reactions following laser tattoo removal. Plast Reconstr 
Surg. 2010;126(6):313e-314e. doi:10.1097/PRS.0b013e3181f63fde
38. Ashinoff R, Levine VJ, Soter NA. Allergic reactions to tattoo pigment after laser treatment. 
Dermatol Surg. 1995;21(4):291-294. doi:10.1111/j.1524-4725.1995.tb00175.x
39. Yorulmaz A, Onan DT, Artuz F, Gunes R. A case of generalized allergic contact dermatitis after laser 
tattoo removal. Cutan Ocul Toxicol. 2015;34(3):234-236. doi:10.3109/15569527.2014.933972
40. van der Bent SA, Wolkerstorfer A, Rustemeyer T. Huidafwijkingen bij tatoeages 
[Extended abstractCutaneous Adverse Reactions to Tattoos]. Ned Tijdschr 
Geneeskd. 2016;160:A9808.
41. Kluger N. Tattoo-associated uveitis with or without systemic sarcoidosis: a comparative 
review of the literature. J Eur Acad Dermatol Venereol. 2018;32(11):1852-1861. 
doi:10.1111/jdv.15070
42. Soto-Gomez N, Peters JI, Nambiar AM. Diagnosis and Management of Sarcoidosis. Am 
Fam Physician. 2016;93(10):840-848.
43. Grodner C, Beauchet A, Fougerousse AC, et al. Tattoo complications in treated and non-treated 
psoriatic patients. J Eur Acad Dermatol Venereol. 2020;34(4):888-896. doi:10.1111/jdv.15975
44. Sabio JM, Betolaza S, Vargas-Hitos JA. Characteristics and safety of tattoos in 
patients with systemic lupus erythematosus. Lupus. 2019;28(10):1250-1254. 
doi:10.1177/0961203319867395
45. Ali MM, Atwan AA, Gonzalez ML. Cutaneous sarcoidosis: updates in the pathogenesis. J 
Eur Acad Dermatol Venereol. 2010;24(7):747-755. doi:10.1111/j.1468-3083.2009.03517.x
46. Brown H, Hannaford R. Recurrent lichenoid reaction to black tattoo ink: A case report and brief 
review of the literature. Australas J Dermatol. 2020;61(2):e238-e240. doi:10.1111/ajd.13231
47. Campolmi P, Bassi A, Bonan P, et al. Cutaneous pseudolymphoma localized to black tattoo. 
J Am Acad Dermatol. 2011;65(5):e155-e157. doi:10.1016/j.jaad.2011.06.039
48. Morales-Callaghan AM Jr, Aguilar-Bernier M Jr, Martínez-García G, Miranda-Romero A. 
Sarcoid granuloma on black tattoo. J Am Acad Dermatol. 2006;55(5 Suppl):S71-S73. 
doi:10.1016/j.jaad.2005.12.022
49. Valbuena MC, Franco VE, Sánchez L, Jiménez HD. Sarcoidal granulomatous reaction 
due to tattoos: report of two cases. An Bras Dermatol. 2017;92(5 Suppl 1):138-141. 
doi:10.1590/abd1806-4841.20175860
50. Ghorpade A. Inoculation sarcoidal granulomas on blue-black tattoos in seven ladies. J 
Eur Acad Dermatol Venereol. 2006;20(3):349-350. doi:10.1111/j.1468-3083.2006.01410.x
51. Schewach-Millet M, Ziv R, Trau H, Zwas ST, Ronnen M, Rubinstein I. Sarcoidosis versus foreign-
body granulomas. Int J Dermatol. 1987;26(9):582-585. doi:10.1111/j.1365-4362.1987.tb02310.x
52. Tukenmez Demirci G, Mansur AT, Yıldız S, Güleç AT. Is it a sarcoidal foreign-body granuloma 





53. Scofield-Kaplan SM, Patel SY, Mueller A, et al. Foreign-Body Granulomata Caused by 
Injected Permanent Filler Masquerading as Cutaneous Sarcoidosis. Ophthalmic Plast 
Reconstr Surg. 2019;35(3):e82-e84. doi:10.1097/IOP.0000000000001385
54. Bickett AN, Lower EE, Baughman RP. Sarcoidosis Diagnostic Score: A Systematic Evaluation to Enhance 
the Diagnosis of Sarcoidosis. Chest. 2018;154(5):1052-1060. doi:10.1016/j.chest.2018.05.003
55. Hutton Carlsen K, Larsen G, Serup J. Tattoo pigment agglomerates measured in skin 
biopsies by computerised light microscopy: Study of 161 patients with adverse reactions 
in black and red tattoos. Skin Res Technol. 2020;26(2):284-291. doi:10.1111/srt.12798
56. Gallo R, Parodi A, Cozzani E, Guarrera M. Allergic reaction to India ink in a black tattoo. 
Contact Dermatitis. 1998;38(6):346-347. doi:10.1111/j.1600-0536.1998.tb05779.x
57. de Cuyper C, Lodewick E, Schreiver I, et al. Are metals involved in tattoo-related 
hypersensitivity reactions? A case report. Contact Dermatitis. 2017;77(6):397-405. 
doi:10.1111/cod.12862
58. Kluger N. Tattoo Reactions Associated with Targeted Therapies and Immune Checkpoint 
Inhibitors for Advanced Cancers: A Brief Review. Dermatology. 2019;235(6):522-524. 
doi:10.1159/000501590
59. Sheu J, Saavedra AP, Mostaghimi A. Rapid response of tattoo-associated cutaneous 
sarcoidosis to minocycline: case report and review of the literature. Dermatol Online J. 
2014;20(8):13030/qt6dd1m2j9. Published 2014 Aug 17.
60. Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review 
and update for the dermatologist: part I. Cutaneous disease. J Am Acad Dermatol. 
2012;66(5):699.e1-718. doi:10.1016/j.jaad.2011.11.965
61. Doherty CB, Rosen T. Evidence-based therapy for cutaneous sarcoidosis. Drugs. 
2008;68(10):1361-1383. doi:10.2165/00003495-200868100-00003
62. Baughman RP, Lower EE. Evidence-based therapy for cutaneous sarcoidosis. Clin Dermatol. 
2007;25(3):334-340. doi:10.1016/j.clindermatol.2007.03.011
63. Serup J, Carlsen KH, Sepehri M. Tattoo complaints and complications: diagnosis and 
clinical spectrum. Curr Probl Dermatol. 2015;48:48-60. doi:10.1159/000369645
64. Kluger N. Tattooing and psoriasis: demographics, motivations and attitudes, complications, 
and impact on body image in a series of 90 Finnish patients. Acta Dermatovenerol Alp 
Pannonica Adriat. 2017;26(2):29-32. doi:10.15570/actaapa.2017.9
65. Braverman S: One in Five U.S. Adults Now Has a Tattoo. New York, NY, Harris Polls, 
2012. Retrieved from http://www.harrisinteractive.com/NewsRoom/HarrisPolls/tabid/447/
mid/1508/articleId/970/ctl/ReadCustom%20Default/Default.aspx. Accessed April 22, 2014.
66. Swami V. Marked for life? A prospective study of tattoos on appearance anxiety and 




GENErAL SUMMArY / 
ALGEMENE SAMENVATTING
Sebastiaan A.S. van der Bent





Tattoos are a popular form of body art. In Europa and the USA, the prevalence varies 
between 10-20%. The number and sort of usages of tattoos are rising. Despite its popularity, 
little is known about tattoo complications and its clinical aspects, pathomechanism 
and treatment. 
In the General introduction an overview of cutaneous tattoo complications is 
presented. These complications can be divided in infectious, inflammatory, neoplastic 
and miscellaneous complications. Infections are mainly superficial and of bacterial origin. 
Inflammatory complications include allergic reactions and auto-immune skin diseases. 
Of all allergic reactions to tattoo pigments, red pigments are most frequently involved. 
Auto-immune skin disease that may be related to tattoos include psoriasis, lichen planus, 
sarcoidosis, vitiligo and lupus erythematosus. They may be locally triggered by the procedure 
of tattooing which is referred to as Köbner phenomenon. Not rarely, the affected tattooed 
skin is the first manifestation of a systemic autoimmune disease. Although tattoo ink is 
thought to contain potential carcinogenic substances, the association between tattoos 
and skin cancer is interpreted to be coincidental because of the low reported number of 
cases. Miscellaneous complications include misapplication, pigment changes, blow-outs, 
neurosensory reactions, scars and keloids. 
Of all chronic tattoo reactions, red tattoo reactions are the most frequent. Chapter 2 
includes the clinical aspects of red tattoo reactions: chronic itch, pain or swelling affecting 
one or more tattoos and restricted to red or nuances of red. In a prospective study in 
the Academic Tattoo Clinic Amsterdam, clinical information of 101 patients with a red 
tattoo reaction was collected during four years. This study revealed that the mean time of 
onset of symptoms is 12 months. Clinically, a plaque type reaction was observed in 92%, 
a hyperkeratotic reaction in 3% and an ulcero-necrotic pattern in 5%. A high percentage of 
reactions was located on sun-exposed areas; the distal extremities and face accounted for 
83%. Symptoms worsened after sun exposure in 32%. Although the exact pathomechanism 
is unknown, these clinical aspects indicate a delayed allergic reaction and a potential role 
for sunlight in forming the allergen.
In Chapter 3 the prevalence of tattoos and associated adverse events in sarcoidosis 
patients is studies. The demand of tattoos is high, also under patients with auto-immune 
diseases. However, little is known about the percentage of adverse events in sarcoidosis 
patients as no previous studies have been performed. A multicentre cross-sectional study 
was conducted, using an online survey amongst sarcoidosis patients. Of all eligible patients 
who completely filled in the questionnaire, 22.2% reported to have a tattoo. Of these, 
21.3% experienced adverse events, mainly in black tattoos (90%). Papules and nodules 
were reported in 70%. For reasons still unknown, darker skin types were associated with 
the risk of adverse events in tattoos. 
Chapter 4 concerns a case-series of 5 patients with a granulomatous reaction to 




yellowish plaques in the cosmetic tattoo. Remarkably, these patients had 2 to 15 sessions 
of tattooing before developing adverse reactions. Time of onset of symptoms varied 
between 1 and 18 months. Differentiation between sarcoidosis, a foreign body reaction 
or allergic tattoo reaction is difficult, as all these diagnoses can histologically present as 
a granulomatous inflammation. In 1 of the 5 patients, systemic sarcoidosis was diagnosed. 
In this case, the affected tattoo was the first manifestation of the disease. Furthermore, we 
suggest that an association may exist between the number of tattoo sessions and the risk 
for developing a granulomatous reaction.
In Chapter 5 we studied the histopathology of red tattoo reactions. Skin biopsies of 74 
patients with allergic red tattoo reactions were reviewed, focusing on inflammation patterns, 
inflammatory cells and pigments. Thus far, no large studies concerning the histopathology 
of tattoo complications have been performed. The results showed that histiocytes were 
the predominant inflammatory cells in 74.3% of the patients. Remarkably, eosinophils were 
observed in only 8.1%. In 37.9%, the most frequent inflammation pattern, a predominant 
histiocytic reaction with interface dermatitis was detected. Interface involvement itself was 
observed in 64.8%. Moreover, in six cases (8.1%), we were unable to detect any tattoo 
pigment particles microscopically, which is remarkable since the biopsies were taken from 
macroscopically affected tattooed skin. Furthermore, an association was found between 
the severity of inflammation and the depth of the pigment. This could be explained by 
a stronger inflammatory stimulus if pigment depositions are more abundant throughout 
the skin. The large presence of histiocytes could be explained by their role as a major 
component of the innate immune system. Because the red pigment particles were abundant 
throughout all the skin layers, including the basal layer of the epidermis, they may have 
contributed to the interface dermatitis by formation of neo-antigens.  The combination 
of a histiocytic pattern and interface dermatitis may point to a specific immunologically 
mediated red tattoo reaction. Because of the clinical aspects of red tattoo reactions and 
the inflammatory pattern and cells found in this study, we suggest these reactions are most 
likely a combination of a subtype IVa and IVc delayed hypersensitivity reaction.
Chapter 6 concerns the comparison of the skin sensitization potential of 3 red and 2 
black tattoo inks using interleukin-18 as a biomarker in a reconstructed human skin model. 
In this in vitro study, 3 red and 2 black tattoo inks, 1 additive (Hamamelis virginiana extract) 
and 1 irritant control (lactic acid) were tested. The culture medium of RHS (reconstructed 
epidermis on a fibroblast-populated collagen hydrogel) was supplemented with test 
substances in a dose dependent manner for 24 hours, after which cytotoxicity and skin 
sensitization potential were assessed by histology (thiazolyl blue tetrazolium bromide 
assay) and IL-18 secretion (enzyme-linked immunosorbent assay) respectively. Results: 4 
of 5 tattoo inks showed cytotoxicity. Notably, 1 red ink and 1 black ink were able to cause 
an inflammatory response, indicated by substantial release of IL-18. We concluded that 
the model showed that 4 tattoo inks were cytotoxic (and therefore have irritant properties) 
and 2 were able to cause an inflammatory IL-18 mediated response, indicating that an 
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individual may develop allergic contact dermatitis when exposed to these tattoo inks, as 
they contain contact sensitizers.
In Chapter 7 a feasibility study is performed for using 3D optical imaging in 
the quantification of cutaneous allergic tattoo reactions. User independent measures 
of cutaneous allergic reactions can help in management and treatment evaluation of 
cutaneous allergic reactions. The skin surface of allergic tattoo reactions was imaged using 
an optical 3D scanner, measuring elevation, volume and area compared to a reference 
surface. The clinical feasibility of the method was tested in 83 lesions in 17 patients. 
The measurement error was quantified using an arm model and a lesion phantom, 
showing good measurement for lesions with diameters above 2.5 mm and areas smaller 
than 600 mm2. Significant changes in elevation and volume of lesions on arms and legs 
could be measured over time. Therefore, we conclude that quantification of lesions of 
allergic reactions using a 3D optical scanner is feasible and a promising technique for 
the evaluation and quantification of the effectiveness of therapies.
Chapter 8 concerns a retrospective study of ablative CO2 laser therapy of allergic red 
tattoo reactions. Treatment of allergic tattoo reactions is difficult, as tattoo pigments are 
permanently stored in all layers of the dermis. Topical or intralesional corticosteroids are 
indicated as first line treatment but results are frequently insufficient or temporary. Thus 
far, the continuous wave CO2 laser was only studied in six patients with allergic tattoo 
reactions. Even less is known about the efficacy of the fractional CO2laser.
The study was performed by using clinical chart information and a 25-item 
questionnaire concerning symptoms and satisfaction. Sixteen patients were treated, 
either by full surface ablation or fractional ablation. Of these, 15 patients (94%) achieved 
improvement of their symptoms. The vast majority of the full surface ablation group was 
satisfied or very satisfied with the outcome of laser treatment (75%) and would recommend 
this therapy to others (87.5%). Eleven of 16 patients reported scars, however the level of 
inconvenience was low. The advantages of the CO2 laser include the permanent removal 
of the pigments, the possibility of treating more accurately along the borders of the tattoo 
and the coagulation which limits the bleeding during the procedure. We concluded that 
CO2 laser therapy can improve the symptoms of allergic tattoo reactions when topical 
or intralesional corticosteroids are insufficiently effective. Furthermore, other reported 
treatment options are discussed such as conventional full-thickness excision, dermatome 
shaving, allopurinol, hydroxychloroquine and Q-switched laser.
Chapter 9 defines the treatment and course of tattoo complications in specific cases. 
Chapter 9 A describes the treatment of a cutaneous allergic reaction to a red pigment 
tattoo on the lips of a 73-year old patient. The symptoms occurred 1.5 years after her entire 
lips were tattooed. Treatment with hydroxychloroquine 200 mg twice daily was initiated, 
showing clear improvement within 3 months. After 18 months, there was a complete 
remission of all symptoms. Chapter 9 B shows the successful treatment of a granulomatous 
tattoo reaction with associated uveitis in a 52-year-old woman. The clinical presentation 




recurrent uveitis shortly thereafter. No evidence was found for other uveitis-associated 
diseases such as sarcoidosis. The patient was treated with high-dose oral prednisone and 
with methotrexate that led to the simultaneous improvement of the ocular inflammation 
and complete resolution of the skin lesions. Tattoo-associated uveitis is a frequently 
unrecognized entity and its underlying pathophysiology remains unclear. However, it 
has been suggested to be related to a specific granulomatous-delayed hypersensitivity 
reaction to tattoo ink or a specific presentation of sarcoidosis. Chapter 9 C concerns 
a patient with spontaneous resolution of a multidrug-resistant Mycobacterium abscessus 
infection in a tattoo of a 56-year-old immunocompetent man. The presentation included 
multiple erythematosquamous papules and pustules, especially in the black and white 
tattooed skin. Culture of a skin biopsy showed Mycobacterium abscessus. Resistance was 
shown for ciprofloxacin, clarithromycin, co-trimoxazole, doxycycline, imipenem, linezolid 
and moxifloxacin. Remarkable, the patient reported spontaneous clinical improvement. 
After 1.5 months, total clearance of the symptoms and skin manifestation were observed. 
Follow-up 8 months later showed no clinical signs of recurrence of the infection.




De wetenschappelijke inhoud van dit proefschrift is tot stand gekomen tijdens de opleiding 
tot dermatoloog in het Amsterdam UMC. De klinische basis voor al de wetenschappelijke 
werkzaamheden vormden de Tattoo poli die is opgericht op 13 januari 2017 in het 
VU medisch centrum. Naast de reguliere patiëntenzorg konden hierdoor de klinische 
complicaties van tatoeages in kaart worden gebracht en onderzoek worden verricht naar 
pathomechanismen en therapiemodaliteiten, wat uiteindelijk heeft geleid tot nationale en 
internationale samenwerkingen. 
Tatoeages zijn een populaire vorm van body art. De prevalentiecijfers in Europa en 
de VS variëren tussen de 10 en 20%. Het aantal getatoeëerden en de soorten toepassingen 
van tatoeages zijn stijgende. Ondanks de populariteit is weinig bekend over de mogelijke 
complicaties van tatoeages, diens klinische aspecten, pathomechanisme en behandeling.
In de algemene introductie wordt een overzicht gegeven van de dermatologische 
complicaties bij tatoeages. Deze kunnen worden onderverdeeld in infectieus, inflammatoir, 
neoplasma en overige complicaties. De gerapporteerde infecties zijn voornamelijk 
oppervlakkig en van bacteriële origine. Tot de inflammatoire reacties behoren de allergieën 
en auto-immuun huidziekten. Van alle allergische reacties op tattoo pigmenten, zijn de rode 
pigmenten het meest frequent betrokken. Tot de auto-immuun huidziekten behoren onder 
andere psoriasis, lichen planus, sarcoïdose en lupus erythematodes. Deze kunnen een lokale 
opvlamming geven in de getatoeëerde huid door de procedure van het tatoeëren; dit kan 
verklaard worden door het Köbner fenomeen. Niet zelden is de aangedane getatoeëerde 
huid de eerste manifestatie van een (systemische) auto-immuun ziekte. Tatoeage-inkt 
bevat mogelijk potentieel carcinogene stoffen, echter wordt de relatie tussen huidkanker 
en tatoeages als co-incidenteel beschouwd gezien het lage aantal gepubliceerde casus. 
Tot de overige complicaties horen onder andere misapplicatie, pigment veranderingen, 
blow-out, neurosensorische reacties, littekens en keloïd.
Van alle chronische tattoo reacties zijn allergische reacties op rode tattoo pigmenten 
het meest voorkomend. In hoofdstuk 2 worden de klinische aspecten van deze reacties 
besproken: chronische jeuk, pijn of zwelling in één of meer tatoeages, scherp begrensd 
rondom de rood (of diens spectrum) getatoeëerde huid. In een 4 jaar durend prospectief 
onderzoek van de Tattoo poli werden 101 patiënten met een allergische reactie op rode 
tatoeage geïncludeerd. De studie toonde aan dat de tijd voor het ontstaan van klachten 
gemiddeld 12 maanden is. De klinische presentatie was in 92% een ‘plaque-type’ reactie, 
in 3% een hyperkeratotische en in 5% ulceratief. Een hoog percentage van de reacties 
werd gevonden op zon geëxposeerde lichaamsdelen: distale extremiteiten en het gelaat 
(83%). Verergering van de klachten na zonexpositie werd door 32% van de patiënten 
gerapporteerd. Het exacte pathomechanisme van deze reacties is vooralsnog onbekend, 
maar deze klinische bevindingen duiden op een vertraagde allergische reacties en dat 





In hoofdstuk 3 onderzochten we de prevalentie van tatoeages en geassocieerde 
klachten in patiënten met sarcoïdose. Tegenwoordig is er een grote vraag naar tatoeages, 
ook onder patiënten met een auto-immuun ziekte. Er is echter weinig bekend hierover 
aangezien er hierna geen eerdere onderzoeken zijn verricht. Een multicenter cross-
sectioneel onderzoek werd verricht met gebruik van een online vragenlijst onder patiënten 
met sarcoïdose. Van alle geschikte patiënten die de vragenlijst compleet hadden ingevuld, 
had 22.2% een tatoeage. Hiervan gaven 21.3% aan klachten te hebben ervaren van de 
tattoo. In 90% van de gevallen betrof het een zwarte tatoeage en in 70% werden papels 
en nodi gerapporteerd. Een donkere huid was geassocieerd met klachten in de tatoeages, 
de reden hiervoor is nog onbekend.
Hoofdstuk 4 omvat een case-serie van 5 patiënten met een granulomateuze reactie 
op permanente make-up van de wenkbrauwen. Klinisch uitte deze reactie zich in elevatie 
en gelige plaques in de cosmetische tatoeages. Het aantal tattoo sessies varieerde van 
2 tot 15 voordat de klachten zich ontwikkelden. De tijd voor ontstaan van de klachten 
varieerde tussen de 1 en 18 maanden. Diagnostische differentiatie tussen sarcoïdose, 
vreemdlichaamreactie en allergische tattoo reactie is lastig, aangezien al deze diagnosen 
histologisch een granulomateuze reactie kunnen tonen. In één van de vijf patiënten werd 
systemische sarcoïdose gediagnosticeerd, hierbij was de tattoo de eerste manifestatie 
van de aandoening. We opperden dat er mogelijk een associatie bestaat tussen het aantal 
malen tatoeëren en het ontwikkelen van een granulomateuze tattoo reactie. 
In hoofdstuk 5 onderzochten we de histopathologie van allergische reacties op 
rode tatoeages. De huidbiopten van 74 patiënten werden geanalyseerd, gericht op het 
inflammatie patroon, cellen en pigmenten. Tot dusver zijn geen grote studies verricht 
naar de histopathologie bij tattoo complicaties. De resultaten toonden dat histiocyten 
de dominante inflammatoire cellen waren in 74.3%. Eosinofiele granulocyten werden 
geobserveerd in slechts 8.1%. Het meest voorkomende histologische inflammatie patroon 
(37.9%) was een histiocyten dominante inflammatie met een grensvlak ontsteking.  Een 
grensvlakontsteking op zichzelf werd geobserveerd in 64.8%. In 6 casus (8.1%) werden 
microscopisch geen tattoo pigmenten waargenomen. Dit is opmerkelijk aangezien uit 
een macroscopisch aangedane getatoeëerde huid is gebiopteerd. Een associatie werd 
aangetoond tussen de diepte van de tattoo pigmenten en de ernst van de inflammatie. 
De grote aanwezigheid van histiocyten kan verklaard worden door diens grote rol in 
het aangeboren immuunsysteem. Aangezien rode pigmenten aanwezig waren in alle 
huidlagen, inclusief rondom de basale epidermis, is het mogelijk dat deze pigmenten 
hebben bijgedragen aan de vorming van een of meerdere neo-antigenen, resulterend 
in een grensvlakontsteking. De bijzondere combinatie van een dominant histiocytaire 
inflammatie en een grensvlakontsteking duidt mogelijk op een specifiek immuun 
gemedieerde reactie op tattoo pigmenten. Op basis van de klinische aspecten van 
reacties op rode tatoeages en de gevonden inflammatie patronen en cellen in deze studie, 
opperen we dat deze reacties mogelijk een combinatie zijn van een subtype IVa en IVc 
vertraagde overgevoeligheidsreacties. 
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Hoofdstuk 6 omvat de vergelijking van de potentie tot huidsensibilisatie van 3 rode 
en 2 zwarte tattoo inkten door middel van het gebruik van interleukine-18 als biomarker in 
een gereconstrueerd menselijk huidmodel. In deze in vitro studie werden getest: 3 rode en 
2 zwarte tattoo inkten, 1 hulpstof (Hamamelis virginiana extract) en 1 controle irritativum 
(melkzuur). Het kweekmedium van RHS (gereconstrueerde epidermis met fibroblast-
bevattende collageen hydrogel) werd dosisafhankelijk aangevuld met de testsubstanties 
in 24 uur. Hierna werden cytotoxiciteit en potentie tot huidsensibilisatie beoordeeld door 
middel van respectievelijk histologie (Thiazolyl Blue Tetrazolium Bromide-test) en IL-18 
secretie (enzymgebonden immunosorbensbepaling). 
Resultaten: 4 van de 5 tattoo inkten toonden cytotoxiciteit. Tevens toonde 1 rode en 
1 zwarte tattoo inkt een inflammatoire respons, geduid op basis van substantieel secretie 
van IL-18. Op basis van de resultaten van dit model concludeerden we dat 4 tattoo inkten 
cytotoxisch zijn (en derhalve irritatieve eigenschappen hebben) en 2 inkten in staat waren 
om een inflammatoire IL-18 respons te produceren. Dit laatste wijst erop dat een individu 
een contactallergische reactie kan ontwikkelen na expositie aan een van deze tattoo inkten 
omdat deze contact-sensibilisatoren bevatten.
Hoofdstuk 7 is een haalbaarheidsonderzoek voor het gebruik van 3D optische 
beeldvorming in de kwantificering van allergische huidreacties op tatoeages. 
Gebruikersonafhankelijke metingen van cutane allergische reacties kunnen helpen in 
diens beoordeling, management en evaluatie van behandeling. Het huidoppervlak van 
de allergische reacties werd in beeld gebracht door een optische 3D scanner waarbij de 
elevatie, volume en oppervlak werd vergeleken met een referentieoppervlak. De klinische 
haalbaarheid van deze methode werd getest in 83 laesies in 17 patiënten. De meetfout werd 
gekwantificeerd door middel van het gebruik van een arm- en fantoommodel. Dit toonde 
betrouwbare metingen voor laesies met een diameter boven de 2.5 mm en oppervlakten 
kleiner dan 600 mm2. Significante veranderingen in elevatie en volume van laesies van 
extremiteiten konden worden waargenomen. We concludeerden dat de kwantificatie 
van allergische huidreacties haalbaar is en tevens een veelbelovende methode voor de 
evaluatie en kwantificatie van diens behandelingen. 
Hoofdstuk 8 betreft een retrospectief onderzoek naar gebruik van de ablatieve CO2 
laser als behandeling van allergische reacties op rode tatoeages. De behandeling van 
deze reacties is lastig, aangezien de tattoo pigmenten permanent en tot diep in de dermis 
aanwezig zijn. Lokale en intralesionale corticosteroïden zijn de eerstelijnsbehandelingen, 
echter is hierbij het effect vaak tijdelijk of beperkt. Tot dusver was de full surface ablatieve 
laser, bij een allergische tattoo reactie, onderzocht in slechts 6 patiënten.  In het onderzoek 
werd klinische informatie verkregen uit de status en tevens werd gebruik gemaakt van 
een 25-delige vragenlijst wat betreft symptomen en tevredenheid. In totaal werden 16 
patiënten behandeld door middel van full surface of fractionele ablatieve CO2 laser.  Bij 15 
patiënten (94%) werd verbetering van de symptomen waargenomen. Het merendeel van 
de patiënten die behandeld was met de full surface CO2 laser was tevreden tot erg tevreden 




aan anderen (87,5%). Bij 11 van de 16 patiënten werden littekens gerapporteerd, de mate 
van het hieruit voortvloeiende ongemak was echter laag. Voordelen van de CO2 laser 
zijn dat het een permanent, accurate en een niet-bloederige behandeling betreft. We 
concludeerden dat de CO2 laser verbetering kan geven in de klachten bij allergische 
tattoo reacties indien lokale corticosteroïden niet toereikend zijn. Tevens worden 
andere behandelingsmogelijkheden kort belicht in dit hoofdstuk: conventionele excisie, 
dermatome shaving, allopurinol, hydroxychloroquine en de Q-switched laser.
In hoofdstuk 9 wordt de behandeling en beloop van verschillende tattoo complicaties 
in specifieke patiënten besproken. In Hoofdstuk 9 A wordt de behandeling beschreven 
van een 73-jarige patiënte met een contactallergische reactie op een rode tatoeage van 
haar lippen. De klachten ontstonden 1.5 jaar nadat patiënte haar gehele lippen had laten 
tatoeëren. Behandeling met hydroxychloroquine 200 mg 2dd werd gestart waarna de 
klachten verbeterden in 3 maanden. Na 18 maanden werd een complete remissie van 
de huidafwijkingen waargenomen. In hoofdstuk 9 B werd de succesvolle behandeling 
beschreven van een 52-jarige patiënt met een granulomateuze tatoeagereactie met 
geassocieerde uveitis. De klinische presentatie bestond uit het acuut ontstaan van zwelling 
en jeuk in al haar 11 zwarte tatoeages met simultaan een bilaterale recidiverende uveitis. 
Geen aanwijzingen werden gevonden voor andere uveitis-geassocieerde aandoeningen 
zoals sarcoïdose. De behandeling bestond uit hoge dosis prednison oraal en methotrexaat, 
dit leidde tot verbetering van de oog- en huidklachten. Een granulomateuze tatoeagereactie 
met geassocieerde uveitis is een veelal onbekende entiteit en diens onderliggende 
pathomechanisme is nog onbekend. Gesuggereerd wordt dat deze aandoening een 
granulomateuze vertraagde allergische reactie (type IV) op de tatoeage-inkt is of toch 
een uiting in het spectrum van sarcoïdose. In hoofdstuk 9 C wordt de spontane remissie 
beschreven van een multiresistente Mycobacterium abscessus infectie in de tattoo van 
een 56-jarige immuuncompetente man. De klinische presentatie bestond uit multipele 
erythematosquameuze papels en pustels, voornamelijk gelokaliseerd in de zwart en wit 
getatoeëerde huid. Een kweekbiopt toonde Mycobacterium abscessus. Resistentie werd 
gevonden voor ciprofloxacine, clarithromycine, co-trimoxazol, doxycycline, imipenem, 
linezolide and moxifloxacine. Opmerkelijk genoeg werd tussentijds spontane klinische 
verbetering door de patiënt gerapporteerd. Na 1.5 maand werd totaal remissie van 
de huidafwijkingen waargenomen. Follow-up na 8 maanden toonde geen klinische 
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 Nederlandse Vereniging van Huidtherapeuten. Online congres.
2020 De Tattoopoli: kliniek en onderzoek. Wetenschappelijke Vergadering 
 Dermatologie 2020 door het Amsterdam UMC. Online congres. 
2020  Abstract: Identifying Tattoo Pigments in Human Skin Samples with Adverse 
 Reactions Based on Mass Spectral Library Matching and µXRF. C. Brungs, R. 
 Schmid, C. Wolf, S. van Der Bent, U. Karst. 53rd annual conference of the Deutschen 
 Gesellschaft für Massenspektrometrie, Münster, Germany. Postponed due 
 to COVID-19.
2020  Abstract: Identifying Tattoo Pigments in Human Skin Samples with Adverse 
 Reactions Based on Mass Spectral Library Matching and µXRF. C. Brungs, R. 
 Schmid, C. Wolf, S. van Der Bent, U. Karst. ASMS Conference on Mass Spectrometry 
 and Allied Topics, Houston, United States of America.  Postponed due 
 to COVID-19.
2020 Abstract: Tattoo Allergy: Towards a Patch Test Series to Identify Culprit 
 Compounds. 174-T. Rustemeyer, J. Serup,  S. van der Bent, S. Schubert, M. Kaveh, 
 A. Luch, I. Schreiver. European Society of Contact Dermatitis Congress, 
 Amsterdam, The Netherlands. Postponed due to COVID-19.
2020 Complications in tattooing and permanent makeup. Dutch Permanent Makeup 





2020 Tattoo complications. Dermatologie Congres 2020: Arnhem, The Netherlands 
 (oral presentation). Postponed due to COVID-19.
2019 Treatment of allergic tattoo reactions. 28th European Academy of Dermatology 
 and Venereology Congres: Madrid, Spain (oral presentation).
2019 Dermatologic complications in tattoos. Presentation for Master students Medicine 
 at symposium ‘pronkstukken van het VUmc’. VU medisch centrum, Amsterdam.
2019 Abstract:  Treatment of allergic reaction to red tattoos. S. van der Bent, A. 
 Wolkerstorefer, T. Rustemeyer. 4rd European Congress on Tattoo and Pigment 
 (ECTP): Bern, Switserland (oral presentation).
2019  Abstract: Kwantificatie van allergische reacties met 3D optical imaging.  M. den 
 Blanken, S. van der Bent, N. Liberton, M. Hofman, M. Grimbergen,  R. Verdaasdonk, 
 T. Rustemeyer. Jaarlijkse conferentie van de Nederlandse Vereniging voor 
 Klinische Fysica, Woudschoten, The Netherlands.
2018  Abstract: Analysis of tattoo pigments in human skin tissue with µXRF and 
 LDI-MS. C. Brungs, T. Berg, S. van der Bent, M. Sperling,U. Karst. ANAKON, 
 Fachgruppe Analytische Chemie in der Gesellschaft Deutscher Chemiker, 
 Münster, Germany.
2018  Abstract: Determination of the skin sensitization potency of red and black tattoo 
 inks using human reconstructed skin and IL-18. W. Bil, S.A.S. van der Bent, S.W. 
 Spiekstraa, K. Nazmib, T. Rustemeyer S. Gibbs.54th Congress of the European 
 Societies of Toxicology (EUROTOX 2018), Brussels, Belgium.
2017 Dermatologic complications in tattoos. Presentation for Master students Medicine 
 at symposium ‘pronkstukken van het VUmc’ . VU medisch centrum, Amsterdam. 
2017 Abstract: Allergic reaction to red pigment tattoos and treatment methods. S. van 
 der Bent, A. Wolkerstorefer, T. Rustemeyer. 3rd European Congress on Tattoo and 
 Pigment (ECTP): Regensburg, Germany (oral presentation).
2017 “Think before you ink: complications in tattoos”. Course for Dutch Dermatologists 
 at Eilanddagen, Schiermonnikoog, The Netherlands (oral presentation).
2015 Abstract: Cutaneous allergic reactions to red dye in tattoos. S. van der Bent, A. 
 Wolkerstorefer, T. Rustemeyer. 2rd European Congress on Tattoo and Pigment 
 (ECTP): Brugge, Belgium (poster presentation).
2015 Training of nurses of the GGD (Community Health Services) visiting tattoo shops 
 about adverse events in tattooing (oral presentation), Utrecht, Netherlands.
2014 Population pharmacokinetics and pharmacogenetics of once daily tacrolimus 
 formulation in stable liver transplant recipients. Annual Meeting of American 






2020 Wetenschappelijke Vergadering Dermatologie 2020 (Amsterdam UMC): 
 online conference
2020 46. Deutscher Koloproktologen-Kongress, München, Germany (Postponed due 
 to COVID-19)
2019 European Academy of Dermatology and Venereology 28th Congress:  
 Madrid, Spain
2019 4rd European Congress on Tattoo and Pigment (ECTP): Bern, Switserland
2018 American Academy of Dermatology, San Diego, United States of America
2017 3rd European Congress on Tattoo and Pigment (ECTP): Regensburg, Germany
2015 2rd European Congress on Tattoo and Pigment (ECTP): Brugge, Belgium
2014 Annual Meeting of American  Society for Clinical Pharmacology and Therapeutics, 
 Atlanta, Georgia, United States of America
Teaching
2019 Ellen Oyen, scientific internship, Master student Medicine MUMC
2018 Marloes Engel, scientific internship, Master student Medicine VUmc
2018 Mark den Blanken, scientific internship VUmc, resident Clinical Physics
2017 Sanne Huisman, scientific internship, Master student Medicine VUmc
2016 Daan Rauwerdrink, extracurricular research project, Master student   
 Medicine LUMC
2016 Wieneke Bil, scientific internship, Master student Toxicology UMCU
2016  Tess Heijs, scientific internship, Bachelor student Medicine VUmc
2016  Ruben de Winter,  scientific internship, Master student Medicine VUmc
Awards
2018  Dutch (resident) Dermatology award (JONGE LEEUW Dermatologieprijs): prize 
 for ‘resident dermatology of the year’, annually awarded (nominated by colleagues) 
 in the Netherlands, as a result of exceptional or innovative initiatives 
 or performances.
2014 KNAW Van Walree Grant (Royal Netherlands Academy of Arts and Sciences) for 





04/09/2014 Het Parool  GGD luidt noodklok over thuistatoeëerder
12/03/2015 VUmc Magazine  Veilig versieren: Meester-tatoeëerder Henk 
     Schiffmacher en dermatoloog in opleiding 
     Van der Bent slaan handen ineen.
13/01/2017 rTL Editie NL  Tattoo-allergie: vooral rode inkt   
     veroorzaakt klachten
13/01/2017  NOS   Speciale tattoopoli voor   
     pijnlijke probleemtatoeages
13/01/2017  Volkskrant  Tattoopoli gaat pijnlijke tatoeages verwijderen
13/01/2017  De Telegraaf  VUmc opent tattoopoli
13/01/2017 Medisch Contact Dermatologen beginnen tattoopoli
13/01/2017 radio 538, NPO 1 VUmc opent eerste tattoopoli
13/01/2017 Metro   VUmc opent eerste tattoopoli van Nederland
13/01/2017 www.nu.nl  VUmc opent tattoopolikliniek
16/01/2017 AT5   VUmc opent speciale tattoopoli
10/08/2017 Algemeen Dagblad Helft van tattoo-allergieën ontstaat pas lang 
     na zetten
10/08/2017 Social Media*  Tattoo-allergieën ontstaat lange tijd ná 
     het zetten
01/12/2017 HEELdeHUID  Tatoeages en de huid:“Think before you ink” 
     (i.s.m. M. Wintzen)
07/04/2018 Bionieuws  Het geheim van de eeuwige tattoo
21/04/2018 www.scientias.nl Tatoeages: een onschuldige versiering of een  
     bedreiging voor je gezondheid?
01/07/2018 Ned.Tijd. v. Huidzorg Complicaties bij permanente make-up 
29/07/2018 Volkskrant  Onder het mes voor de perfécte wenkbrauw
30/10/2018 Quest   Hoe schadelijk is een tatoeage voor 
     je lichaam?
09/11/2018 Trouw   Is rondreizende tatoeage-inkt schadelijk?
21/12/2018 Boek   ‘Tatoeage en toezicht in Amsterdam’, Hygiëne 
     & Inspectie GGD Amsterdam
13/06/2019 Social Media*  Zeven feitjes over de Tattoopoli
18/07/2019 www.doq.nl  ‘Allergische reactie op rode inkt in tattoo voor 
     overleden kind’
01/08/2019 Medisch Contact Opgezette tatoeage en oogklachten
21/08/2019 www.rtlnieuws.nl In Duitsland mogen alleen artsen straks 
     tattoos weghalen: ‘Het is best ingewikkeld’
02/12/2019 Medisch Contact Blauw verkleurde lymfeklier in de lies (i.s.m. 







10/11/2019 Het Parool  In de tattoopoli:‘De korsten waren zo groot 
     dat ze scheurden’
12/03/2020  De Telegraaf  ‘Laseren voor een prikkie’
01/06/2020 SarcoScoop  Sarcoïdose op de Tattoopoli
01/09/2020 HEELdeHUID  Tattoopoli in Leiden als kenniscentrum
23/10/2020 radar - AVrOTrOS Tattoo verwijderen: hoelang duurt het en wat 
     zijn de kosten?
* Twitter, Facebook, Instagram, LinkedIn, Amsterdam UMC website
Other activities
2017 – 2020   Board member European Society on Tattoo and Pigment Research (ESTP)
2017 – 2020  Reviewer for JEADV, Dermatology, International Journal of Dermatology
2015 – 2020  Consultations by e-mail (info@tattoopoli.nl / tattoo@vumc.nl) or 
  telephone for dermatologists, skin therapists, general practitioners and 





Het bijzondere aan dit proefschrift is dat het vanuit niets is opgebouwd. Het is ooit 
begonnen met een case-report van een patiënt met een tattoo allergie. Dit leidde tot 
verder onderzoek, veel specialistische patiëntenzorg en de oprichting van de Tattoo 
poli, gepaard met landelijke media aandacht. De vele onderzoeksvoorstellen, databases, 
congressen, subsidieaanvragen en artikelen resulteerden uiteindelijk in dit proefschrift. 
In deze lange looptijd zijn ontzettend veel mensen betrokken geweest (meer dan 50!). 
Daarom wil ik hier graag iedereen bedanken die heeft bijgedragen aan of geholpen 
bij de totstandkoming van dit proefschrift. Het onderzoek vergde veel tijd, toewijding 
en inspanning. Echter, de meeste werkzaamheden bestonden uit de reguliere (tattoo) 
patiëntenzorg, het opzetten van de Tattoo poli en het contact met de tatoeëerders en 
media. Al deze niet-gesubsidieerde activiteiten zijn gedaan naast mijn opleiding tot 
dermatoloog, wat resulteerde in soms drukke tijden. Desondanks heb ik dit alles als zeer 
leerzaam en plezierig ervaren. 
What makes this thesis special is that it started from scratch. It all began with a case-
report of a patient with a tattoo allergy. This led to further research, specialised patient 
care and the founding of the Tattoo Clinic resulting in nationwide media coverage. 
Many research proposals, databases, conferences, grant applications and articles finally 
resulted in this thesis. During this period, many people have been involved (more than 
50!). Therefore, I hereby want to thank everyone who has contributed or helped in any 
way realizing this thesis. The research took a lot of time, dedication and effort. However, 
most activities consisted of regular tattoo patient care, founding of the Tattoo Clinic and 
contact with tattoo artists and the media. All these non-funded activities were done before 
and in addition to my fulltime Dermatology residency, resulting in a busy work schedule. 
Nevertheless, I have always experienced it all as very educational and pleasant. 
DANKWOOrD
Het eerste kamerbordje van de Tattoo poli op 13 januari 2017.  
The first room sign of the Tattoo Clinic on January 13th 2017.
Dankwoord 

































Om te beginnen, wil ik graag alle betrokken tatoeëerders en permanente make-up 
artiesten bedanken. In 2014, toen ik werkte in het Albert Schweitzer Ziekenhuis, ben ik 
samen met jullie de eerste onderzoeken begonnen. Jullie open houding, interesse en 
enthousiasme waren, en zijn, ontzettend fijn en inspirerend. De goede contacten met 
o.a. Henk Schiffmacher (Schiffmacher & Veldhoen), Ralph Moelker (Team Tattoo Bob) en 
Anoesh Vroomman (SkinQuip), waardeer ik enorm!
Beste Thomas, promotor, bedankt voor alle mogelijkheden en vrijheid die je me 
hebt gegeven. Je reageerde altijd enthousiast op al mijn ideeën: van patiëntenzorg 
tot het opzetten van de Tattoo poli. Maar vooral: bij jou heb ik aangeklopt met mijn 
onderzoeksvoorstel naar tattoo complicaties. Hierop reageerde jij positief, en dat zal ik 
nooit vergeten. Bedankt voor dit vertrouwen. Onze samenwerking heeft tot mooie dingen 
geleid met in de toekomst mogelijk nog meer. 
Beste Albert Wolkerstorfer, co-promotor, ik ga onze samenwerking erg missen. 
Door jouw kennis er ervaring, als autoriteit op het gebied van laserbehandelingen en 
pigmentaandoeningen, heb ik veel geleerd en vele onderzoeken kunnen realiseren. Je 
bent altijd enthousiast, kritisch en geïnteresseerd geweest in mijn onderzoeken en dat 
heb ik erg gewaardeerd. Soms zelfs zó enthousiast, dat ik na een bespreking vaak met nóg 
meer onderzoek ideeën de deur uit liep dan ik zelf voor mogelijk hield. 
Alle co-auteurs, ik ben jullie erkentelijk voor jullie bijdrage, feedback en 
prettige samenwerking.
Geachte leden van de lees- en promotiecommissie, hartelijk dank voor uw deelname 
en het kritisch lezen en beoordelen van het manuscript. I would like to thank you for the 
critical assessment of this manuscript.
Beste Rick Hoekzema, ontzettend bedankt voor mijn fantastische opleidingstijd. 
Als ‘lopende Bolognia’ heb ik enorm veel van u geleerd; niet alleen dermatologisch 




Beste Marjolein, dank voor alle steun, wijze lessen en mogelijkheden die ik heb 
gekregen tijdens mijn opleiding en onderzoeken. Ik heb onze gesprekken altijd als zeer 
waardevol en prettig ervaren.
Alle andere stafleden van het Amsterdam UMC, in het bijzonder Edith de Boer, wil 
ik graag bedanken voor mijn opleidingstijd en het stimuleren van het voltooien van 
mijn onderzoek. Ook de MMA, secretariaat en verpleging van het Amsterdam UMC, 
voornamelijk Marjon, Yvonne, Mariska, Kees en Peter, jullie zijn onmisbaar op de afdeling!
Dear Jørgen Serup, already in 2014 you welcomed me in your Tattoo Clinic in 
Copenhagen. At that time I wasn’t even a dermatology resident. You introduced me to the 
medical world of tattoos, for this I am very grateful to you and I will never forget it. I wish 
to thank all other board members of the ESTP, especially Christa de Cuyper, Marie Leger, 
Nicolas Kluger, Wolfgang Baumler and Thijs Veenstra. Beste Thijs, we hebben elkaar 
ontmoet tijdens een van de eerste congressen van het European Congress on Tattoo and 
Pigment Research (ECTP). Sindsdien werken we ontzettend prettig samen en houden we 
elkaar op de hoogte van ieders vak op het gebied van tatoeëren.
Beste Caroline Arps en Loes Magnin (afdeling communicatie AUMC), onze 
samenwerkingen heb ik altijd als zeer prettig ervaren. Ik vind jullie een ontzettend 
professioneel, leuk, innovatief en enthousiast team. Ik heb enorm veel van jullie geleerd 
wat betreft ‘omgaan’ met de media: NOS, RTL, alle kranten en social media. Niets is jullie 
te groot en jullie zijn altijd enthousiast.
Beste proctologie mentoren, Bart Nanninga, Mente Bousema, Charlotte Molenaar 
en Juan-Carlos Galvis Martinez: hartelijk dank voor alle lessen in dit bijzondere 
vakgebied. Het is een hele andere tak van sport in de dermatologie, maar één met zeer 
dankbare patiënten!
Beste studenten wetenschappelijke stage (inmiddels basisartsen of dermatologen i.o.): 
Ruben de Winter, Sanne Huisman, Marloes Engel, Mark den Blanken, Ellen Oyen, Daan 
Rauwerdink, Tess Heijs, Wieneke Bil: bedankt voor al jullie onmisbare inspanningen. Jullie 
hebben bergen werk verzet, zonder jullie was dit alles niet gelukt. Ik vond het leuk en 
gezellig om met jullie samen te werken.
Alle (oud-)collega AIOS van het Amsterdam UMC (VUmc en AMC), in het bijzonder 
Karen Maijer, Niels Deenen, Darryl Tio, Rosanna Kuin, Dennis Hack, Ellen Hamers, Maryam 
Soltanipoor, Thijs Siegenbeek van Heukelom, Hannah Verhagen en Irene Holtslag: het 
was een enorm leuke opleidingstijd en ik heb er ontzettend van genoten. Alle COCOMs, 
skireizen, borrelavonden, AAD en snijcursus San Diego, weekenden weg en farmacie-
avonden: ze waren geweldig! Er gebeurden altijd bijzondere dingen: sommigen konden 
hun huis niet meer terug vinden, glazen werden rondgegooid of de trap kreeg een kleurtje. 
Gelukkig zijn we er heelhuids vanaf gekomen. Beste Niels, de Rotterdamse blufkikker in 
Amsterdam, het is jammer dat er niet meer kerels (lees boefjes) zoals jij zijn in een AIOS 
groep! Roodkapje team, door de ontelbaar mooie momenten en herinneringen hebben 




Beste Jonathan Kadouch, met jouw kennis en ervaring vanuit de cosmetische 
dermatologie en jouw promotieonderzoek heb je mij enorm geholpen, nogmaals dank 
voor al je adviezen!
Beste dermatologen van het Alrijne Ziekenhuis: Andy Kusuma, Laurence Khoe, Rachel 
Bakkum, Ronald Siphanto, Douwe Vellinga, Pascale Diederen, Clemens van Eijk, Robert 
van Leeuwen, Barbara Bussink en Ines Schornagel: het is een plezier om in deze mooie 
maatschap te mogen werken, bedankt voor de prettige samenwerking! Het is erg fijn dat 
ik alle ruimte heb gekregen om de Tattoo poli te starten in het Alrijne ziekenhuis. Beste 
Ines, wat bijzonder dat wij samen ooit de 1e  tattoo patiënt hebben gezien, wat uiteindelijk 
onverwacht het begin is geweest van dit alles!
Ook alle lieve doktersassistenten en medisch secretaressen van het Alrijne: het is heel 
fijn om met jullie samen te werken op onze afdeling. Veel dank voor de flexibiliteit en 
ondersteuning bij de drukke poli’s na de soms korte nachten.
Boks: harde gasten, Leidsche bekkies, wat hebben we afgelopen jaren veel meegemaakt. 
Van BBA tot BBS, van afstudeerborrels tot O&N, van lippenstift tot emigreren naar 
Indonesië, van BODE tot de Roze Beurs. Ik heb een gevoel dat er nog veel gaat komen. 
Adeodatus, voornamelijk Vincent Verhulst, Boyd Wolffers, Tommy van den Bergh, 
Daniel Rodenburg en Felix Oostindie: jullie hebben totaal niets bijgedragen aan mijn 
promotieonderzoek, eerder tegengewerkt. Na sommige heetclub avonden moest ik soms 
drie dagen herstellen. Desondanks heb ik ervan genoten, waarvoor dank. 
Lieve Wilma, Cocq en Mabel, bedankt voor jullie steun en oprechte interesse. Ook veel 
dank voor de vele (ontspannen) vrijdagavonden: deze worden enorm gewaardeerd. Cocq, 
bedankt voor jouw taalkundige correcties, we drinken er binnenkort weer een ‘grappa’ op!
Beste Jeroen, de Jay, Jiske. Er zijn maar weinig mensen die me midden in de nacht 
mogen wakker bellen. Onze vriendschap is iets unieks. Als (oud-)studie-, huis-, club- en 
dispuutsgenoot, maar voornamelijk vriend kennen wij elkaar door en door en is er vaak 
maar één woord nodig om iets te zeggen. Zoals het hoort bij twee Brabantse boefjes 
zoeken we soms het randje op, met vaak grote hilariteit tot gevolg. We denken vaak 
hetzelfde en kunnen altijd op elkaar rekenen, en dat waardeer ik enorm. Overigens hebben 
we allebei in het verre verleden gezworen dat we nooit onderzoek zouden gaan doen: dat 
is voor beiden niet helemaal gelukt.  
Beste Alexander & Anouk, Jesse & Hannah, bedankt voor jullie steun, interesse, 
afleiding en relativering de afgelopen jaren. Het is fantastisch om te zien hoe onze kids 
met elkaar opgroeien, hopelijk krijgen zij later net zo een goede band als wij.
Alle andere familieleden: dank voor de lieve berichtjes, steun en interesse 
de afgelopen jaren!
Ha die lieve ma. Een betere moeder is er niet. Je bent er altijd. Jij en pa hebben 
me gestimuleerd mijn doelen te bereiken, zo ook hier. Bedankt voor de altijd 
onvoorwaardelijke steun. Het is overigens wel jammer dat ik na een 13-jarige opleiding 




en niet op die babybilletjes moet smeren. Achja, ik hou me maar voor dat zoiets ‘moeder 
eigen is’ en dat het me ‘met beide benen op de grond’ houdt. 
Lieve Gerard, het is ontzettend fijn dat je in ons leven bent gekomen. Je bent een 
enorm lieve man voor ons, en mijn moeder. We vinden je een fantastisch leuke en lieve 
opa, voor ál je kleinkinderen!
Lieve Sharon, Beau & Hugo, wat ontzettend bijzonder en mooi waren de afgelopen 
jaren. Het was soms ook hectisch (o.a. met cashewnootjes), maar jullie waren er altijd 
om mij te helpen relativeren. Jullie zijn dan ook van onschatbare waarde en betekenis 
voor mij. Nu het grootste deel van de promotie achter de rug is, kijk ik uit naar de extra 
tijd die we met elkaar kunnen doorbrengen. Lieve Sharon, zonder jou was dit alles zeker 
niet mogelijk geweest. Ook al is geneeskunde niet jouw ‘vakgebied’, je hebt me altijd 
gestimuleerd en gesteund. En dat vind ik heel lief en bijzonder. Lieve Beau en Hugo, zijn 
jullie de allerliefste en mooiste mannetjes die ik ken. Jullie lach is onbetaalbaar. Lieve 
Beau, je bent nog maar 2,5 jaar oud, maar wat ben ik al ongelofelijk trots op je. Je bent 
sociaal en verbaal ontzettend bedreven. Je weet dan ook altijd iedereen voor je te winnen, 
zo ook mij. Als ik na een 11 uur durende werkdag, hongerig en moe thuis kom en jij met je 
schattige stemmetje direct vraagt “Papa ook treinbaan maken?”, dan ga ik als volwassen 
man gewoon eerst uitgebreid een treinbaan maken.
Lieve pa, uiteraard had jij hier ook bij moeten zijn. Helaas mocht dit niet zo zijn. Ik denk 
dat je dit, maar nog meer de afgelopen jaren, ontzettend mooi had gevonden. 
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